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ABSTRACT  
Preterm delivery is the leading contributor to neonatal death globally, with half of these 
deaths being associated with inflammatory conditions. An immature ability to regulate 
the innate immune response may contribute to the higher rate of morbidity and 
mortality among preterm neonates. Neonates rely on their innate immune response to 
protect them from infection. Toll-like receptors (TLRs) are ubiquitously expressed 
innate immune receptors that signal for pro-inflammatory cytokine transcription. This 
process requires strict regulation at different levels of its intracellular signalling cascade 
to avoid pathological inflammation. MicroRNAs (miRs) are post-transcriptional 
regulators that have been identified as critical regulators of inflammatory gene 
expression. Currently, miR expression is sparsely characterised in the context of 
neonatal TLR signalling. This thesis therefore aimed to examine immune regulation by 
term and preterm neonates through characterising the expression of miRs that regulate 
TLR signalling in placenta and cord blood. 
Cord blood and placenta were collected following term (≥ 37 weeks gestation), late 
preterm (32-36 weeks) and early preterm delivery (≤ 32 weeks), and assessed for 
baseline gene expression (Chapters 3 and 4). Cord blood was cultured and stimulated 
with TLR2, TLR3 and TLR4 agonists, and collected over a 24 hour period (Chapters 5 
and 6). RNA was extracted and the relative expression of genes associated with TLR 
signalling (including select miRs) was quantified using qPCR. Bioinformatics analyses 
were used to determine network-level alterations in inflammatory signalling using 
publicly available microarray data on peripheral blood from neonates with infection 
(Chapter 7).  
There was no difference in the expression of miRs or genes associated with TLR 
signalling in the placenta or cord blood between term and late preterm deliveries. Early 
preterm cord blood showed decreased miR-155 and let-7e expression at birth, and 
demonstrated no change in miR expression following TLR stimulation despite 
increasing the expression of IL6, IL10 and NF-κB1. Term and late preterm cord blood 
also increased IL6 expression, but this occurred alongside increased anti-inflammatory 
let-7e expression. Further, term cord blood increased TNFα and IL6 protein production 
until 6 hours in vitro, while preterm cord blood continued to increase IL6 between 6 and 
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24 hours post-stimulation. Bioinformatics analysis confirmed an upregulation of innate 
immune pathways (including JAK-STAT and Nod-like Receptor signalling) in 
peripheral blood from preterm neonates with infection compared to term neonates with 
infection.  
In summary, our findings demonstrate preterm cord blood is able to mount a robust 
response to TLR stimulation through increasing pro-inflammatory gene expression. As 
this response occurs in the absence of any change in the miRs we measured, we 
postulate that the inflammatory response is dysregulated in preterm neonates. These 
results are the first to suggest differential miR expression alters the neonatal innate 
immune response. As such, in addition to an increased risk of contracting infection, 
preterm neonates may be unable to regulate inflammation effectively. Inappropriate 
inflammatory signalling may therefore underlie preterm neonates’ susceptibility to 
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Preterm delivery is the leading precursor to adverse neonatal health outcomes and 
neonatal deaths2. As the rate of preterm delivery is increasing, prematurity has become 
a focus of WHO millennium development goals to reduce childhood mortality2. 
Approximately 75% of conditions leading to severe morbidity and mortality among 
preterm neonates are associated with inflammation. A better understanding of 
inflammatory processes by preterm neonates is therefore critical. Currently, innate 
immune responses and inflammatory regulation are poorly characterised in preterm 
neonates. This thesis includes a review that explores neonatal innate immune function, 
the potential impact of in utero perturbations on preterm immunity, Toll-like Receptor 
(TLR)-induced inflammation in cord blood and the regulation of these pathways by 
microRNAs (miRs). The reviewed literature explores different factors that may 
influence preterm neonates’ increased susceptibility to inflammatory conditions. 
Following a review of the literature, this thesis presents four experimental chapters that 
characterise the expression of genes associated with TLR signalling following preterm 
delivery. Specifically, the expression of these genes in the placenta (Chapter 3) and cord 
blood (Chapter 4) are characterised at birth, in addition to cord blood serum cytokines. 
Gene expression is also characterised in term and preterm cord blood following TLR 
stimulation in vitro (Chapter 5), including a sub-analysis of gene expression over 24 hours 
following stimulation (Chapter 6). Given the ubiquitous expression and influence of miRs, 
Chapter 7 explores theoretical networks involving TLR signalling in neonates using 
bioinformatics. This thesis concludes with a discussion of main findings in context of their 
broader clinical implications and future avenues for investigation: specifically, the idea that 
preterm neonates are unable to appropriately regulate TLR signalling through miR 
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1.1. PRETERM DELIVERY 
15 million neonates are delivered prematurely (before 37 weeks of gestational age)3 
every year and this rate is increasing3, 4. Premature birth is classified into sub-groups 
according to gestational age at delivery, including: late (32-36 weeks), early (28-32 
weeks) or extremely preterm (<28 weeks)3. Preterm delivery is the leading contributor 
to neonatal deaths, half of which are related to pathological inflammation3. Surviving 
preterm neonates have a significantly increased risk of morbidity, permanent disability 
or death during the neonatal period compared to their term-born counterparts4, 5. This 
places long-term social and financial strain on their families, communities and health 
resources4, 6. The prevention and management of preterm delivery is therefore 
prominently featured in the WHO’s millennium development goal to reduce childhood 
mortality3. 
Preterm delivery is an obstetric syndrome encompassing conditions with varied 
aetiologies7-9. These can include maternal inflammation10-13 and smoking during 
pregnancy14, though, a majority of preterm births are idiopathic7, 8. In developed 
countries such as Australia, preterm delivery affects over 8% of live births15, 16, with a 
greater prevalence amongst the Indigenous population (13.5% of live births)16. The 
increasing incidence of preterm delivery places more neonates at greater risk of 
developing severe inflammatory morbidities. A better understanding of these outcomes 
will facilitate improved clinical management and prevention strategies to reduce the 
burden of preterm delivery on society. 
1.1.1. NEONATAL OUTCOMES FOLLOWING PRETERM DELIVERY 
Despite representing only 1.7% of all deliveries, the management of preterm neonates 
accounts for 30% of all newborn healthcare costs15. Lower gestational age, birthweight, 
male sex, lack of antenatal steroid administration and multiple pregnancy are all 
associated with an increased risk of neonatal death17, 18. While preterm males have a 
higher average birth weight than preterm females19, they have increased rates of 
infection and more severe complications5, 19-21. Males therefore represent 57% of 
admissions into the Neonatal Intensive Care Unit (NICU)5, 15, 16 and are more prone to 
oxygen dependence and Respiratory Distress Syndrome (RDS) throughout the neonatal 
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period10, 19, 20. The adverse impact of preterm birth on long-term health outcomes is also 
well-established and includes higher rates of heart disease, stroke, type 2 diabetes, 
obesity, osteoporosis and neurodevelopmental disorders compared to adults born at 
term gestation22-25. Overall, it is well established that premature delivery predisposes 
the individual to life-long adverse health outcomes.   
Infection is the leading cause of neonatal morbidity and mortality26, with an increased 
risk of severe infection among preterm neonates compared to term27. The most common 
pathogens affecting neonates include Group B Streptococci (GBS), Escherichia coli 
and Staphylococcus aureus28, which all underlie 70% of cases of neonatal sepsis 29. 
Further, neonatal sepsis is associated with 42% of neonatal deaths within the first week 
of life30. Early-onset neonatal sepsis occurs within 72 hours of delivery and is 
associated with in utero insults such as chorioamnionitis31 and funisitis32, while late-
onset neonatal sepsis is associated with nosocomial infection33.  
Preterm neonates are at higher risk of inflammatory morbidities than their term-born 
counterparts, including bronchopulmonary dysplasia (BPD), retinopathy of prematurity 
(ROP), sepsis, cerebral palsy and necrotising enterocolitis (NEC)34. Nosocomial 
infections commonly lead to morbidity due to the frequent exposure of preterm 
neonates to invasive clinical interventions35-37. Lung ventilation, respiratory surfactant 
administration and nasogastric feeding are all common within NICU38 and these 
interventions have been associated with iatrogenic disease including infection and 
hypothermia39. In spite of system immaturity and clinical interventions, not all preterm 
neonates will develop inflammatory morbidities. Underlying mechanisms for this are 
yet to be identified. 
90% of neonates who develop NEC are preterm, with the risk of disease being inversely 
associated with gestational age and birthweight40. The increased prevalence of NEC 
among preterm neonates demonstrates attenuated innate immune barriers and an 
immaturely regulated inflammatory response. NEC involves aberrant inflammation that 
affects the gastrointestinal tract, causing severe haemorrhaging, necrosis41 and in 20% 
of cases, death42, 43. While the cause of NEC is unclear, dysbiosis and gastrointestinal 
immaturity appear to predispose preterm neonates to excessive inflammation in the gut 
(driven by both pathogenic and commensal bacteria)44. At birth, the gut is colonised by 
commensal bacteria, which are not harmful and do not normally elicit an immune 
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response. Typically, gut immune homeostasis develops through tolerance towards these 
commensal bacteria to prevent aberrant and unnecessary inflammation that can cause 
damage to the mucosa (which can lead to NEC). The transition from the in utero 
environment with low bacterial diversity to the high-diversity ex utero environment 
therefore needs to involve appropriate regulation of inflammatory pathways. The 
increased incidence of inflammatory morbidities in preterm neonates suggests that 
rather than having attenuated innate immunity, they exhibit an inappropriate and 
dysregulated inflammatory response. The specific immune events contributing to 
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1.2. THE IMMUNE SYSTEM 
The immune system consists of a network of tissues, cells and mechanisms that protect 
the body from disease. An immune response involves recognising a foreign presence in 
the body, activating defence mechanisms and repairing collateral tissue damage. Each 
of these stages must be tightly regulated so that the response is sufficient to clear a 
pathogen without excessively damaging the host organism. Without regulation, 
immunity can become excessive, self-perpetuating or responsive to non-harmful cues.  
Innate and adaptive immunity drive ‘early’ and ‘late’ response mechanisms, 
respectively. Innate immunity uses evolutionarily-conserved effector mechanisms to 
provide an immediate and generalised response to an antigen. Adaptive immunity 
develops subsequently and is more specific because it forms immunological ‘memory’ 
to an antigen, allowing for a faster response during later encounters with the same 
antigen. During the first two years of life, infants are reliant on their innate immune 
system for protection from pathogens48 as they have yet to develop the immunological 
memory associated with adaptive immune responses.  
1.2.1. INNATE IMMUNITY 
Innate immunity is the first line of defence to a pathogenic presence in the body and 
comprises both passive and active components. Although it does not target specific 
pathogens, innate immunity provides a large-scale and fast-acting response. Its passive 
components can be anatomical or chemical, filtering a majority of immune threats by 
acting as a physical barrier, shedding pathogens or inhibiting pathogen growth. The first 
stage of an innate immune response occurs when an antigen evades these barriers and is 
distinguished from the ‘self’. Antigens are recognised by generalised receptors on 
sentinel innate immune cells such as pattern recognition receptors (PRRs). PRRs are 
structured to recognise evolutionarily-conserved Pathogen Associated Molecular 
Patterns (PAMPs) on microbes or Damage Associated Molecular Patterns (DAMPs) 
expressed by host cells. PAMPs are essential for microbial survival and therefore, have 
minimal variability between different species of microbes. Toll-like Receptors (TLRs) 
are the best studied PRRs, with 11 classes characterised in humans49. When TLRs 
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recognise PAMPs, they initiate a cascade of intracellular signalling that leads to the 
expression of inflammatory mediators.  
Inflammation is an innate immune response to sterile or infectious injury and can be 
localised or systemic. It begins when sentinel immunocytes recognise PAMPS and 
produce cytokines and chemokines to recruit other cells to the site of PRR ligation. The 
chemotaxis of cells to the affected area creates an influx of cytokines, complement 
proteins (that opsonise pathogenic organisms), antimicrobial proteins and chemotactic 
factors. While inflammation can be triggered by different molecular patterns, its 
ultimate goal is to clear antigens.  
TLRs are ubiquitously expressed by innate immune cells including dendritic cells 
(DCs), macrophages and neutrophils. These immunocytes communicate with each other 
through cytokine signalling that occurs following TLR activation. Cytokines can act 
synergistically or antagonistically, and therefore link different stages of the 
inflammatory response. They regulate cellular growth and differentiation, pathogen-
killing and the production of other immune mediators which influence inflammation. 
Different classes of cytokines can be grouped according to their pro- and anti-
inflammatory roles. Interferons (IFNs) are typically expressed during responses to viral 
infection and lead to a cell-mediated or cytotoxic immune response, producing other 
pro-inflammatory cytokines such as Tumor Necrosis Factor-α (TNFα) and Interleukin-
12 (IL12)50. Alternately, anti-inflammatory or tolerogenic cytokines including IL10 and 
Transforming Growth Factor-β (TGFβ) down-regulate inflammatory signalling. The 
overall balance of these different immune mediators leads to either perpetuation or 
resolution of inflammation. 
Neonatal immunity continues to develop gradually following pathogenic exposures at 
birth, beginning with the introduction to maternal vaginal microflora during labour51. 
Exposure to an antigen-rich ex utero environment increases the importance of 
tolerogenic immune mechanisms for the neonate. As such, anti-inflammatory 
cytokines52, 53 and an increased presence of regulatory T cells (Tregs) are observed in 
cord blood and peripheral neonatal blood compared to adult blood54.  
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1.2.1.1. Toll-like Receptors 
TLR activation is a central innate immune response mechanism that also establishes 
antigen presenting cell (APC) and lymphocyte maturation55, 56. Different classes of 
TLRs provide unique patterns of inflammatory protein expression specific to different 
ligands57. Specificity is conferred by TLR dimerisation and networks of signalling 
involving unique combinations of Mitogen Activated Protein kinases (MAPKs), adaptor 
molecules and transcription factors58. TLRs also have some upstream specificity, given 
their capacity to heterodimerise with other classes of receptors. Following TLR ligation, 
an intracellular cascade of protein activation occurs, which allows the development of a 
specific response based on the downstream signalling molecules recruited (Figure 1.1).  
TLR signalling begins with the Toll/IL1-Receptor domain (TIR; common to all TLRs) 
binding one of five cytosolic adaptor proteins; MyD88, TRIF, TRAM, Mal or SARM50, 
59 (Fig. 1.1). All TLR signalling, except for TLR3, can occur via the MyD88-dependent 
pathway55, 60; where MyD88 forms a complex with the Mal adaptor that interacts with 
the TLR’s TIR domain to recruit IRAK4 and IRAK1. TRIF is an adaptor for TLRs 3 
and 4, and results in Interferon (IFN) expression independently of MyD8859. Both TRIF 
and TRAM are able to stimulate NF-κB through an alternate cascade of signalling, 
while also activating Interferon pathways through Interferon Regulatory Factors (IRFs) 
3 and 759. Alternately, the phosphorylation of IRAK1 following MyD88 induction leads 
to independent binding with TNF-Receptor Associated Factor-6 (TRAF6). 
IRAK1/TRAF6 binds the TAK1/TAB1/TAB2 complex and activate three pathways 
through TAK1, which phosphorylate transcription factors p38 and JNK, and the NF-κB 
inhibitor, IKK. In unstimulated immune cells, NF-κB exists in a quiescent state, bound 
to an Inhibitor of κB (IκB) unit61. The degradation of IKK results in the translocation of 
NF-κB into the nucleus, alongside p38 and JNK. Notably, p38 and ERK1/2 activation is 
decreased in term and preterm cord blood compared to adult monocytes following 
TLR2 and TLR4 stimulation35, 62. Overall, TLR signalling leads to the activation of 
MAPKs that translocate transcription factors NF-κB or IRFs into the nucleus that 
induce pro-inflammatory cytokine transcription including IFNs, IL1β, IL6, IL8, IL12 
and TNFα.  
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Figure 1.1. A diagrammatic representation of the TLR signalling pathway. (A) TLR4 forms a 
homodimer and proceeds to signal through both MyD88- and TRIF- dependent pathways when 
ligated by lipopolysaccharide (LPS). (B) TLR2 can heterodimerise with TLR1 or TLR6 and 
signals through the MyD88-dependent pathway following peptidoglycan (PGN) ligation. The 
MyD88-dependent pathway signals through a cascade involving IRAK and TRAF6, followed 
by the translocation of NF-κB or AP-1 into the nucleus to induce pro-inflammatory cytokine 
transcription. (C) An endosome containing the TLR4 homodimer or TLR3 dimer (bound to 
double stranded viral DNA), which can both signal via MyD88-independent or TRIF-dependent 
pathways. TRIF-dependent signalling occurs through the TRIF/TRAF6 cascade and ultimately 
results in the transcription of Interferon inducible genes.   
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1.1.1.1.1. TLR2 
TLR2 can heterodimerise with either TLR1, TLR6 or TLR10 to allow for greater 
specificity in recognising peptidoglycan or lipoprotein components of gram-positive 
bacteria56, 63. In this manner, TLR2 recognises the largest range of ligands in the TLR 
family63. The ligation of either of its heterodimers will result in signalling through 
MyD8860. TLR1/2 is specific to the recognition of tri-acetylated lipopeptides56, 60, while 
TLR2/6 recognises peptidoglycan and zymosan. Gram-positive bacteria maintain a cell 
wall containing peptidoglycan (PGN) and most species are commensal. However, 
Coagulase-negative Staphylococcus (CoNS) is a gram-positive bacterium, and is the 
most common cause of infection in preterm neonates64. Further, 32% of sepsis-related 
mortalities are associated with gram-negative infections, while 90% of neonatal 
septicaemia is caused by CoNS39, 65. 
Alterations in the human tlr2 gene have been linked with susceptibility to 
Staphylococcal infection during sepsis66. This is also demonstrated by TLR2-/- mice, 
which express decreased pro-inflammatory cytokines compared to WT mice following 
exposure to Staphylococci67. Studies on murine neonates have also shown TLR2 
expression by neutrophils is essential for clearing Chlamydia pneumonia infection, 
where TLR2-/- but not TLR4-/- murine neonates demonstrate more severe disease and 
prolonged infection compared to WT neonates68. Together, these studies demonstrate 
the importance of TLR2 in recognising and clearing gram-positive bacteria. 
In humans, cord blood monocytes produce decreased TLR2 and TNFα and show 
decreased phosphorylation of MAPKp38 compared to adult monocytes. This may 
decrease the capacity for monocytic apoptosis during the resolution of inflammation in 
neonates69. Neonatal peripheral blood increases MyD88, TLR2 and TLR4 expression 
following gram-positive and gram-negative infections, but TLR4 and the co-signalling 
molecule MD2 only increase with gram-negative infections70. TLR2 is typically 
upregulated during diseases such as sepsis, which is often polymicrobial, confirming 
that the ability to heterodimerise increases its capacity to recognise a wider range of 
pathogens than any other TLR class60, 71. While the rate of phagocytosis and pathogen 
killing of gram-negative bacteria by cord blood granulocytes is equivalent to that 
observed in adult granulocytes, the same response to whole GBS is impaired in cord 
blood in vitro72. These findings are likely related to an increased incidence of 
contracting these infections and developing neonatal sepsis.  
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1.1.1.1.2. TLR3 
TLR3 exists as a dimer in intracellular endosomal membranes and primarily recognises 
double-stranded viral RNA components. TLR3 heterodimer formation and the 
pleiotropic nature of TLR signalling allows for greater specificity in its downstream 
response. Notably, only TLR3 signals via the TRIF pathway, independently of MyD88. 
Interferon cytokines are characteristic of a Type 1 T-helper (Th1) cytokine response and 
are primarily induced via this signalling pathway. Notably, the TRIF pathway can also 
activate NF-κB through TRAF73, 74. The role of TLR3 is highlighted by TLR3-/- mice 
that cannot respond to viral stimulation with dsRNA or Polyinosinic-polycytidylic acid 
(Poly I:C)75, 76 and therefore, cannot activate Th cells during viral infection77. Cord 
blood mononuclear cells (CBMCs) show neither constitutive TLR3 expression, nor an 
inflammatory response to Poly I:C stimulation in vitro78. This inability to recognise 
viral stimuli may underlie the increased prevalence of viral infection among neonates 
compared to adults. 
1.1.1.1.3. TLR4 
TLR4 is best known for its LPS (or endotoxin) binding-specificity. LPS is a major 
component of gram-negative bacterial outer membranes. TLR4-deficient mice cannot 
respond appropriately to LPS, showing an increased bacterial load during infection and 
a higher rate of mortality compared to WT mice55, 79, 80. Similarly, humans with 
mutations in the TLR4 gene are hypo-responsive to inhaled LPS under experimental 
conditions, demonstrating decreased lung volumes that are characteristic of respiratory 
restriction81. LPS recognition occurs on binding to LPS binding protein (LBP) in the 
serum, followed by CD1455. The co-receptors CD14 and LBP then form a complex with 
LPS at the cell membrane, prior to interacting with a TLR4 molecule homodimer 82. 
The TLR4 homodimer exists as a complex with MD283 and following LPS/co-receptor 
ligation, it proceeds down the MyD88-dependent pathway or is translocated within an 
endosome and signals via the MyD88-independent, TRIF-dependent pathway84. TLR4 
needs to be accompanied by appropriate co-receptors to be activated, as demonstrated 
by studies of TLR4 over-expression in a human kidney nephrocyte cell line, which are 
not responsive to LPS unless MD2 is present63. Blocking CD14 using antibodies 
decreases IL8 expression to a greater extent in term and preterm cord blood compared 
to adults and inhibits IL10 and TNFα expression following LPS stimulation85. This 
suggests IL10 and TNFα expression by neonates requires CD14/TLR4 signalling plus 
_____________________________________________________________________________ 
Chapter One: 
Introduction & Literature Review  Page 43 
CD14 and another TLR. Neonates may therefore require co-stimulation through 
multiple TLRs or co-receptors to achieve the same cytokine response as adults. 
Constitutive expression of CD14 is similar between preterm and term cord blood, but 
following LPS stimulation it is decreased in both preterm and term monocytes 
compared to adults82, 86, 87. In preterm cord blood, decreased CD14, TLR2, TLR4 and 
MD2 expression have all been reversed by incubation with IFNγ in vitro82. Overall, 
impaired viral cytokine pathways may contribute to attenuated TLR responses in 
neonates compared to adults.  
Endotoxin tolerance 
Endotoxin tolerance develops with the repeated ligation of TLR4 by LPS. Aberrant 
activation of the innate immune response or uncontrolled inflammation can lead to 
severe disease states, including septic shock. During sepsis, severe widespread tissue 
damage occurs due to inadequate immune regulation and the potent nature of the 
inflammatory response in the blood stream. Endotoxin tolerance or immune paralysis 
commonly develops during sepsis or severe infection, as the body reaches an immune 
threshold and cannot respond to further inflammatory stimulation79. This state of 
tolerance is characterised by decreased pro-inflammatory cytokine expression, and is 
observed in septic patients88, 89. This process is protective as it limits damage during 
chronic inflammation 79, 90.  
Animals injected with TLR agonists during sepsis demonstrate increased rates of 
survival (compared to those not administered TLR agonists) 91, 92. This phenomenon 
occurs as the body reaches a threshold in inflammatory signalling, which promotes 
tolerance rather than increased inflammation. Similarly, IRAK1-/- mice are unable to 
completely activate TLR signalling and therefore, cannot mount sufficient cytokine 
responses, making them resistant to endotoxic shock90. Studies in animals and human 
cell lines have linked endotoxin tolerance to NF-κB suppression79, 93, 94. This 
suppression occurs independently of TLR4, MyD88, Mal or TRAF6 expression, instead 
increasing IκB as a repressor of NF-κB induction79. The development of tolerance is 
dependent on the timing and dosage of endotoxin exposure, where chronic doses (e.g. 
sub-lethal doses of LPS administered over a longer period of time) result in more 
damage than acute exposures (e.g. one near-lethal dose of LPS)95. Though tolerance 
seems like a protective mechanism that limits excess inflammation, the nature of 
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immune suppression in the neonate can lead to secondary infections and death96. 
Therefore, appropriate pro-inflammatory stimulation is still required to clear the initial 
infection in order to decrease systemic inflammatory signalling. 
In context of the neonate, general immune tolerance is critical in the transition to an 
antigen rich ex utero environment. At birth, the neonatal gut must develop enteric 
tolerance towards newly-established commensal bacteria. Intestinal explants show 
increased macrophage infiltration and decreased expression of the anti-inflammatory 
cytokine, TGFβ in human and murine preterm neonates compared to adults97,98. 
Additionally, fetal intestinal epithelial cells (IECs) exposed to LPS show increased NF-
κB and chemokine expression compared to neonatal and adult cells, although fetal 
macrophages are non-responsive to LPS challenge99. This study suggests that IECs 
remain in a state of LPS tolerance after birth for commensal bacterial colonisation. 
Seminal work by Nanthakumar et al. demonstrates increased NF-κB and MyD88 
pathway gene expression in intestinal samples from aborted fetuses and sectioned 
intestine from preterm neonates with NEC100. This suggests the fetal and preterm 
neonatal intestine show less-mature tolerogenic mechanisms that may predispose them 
to developing conditions such as NEC. 
1.2.2. PHYSIOLOGICAL EXPOSURES DURING PREGNANCY AND THEIR 
IMPACT ON NEONATAL IMMUNITY 
Fetal immune development is influenced by maternal physiology and environmental 
exposures. Studies in primates and rodents have demonstrated that prenatal exposure to 
pathogens attenuates neonatal immune responses during the postnatal period101-104. 
When pregnant rhesus monkeys were exposed to perinatal stress (behavioural startling), 
their cord blood expressed decreased TNFα and IL6 compared to ‘unstressed’ 
controls105. LPS stimulation of these offspring’s blood ex vivo showed decreased TNFα 
and IL6 expression and lower numbers of lymphocytes compared to offspring from 
unstressed mothers. This study suggests physiological insults to the primate mother 
perturb the immune development of her progeny. Rodents have also demonstrated 
alterations in neonatal immune function following maternal perturbations. Plasma from 
the offspring of dams exposed to LPS during gestation shows decreased expression of 
pro- and anti-inflammatory cytokines compared to unexposed pups103. These offspring 
also show decreased recruitment of monocytes, neutrophils and lymphocytes when re-
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exposed to LPS during the neonatal period compared to unexposed pups101, 106. Overall, 
exposures to infection in utero appear to program the immune phenotype of offspring 
across their lifespan. While the concept of immune programming by in utero 
perturbations is important, it may have different short-term or long-term outcomes.  
1.2.2.1. Intrauterine Inflammation 
Inflammation is central to both term and preterm labour, where there is a shift from 
immune acquiescence to inflammatory activation of gestational tissues9, 107, 108. This 
influx of inflammatory mediators (i.e. the ‘magnitude’ of inflammation) is lower in 
term compared to preterm labour107, 109. The difference in inflammation between term 
and preterm labour is driven by distinct aetiologies, with preterm labour being more 
commonly associated with intrauterine infection10-13. As such, the increased expression 
of pro-inflammatory IL1β, IL6, IL8 and TNFα has been observed with preterm labour 
in cord blood and the maternal compartment52, 110, 111. Murine studies have also shown 
that blocking IL6 expression in amniotic epithelial cells in vivo prevents preterm 
delivery following IL1β and TNFα administration112. Additionally, anti-inflammatory 
placental IL10 expression is decreased in association with preterm parturition and 
chorioamnionitis (inflammation of the fetal membranes)113.  
Aberrant inflammation during pregnancy is frequently associated with adverse 
pregnancy outcomes including intrauterine growth restriction (IUGR) and neonatal 
sepsis114. A study of 701 Kenyan births found an increased incidence of low birth 
weight, still-birth and perinatal mortality in deliveries associated with acute placental 
inflammation relative to normal placentae114. Other prospective studies have supported 
these findings, observing an increased incidence of NEC and sepsis in neonates from 
pregnancies with chorioamnionitis115. While inflammation may be important for 
parturition, where excessive or poorly-timed, it can lead to adverse pregnancy 
outcomes.  
Chorioamnionitis occurs in up to 65% of spontaneous preterm deliveries, with its 
prevalence inversely related to gestational age116. Clinical studies have associated 
chorioamnionitis with an increased incidence of the inflammatory morbidities including 
RDS117, early-onset neonatal sepsis46, 117, 118 and BPD116, 119. Increased amniotic TNFα 
expression and amniotic infection are also associated with increased neonatal mortality 
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and the development of RDS, intraventricular haemorrhage (IVH) and NEC120, 121. 
However, some have argued that intrauterine infection is protective against 
inflammatory disease, as chorioamnionitis is associated with the decreased prevalence 
and severity of RDS122, 123. This may be because RDS accelerates lung maturation via 
increasing surfactant production124 through inflammatory signalling to lung tissues125. 
Further, when LPS or IL1β are infused directly into the fetal ovine trachea to cause 
local inflammation increased lung maturation is also observed122, 126-128. Alternately, 
antagonising IL1 expression in fetal sheep in utero and exposing them to LPS arrests 
systemic inflammation and decreases lung maturation (supporting a direct association 
with inflammation)128 while inflammatory stimuli increase lung development, 
intrauterine infection impairs alveolarisation, increases severity of pulmonary 
hypertension in the newborn and decreases pulmonary blood flow in fetal sheep129. 
Together, these studies highlight that while inflammation can induce respiratory 
maturation, it is not necessarily beneficial for neonatal lungs.  
60% of fetal deaths occur in the presence of chorioamnionitis130, 131. Ovine models of 
chorioamnionitis have demonstrated increased inflammation in the fetal ileum132 and 
decreased anti-inflammatory FOXP3+ expression133, both of which are thought to 
precede inflammatory neonatal diseases such as NEC. Murine models of 
chorioamnionitis using intraperitoneal LPS administration show increased IL1 and IL6 
expression by developing neurons and therefore, an increased incidence of fetal brain 
injury134. Chorioamnionitis and fetal inflammatory response syndrome (FIRS) are both 
associated with increased IL1β, TNFα, IL6 and IL8 in the human amnion and cord 
blood135-138, and increased numbers of neutrophils in cord and peripheral blood 
collected from neonates139. Chorioamnionitis increases the risk of the FIRS, defined as 
fetal plasma (sampled by cordocentesis) containing concentrations of IL6 exceeding 
11pg/mL140, 141. The diagnosis of FIRS is confirmed by placental histopathology which 
also shows inflammatory infiltration in the fetal compartment138. FIRS can be caused by 
microbes entering the amniotic cavity, resulting in excessive chemokine expression and 
neutrophil invasion142. The fetus responds to infection by increasing IL6 expression 
which can also result in funisitis and vasculitis143. IL6 is a systemic acting cytokine 
associated with chronic and acute inflammation, and its increased expression is 
consistent with a systemic fetal response that occurs during severe intrauterine 
infection144. FIRS affects 39-49% of preterm deliveries140, 141 and may lead directly to 
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early activation of labour through inflammatory signalling144, 145. FIRS is also a risk 
factor for neonatal morbidity including early-onset sepsis118, RDS, BPD, IVH, PVL and 
cerebral palsy146. Activation of the inflammatory response in utero is therefore a 
significant contributor to adverse pregnancy outcomes. 
1.2.2.2. Mode of Delivery  
Microbial exposure associated with vaginal delivery may influence fetal immune 
development by altering cord blood cytokine synthesis147-149. Cord blood from non-
labouring Caesarean section deliveries has been associated with lower pro-
inflammatory IL6, IL8, Granulocyte Macrophage Colony Stimulating Factor (GMCSF) 
and Granulocyte Colony Stimulating Factor (GCSF), but increased IL10 compared to 
vaginal deliveries135, 148, 150. Notably, studies demonstrating this have lacked appropriate 
control groups, i.e. cohorts comparing labouring to non-labouring Caesarean section, 
which are important for separating the effect of labour from exposure to vaginal 
microflora. Other authors have observed no difference in a number of cord blood 
cytokines (IL1α, IL1β, IL2, IL4, IL5, IL6, IL8, IL10, IL12p40, IL12p70, IL17, IL1RA, 
sIL2Rα, GMCSF, IFNα2, IFNγ, TNFα or TNF-β) between vaginal and Caesarean 
section deliveries151.   
Studies on cord blood immune stimulation present conflicting evidence concerning the 
impact of mode of delivery on neonatal immune function. In vitro stimulation of whole 
cord blood with TLR ligands has shown no difference in TNFα, IL6 and IL10 
production between term infants born vaginally or via non-labouring Caesarean 
section62. Conversely, increased IFNγ and IL12 expression is observed in CBMCs from 
vaginal deliveries stimulated with the mitogens Conconavalin A (ConA) and 
Phytohaemagglutinin-A (PHA), or LPS, compared to non-labouring Caesarean 
sections152. A recent study in our laboratory has found no difference in cord blood 
cytokine expression according to mode of delivery for a range of cytokines (including 
GMCSF, IL1β, IL1RA, IL6, IL8, IL10, IL12p70, MCP1, sCD40L and TNFα protein 
expression), both at birth and in response to TLR2, 3 and 4 stimulation153. Therefore, 
differences in cytokine expression according to vaginal delivery may only be observed 
at birth and appear to have less of an impact on subsequent neonatal innate immune 
function (i.e. no difference following TLR stimulation).  
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1.2.2.3. Maternal Cigarette Smoking During Pregnancy 
Maternal cigarette smoking during pregnancy creates a pro-inflammatory in utero 
environment154 and is associated with decreased birthweight155, restricted brain 
growth156 and long-term impairments to child neurodevelopment157. 10-20% of women 
smoke throughout pregnancy, with higher rates observed in low socioeconomic and/ or 
poorly-educated populations158. Cigarette smoke is associated with increased reactive 
oxidative species (ROS) and oxidative stress marker production by cord159 and neonatal 
peripheral blood160. CBMCs from neonates whose mothers who smoked during 
pregnancy express decreased constitutive IL6, TNFα and IL10161 and following TLR2, 
TLR3 and TLR4 stimulation in vitro compared to non-smoking mothers162, 163. A study 
of a murine macrophage cell line showed that IL12 and NF-κB expression is decreased 
with LPS exposure when cells are co-cultured with benzene metabolites from cigarette 
smoke, compared to cells cultured with LPS alone164. Overall, it appears that TLRs, the 
TLR signalling cascade and cytokines are all decreased in cord blood associated with 
maternal smoking during pregnancy, which could contribute to altered neonatal innate 
immune function. 
1.2.2.4. Antenatal Glucocorticoid Exposure 
Natural increases in cortisol expression are observed across gestation and drive the final 
stages of fetal organ maturation165, 166. Perinatal practice guidelines therefore support 
the administration of synthetic glucocorticoids (betamethasone or dexamethasone) 
during the management of threatened preterm labour. Glucocorticoids aid fetal lung 
maturation through surfactant production and therefore, reduce the incidence of RDS167, 
168. Antenatal steroid administration originates from Liggins’ landmark work during 
1969, where pregnant sheep were used to investigate the permeability of the placenta to 
glucocorticoids and preterm delivery169. The study demonstrated preterm parturition 
occurred when dexamethasone was infused directly into the fetal lamb, but not the 
pregnant ewe. Incidentally, Liggins discovered that preterm lambs exposed to 
dexamethasone showed increased lung aeration, which he postulated was a product of 
enzymatic activity induced by the glucocorticoid that lead to surfactant production. This 
was later confirmed by studies where prenatal cortisol exposure increased the synthesis 
of proteins and phospholipids that promote alveolar development, and induced 
surfactant production in preterm lamb and human lungs170, 171. 
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In Liggins and Howie’s follow-up, randomised controlled trial of antenatal 
betamethasone administration to mothers presenting in spontaneous preterm labour, a 
significant reduction in RDS and neonatal mortality was observed compared to mothers 
that were not administered betamethasone172. As a result, antenatal glucocorticoid 
administration has become routine practice for women presenting in threatened preterm 
labour173. Recent Cochrane reviews continue to support the use of antenatal 
glucocorticoid administration, indicating significant reductions in neonatal 
inflammatory diseases such as RDS, cerebral haemorrhage, IVH, NEC and systemic 
infection, as well as an overall reduction in neonatal death168, 174-179. Other than these 
associations, the mechanisms and potential effects of antenatal glucocorticoid exposure 
on subsequent neonatal immune function remain unclear. Notably, recent reviews and 
animal studies have argued that antenatal exposure to glucocorticoids may have 
unwanted side-effects including decreased growth173, 180 and poor neurodevelopmental 
outcomes during infancy and childhood181-184. 
Glucocorticoids typically suppress inflammation through several mechanisms including 
reducing T-cell proliferation via IL2 suppression165, 185, repressing endothelial adhesion 
molecule expression186, inhibiting neutrophil chemotaxis186, repressing transcription of 
pro-inflammatory cytokines165, 187, 188 and chemokines186, 187, 189, and decreasing the 
circulation of lymphocytes, monocytes and eosinophils190. These effects occur when 
cortisol binds to the glucocorticoid receptor in leukocytes, which then binds to 
glucocorticoid responsive elements on DNA or to transcription factors specific to TLR 
signalling genes191-195. The impact of glucocorticoids on neonatal immune regulation is 
highlighted by murine models of LPS exposure. Antenatal betamethasone exposure is 
associated with lower lymphocyte counts, reduced ROS production and decreased 
early-response cytokine production (TNFα and IL1β) in rodent offspring, indicating a 
state of immunosuppression106, 196. Rodent models of maternal stress during pregnancy 
(where endogenous glucocorticoids become elevated) also demonstrate suppressed 
lymphocyte proliferation, indicating glucocorticoids may exert long-term effects on 
adaptive immunity in offspring197. 
The impact of glucocorticoids on human neonatal immunity is unclear. Studies on cord 
blood have demonstrated altered immune responses following prenatal glucocorticoid 
exposure. Cord blood treated with dexamethasone in vitro increases CD14 expression 
and endocytosis, suggesting that it enhances monocyte differentiation compared to 
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untreated cord blood198. Evidence from this study was, however, obtained 
independently of antigenic stimulation and while dexamethasone-treated cord blood 
increased IL10 and decreased IL12 compared to untreated cord blood, its effect on 
inflammatory function may be different. Other studies have shown that glucocorticoids 
decrease pro-inflammatory cytokine expression in cord blood in vitro following viral 
stimulation165 and inhibit neutrophil chemotaxis during LPS exposure189. Alternately, 
high doses of dexamethasone have been found to increase NF-κB-luciferase activity in 
mice with endotoxaemia199, supporting increased inflammatory signalling. Overall, the 
impact of these typically immunosuppressive compounds on preterm neonatal 
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1.3. NEONATAL INNATE IMMUNITY 
Neonates demonstrate an increased reliance on tolerogenic immune mechanisms 
compared to adults during their transition to the ex utero environment. A common 
misconception arising from a tolerogenic immune state at birth is that neonates are 
immunosuppressed. Current literature shows varied functional capacity in different 
aspects of immunity. For example, IL6 mRNA and protein expression appears to be 
increased in whole cord blood stimulated with LPS compared to adults51, 201, 202. 
Conversely, some have observed no difference between CBMCs and adult mononuclear 
cell IL6 production following stimulation with GBS, lipoteichoic acid (LTA) or LPS203. 
The same study also showed that the cord blood IL6 response to GBS was greater than 
single TLR stimulation (LTA or LPS). This may occur because whole bacteria are 
complex stimulants, expressing many unique ligands. However, others have used FACS 
to show cord blood monocytes express decreased IL6 following stimulation with whole, 
heat-killed GBS compared to adults204. This could highlight a decreased capacity by 
CBMCs to respond to multiple stimuli simultaneously compared to adult leukocytes. 
Overall, simultaneous activation of different TLRs is common during infection because 
microbes can express multiple ligands and therefore it is likely that neonatal immunity 
functions on a conditional basis according to the pathogenic species encountered. 
Preterm delivery attenuates specific aspects of neonatal immunity. For example, 
preterm cord blood shows leukopenia and lymphopenia that persists into the postnatal 
period for up to seven months205-208. Additionally, neonates have a decreased proportion 
of circulating neutrophils209, 210 and their storage pools are also depleted due to limited 
numbers of progenitor cells211. Neutropenia is therefore common during neonatal 
sepsis, where progenitor cell pools in bone marrow are diminished by persistent 
inflammatory stimulation that results in immune suppression212. The absolute blood cell 
counts of monocytes, DCs, PMNs, NK cells and lymphocytes are decreased in preterm 
compared to term cord blood due to lower volumes of blood in preterm neonates207, 213. 
Overall, preterm cord blood cell populations are decreased as cellular development 
occurs from smaller pools of progenitor cells39 and preterm CBMCs produce decreased 
GCSF and GMCSF(which typically foster cell development)214, 215. As such, GCSF 
administration is shown to restore neutrophil numbers and their function in murine 
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models of sepsis216, 217. Clinical trials have administered GCSF and GMCSF to septic 
neonates with neutropenia and as a prophylactic measure. However, failed to reduce the 
incidence218 or severity of sepsis219 despite increasing neutrophil numbers218, that 
potentially highlights functional deficits by neutrophils themselves.   
While neonatal neutrophils show the same affinity for chemokines as adults, their 
ability to migrate along a chemotactic gradient is significantly impaired220. Chemotaxis 
is the recruitment of cells to a particular tissue site and has a crucial role in 
inflammation. It is driven by chemokines such as IL8 and Monocyte Chemotactic 
Protein-1 (MCP1), whose aberrant expression can lead to the accumulation of 
immunocytes. Increased IL8 is therefore associated with inflammatory diseases in 
neonates such as sepsis221 and inflammatory lung disease222. Further, bronchoalveolar 
lavage samples from neonates that develop CLD show an accumulation of neutrophils 
compared to neonates with RDS223, which is also associated with respiratory failure224. 
Conversely, deficient chemotaxis can contribute to neutropenia and exacerbate 
conditions such as sepsis in neonates225. Therefore, regulation of chemokine expression 
and neutrophil accumulation (through apoptosis) may be critical to a normal immune 
response by neonates. Typically, chemokine expression is positively correlated with 
gestational age and is tissue-dependent226. Overall, the chemotaxis of leukocytes to the 
site of inflammation appears attenuated by preterm neonates and may underlie an 
inability to localise inflammation. 
Neutrophils are polymorphonuclear cells (PMNs) that make up 70% of circulating 
leukocytes and drive pro-inflammatory responses. Prematurity also decreases 
neutrophilic function throughout the neonatal period, where oxidative burst (which is 
required for phagocytosed pathogen killing) is consistently decreased in cord and 
peripheral blood227, 228. Reductions in neutrophil ‘peak activity’ are therefore associated 
with severe infection229. Preterm PMNs stimulated with Staphylococci show intact 
phagocytic activity, but impaired killing capacity, regardless of showing comparable 
superoxide production compared to term neonates86, 230, 231. In fact, neonatal neutrophils 
produced higher levels of reactive oxygen intermediates than adult neutrophils, which is 
normally indicative of persistent tissue damage in chronic inflammatory disorders231, 232. 
Reactive oxygen intermediates are important for neutrophil intracellular killing 
following phagocytosis, however, they are harmful to native cells because they oxidize 
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membranes, proteins and nucleic acids233. During the development of sepsis, endotoxins 
initially cause local inflammation, but subsequently aberrant production of cytokines 
and ROS becomes sustained and can lead to systemic inflammation234. In the second 
phase of sepsis, a ‘compensatory anti-inflammatory response’ occurs, characterised by 
increased regulatory cytokine expression, but it does not completely resolve 
inflammation and instead prolongs a systemic response235. Peripheral blood from 
preterm neonates with sepsis therefore shows increased pro-inflammatory IL6, IFNγ 
and TNFα with increased anti-inflammatory IL4 and IL10 compared to preterm 
neonates with culture-negative sepsis screens236. Although it classically has anti-
inflammatory roles, IL10 is associated with septic shock236 and poor outcomes during 
sepsis237. Together, these findings support a global upregulation of inflammatory 
pathways during sepsis and highlight the importance of effective immunoregulatory 
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1.4. THE INNATE IMMUNE RESPONSE IN NEONATAL BLOOD 
The constitutive expression of innate immune receptors, signalling molecules and 
therefore cytokines, is comparable between cord blood and adult peripheral blood. 
Specifically, cord blood and adult monocytes transcribe comparable levels of mRNA 
for TLRs1-10, and their signalling molecules CD14, MyD88, TIRAP and IRAK462, 211, 
238-243. While these genes are similarly expressed in neonates and adults, differences in 
immune function become apparent clinically (increased susceptibility to infection) and 
experimentally (following in vitro immune stimulation). 
Cord blood is commonly used to assess the neonatal innate immune function as it is 
readily available and reflects the status of the neonate at birth. The administration of 
TLR agonists to cord blood in vitro is also common as it enables the study of specific 
functional aspects of innate immune function. Many authors have used both TLR 
agonists and whole, heat-killed bacteria to characterise cytokine expression by neonates 
compared to adults in isolated cell populations and whole blood. These studies 
demonstrate varied findings and are summarised in Table 1.1.  
Most studies show a concurrent increase in tolerogenic cytokines (IL10 and TGFβ48, 52, 
53, 202, 244, 245) and early-responding cytokines (TNFα62, 202, 246), but attenuated expression 
of anti-viral cytokines (IFNs and IL1248, 52, 202, 244-251) in cord blood compared to adult 
blood stimulated with immune ligands in vitro. Notably, disparities observed by other 
studies can be explained by differences in experimental methods. For example, 
compared to adults, expression of the chemokine, IL8, is increased by CBMCs 
stimulated with whole GBS203, but decreased in cord blood DCs stimulated with 
endotoxin202. Alternately, CBMCs stimulated with GBS express decreased IL12 
compared to singular TLR7,8 or 9 stimulation250. This may be due to differences in cell 
populations, cell interactions or antigen complexity. Hartel et al. have shown that 
singular TLR stimulation in whole preterm cord blood or CBMCs decreases IL10, but 
stimulation with S. epidermis demonstrates comparable IL10 expression compared to 
term cord blood252. Tatad et al. are the only authors that present increased IL10 
expression following GBS exposure and comparable expression between preterm and 
term cord blood following stimulation with E. coli or S. epidermis204. These conflicting 
results may arise from increased levels of IL10 in preterm cord blood at baseline, the 
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use of complex ligands or an inconsistent resting period of these cells following birth, 
prior to in vitro stimulation. This highlights a need to consider methodological 
differences in experiments when examining neonatal immune function.  
The innate immune system of the neonates appears more sensitive to specific classes of 
bacteria. A study compared the response of CBMCs to 11 species of whole, heat-killed 
bacteria and observed increased IL6, IL12 and TNFα, and comparable IL10 expression 
compared to adult mononuclear cells253. Specifically, they showed gram-negative 
bacteria increased IL12, IL6 and TNFα, and expressed similar IL10 in CBMCs 
compared to adult peripheral mononuclear cells. This response was not observed in 
response to gram-positive bacteria. The authors suggest this is a pathological pro-
inflammatory bias towards commensal bacteria. Such a bias could predispose neonates 
to aberrant inflammatory responses during commensal colonisation ex utero and 
highlights the importance of immuno-regulatory mechanisms. Overall, the complexity 
of ligands and cell populations (i.e. isolated cells versus whole blood) should be 
considered in every analysis, given that neonatal immunity does not show generalised 










Table 1.1. A summary of studies on cord blood cytokine expression following immune stimulation compared to adult peripheral blood. 
The expression of select cytokines and chemokines in cord blood relative to adult blood following in vitro stimulation with different 
immune agonists (‘↑’ expression is increased in neonates compared to adults, ‘↓’ expression is decreased in neonates compared to adults 
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1.4.1. The Poly-functionality of Cord Blood Immune Cells 
Differences in poly-functionality (i.e. the ability to express different cytokines 
simultaneously) between adult and neonatal cells may explain disparate results 
presented between studies on in vitro cord blood stimulation. Flow cytometry has 
shown that isolated CBMCs stimulated with TLR agonists in vitro are less capable of 
producing multiple cytokines simultaneously than cells from stimulated whole blood52. 
Cord blood monocytes show a similar degree of poly-functionality compared to adults, 
but flow cytometry of whole cord blood shows a decreased ability to express certain 
cytokines simultaneously (e.g. IL12p40 and TNFα) following TLR2, 4 or 7/8 
stimulation compared to adults. It has therefore been suggested neonatal Th1 immune 
attenuation (see 1.4) can be restored through TLR co-stimulation. Cord blood antigen 
presenting cells (APCs) show robust TNFα and IL12 expression (comparable to adults) 
when stimulated with TLR7/8 at the same time as TLRs 2 or 4264. This has also been 
demonstrated in animal models of neonatal sepsis, where TLR priming results in 
decreased duration of inflammation and therefore, decreased disease severity and 
mortality92. Murine RAG1-/- neonates with polymicrobial sepsis that have been pre-
treated with TLR4 and TLR7/8 agonists show enhanced neutrophil recruitment, 
phagocytic ability and oxidative burst, and therefore less severe disease than unprimed 
mice56, 92. In humans, patients with sepsis are administered IFNγ to increase TNFα 
production and improve phagocytosis107, 306. This treatment aims at resolving 
inflammation through pathogen clearance94, 265. This suggests cord blood immune cells 
may be less poly-functional due to deficiencies in their ability to concurrently express 
different cytokines compared to adults. 
1.4.2. Neonatal Plasma 
Cord blood plasma supports a tolerogenic bias through decreased constitutive 
expression of TNFα, IL12p70 and IFNγ238, 266, and increased anti-inflammatory IL4, 
IL10, IL13 and TGFβ compared to adult plasma267. Adult mononuclear cells cultured in 
cord blood plasma and stimulated with TLR3, 4 and 8 ligands, show decreased IL12p70 
and TNFα, and increased IL10 expression compared to adult mononuclear cells 
cultured in autologous plasma62, 245, 268. The use of different TLR agonists in this study 
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also indicates both MyD88-dependent and independent pathways of TLR signalling are 
supported by plasma-associated factors245.  
Studies on isolated immune cells allow for closer mechanistic analysis, but ignore 
cellular cross talk and could discard the influence of other soluble autologous factors 
found in blood267. Blood plasma consists of organic molecules such as proteins and 
hormones269 and is central to shaping the immune response. Plasma is necessary for 
rapid immune signalling throughout the body, but its mechanisms remain largely 
uncharacterised, particularly in the neonate270. Blood plasma contains many immune 
modulating proteins including IgG (11% of its protein content271), anti-inflammatory 
albumin (50% of its protein content) and adenosine, which regulates immunity270. Cord 
blood plasma contains increased concentrations of adenosine compared to adult 
plasma272 and metabolises less of the nucleoside than adult plasma273. Adenosine 
represses ROS expression by neutrophils and increases IL10 expression in 
macrophages, which then represses IL12 and TNFα expression (reviewed in274). 
Increased cord blood adenosine could contribute to the tolerogenic bias compared to 
adults observed in some stimulation studies.  
When neonatal haemocytes are cultured in adult plasma, their TNFα expression is 
comparable to adults (except following TLR7/8 stimulation)62. This response is dose-
dependent, where higher concentrations of LPS induce similar expression of TNFα 
between cord blood and adult mononuclear cells241. This ‘repaired’ response is thought 
to be due to the higher levels of immune-active plasma proteins (such as platelet 
activating factors) in adult plasma241. These findings highlight the importance of whole 
blood cell culture in characterising neonatal immunity due to differences between the 
way that cells are exposed to or interact with exogenous factors in plasma. In fact, it 
may be a combination of cellular robustness and serum-based factors that contribute to 
differences in neonatal immunity, although the precise mechanisms remain unclear. 
1.4.3. The Neonatal Innate Immune Response to Viral Stimulation  
Anti-viral cytokine expression (IFNs and IL12) by cord blood in vitro is impaired, 
independently of gestational age, cell type or immune agonist (see Table 1.1). Even 
when CBMCs are primed with IFNγ prior to TLR4 stimulation in vitro, they express 
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decreased IL12, IL8, IL23 and IFNs compared to adult blood201. This is significant as 
IFNγ typically activates STAT1 which this leads to microbial killing, antigen 
presentation and increased pro-inflammatory cytokine expression275. IFN production 
also induces an anti-viral state in adjacent cells which downregulates protein 
expression, and enhances NK cell, cytotoxic T cell and dendritic cell activation73, 276. 
Notably, the addition of exogenous IFNγ does not rescue ROS release and pathogen 
killing capacity in neonatal macrophages because STAT1 expression is decreased and 
unresponsive to the IFNγ relative to adults257. The lack of anti-viral mediators and 
responsiveness by cord blood supports clinical evidence that neonates are susceptible to 
viral infections including influenza and RSV that lead to increased mortality compared 
to adults277. 
An absence of IFNγ expression by neonates may be evidence of immune tolerance. 
When cord blood leukocytes exposed to LPS are co-stimulated with IFNγ, they 
demonstrate increased expression of TNFα, IL6 and IL1082 that exceeds 2 month old 
and 1 year old peripheral blood201. Additionally, CBMCs and whole cord blood express 
increased TNFα compared to adult blood following bacterial and viral TLR 
stimulation52, and GBS stimulation203, 262. Conversely, co-stimulation of CBMCs with 
LPS and IFNγ show comparable TNFα expression compared to adults201. Studies from 
rodents support these findings  as IFNγ-/- rodents are resistant to endotoxic shock278. 
These rodents are also protected against NEC compared to WT strains because they 
exhibit reduced inflammatory signalling279. Altogether, the impaired neonatal IFN 
response impacts innate immunity towards both viruses and bacteria.  
Decreased IFN expression by neonates may be explained by downstream adaptor 
molecules in TLR signalling. p38MAPK is involved in PMN degranulation, adhesion 
and respiratory burst and its constitutive expression between neonates and adults is 
similar211, 280. Following LPS stimulation, however, cord blood shows decreased p38, 
ERK and IκBα phosphorylation, which results in decreased cytokine expression 
compared to adult blood35, 62, 201, 211, 241, 256. The attenuated translocation of IRF7 into the 
nucleus of cord blood pDCs following TLR7 and TLR9 stimulation281, and decreased 
constitutive IRF3 expression248 also suggest that MyD88-independent signalling may be 
defective in neonates. Notably, when CBMCs are stimulated with multiple ligands, they 
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increase phosphorylation of NF-κBp65, ERK1/2 and Akt above adult levels, compared 
to stimulation with single ligands282. This could indicate neonates are less sensitive to 
viral antigens and need more stimulatory signals to achieve a robust response to viral 
stimulation.  
1.4.4. The Innate Immune Response in Preterm Compared to Term 
Neonates 
Emerging studies are challenging the traditional paradigm of immune attenuation in 
preterm neonates. Strunk et al.’s aptly titled review ‘innate immunity human newborn 
infants: prematurity means more than immaturity’ contrasts a robust ability by preterm 
neonates to phagocytose and kill pathogens in spite of attenuated cytokine responses283. 
This suggests preterm neonates do not show consistent attenuation in all aspects of their 
innate immune function. In fact, studies have shown that despite decreased populations 
of monocytes and neutrophils in preterm cord and peripheral blood284 and reduced 
opsonophagocytic activity in plasma82, phagocytic capacity is increased in early 
preterm cord blood compared to term284, 285. Additionally, previous work from our 
laboratory has demonstrated preterm cord blood expresses increased IL6 without any 
compensatory anti-inflammatory response (IL10 or TGFβ) following TLR2 and 4 
stimulation in vitro153. A meta-analysis of very preterm deliveries has also demonstrated 
a genetic profile in umbilical cord tissue that is similar to deliveries characterised by 
FIRs, suggesting that lower gestational age predisposes neonates to a pro-inflammatory 
phenotype286.  
Term and preterm cord blood show comparable constitutive cytokine production, with 
the exception of the chemokines IL8 and MCP1, which are higher in preterm neonates 
at birth148, 287. Alternatively, in vitro studies on TLR stimulation have consistently 
demonstrated decreased pro-inflammatory cytokine production in preterm compared to 
term cord blood (see Table 1.2). Further, the expression of IL6 and TNFα are 
consistently decreased in preterm cord blood compared to term, following stimulation 
with TLR1-9 agonists213, 288 or whole bacteria252, 289. Studies using flow cytometry have, 
however, shown conflicting results. Some authors have demonstrated that stimulation 
with LPS increases the frequency of IL6 and IL8 positive cells in preterm compared to 
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term cord blood194, while stimulation with S. epidermis decreases TNFα+ and IL6+ cell 
counts252. Despite these decreased cell counts, stimulation with TLR7-9 agonists or S. 
epidermis shows an increased IL8 response by preterm cord blood PMNs and whole 
blood compared to term204, 290. Alternately, stimulation of whole cord blood or PMNs 
with TLR1-5 agonists demonstrates comparable or decreased expression of IL8 
compared to term82, 290. In comparison to stimulation with whole heat killed bacteria, 
single TLR stimulation produces decreased cytokine responses in preterm cord blood 
compared to term204. These findings support preterm neonates are less sensitive to 
simultaneous stimulation by the multiple ligands that are present on whole bacteria. 
Such reduced sensitivity to pathogens may underlie preterm neonates’ susceptibility to 
contracting infection. 
In addition to an increased susceptibility to infection, preterm neonates demonstrate 
differences in regulatory immunity compared to term. The constitutive expression of 
anti-inflammatory IL10 and TGFβ is increased in preterm cord blood compared to term. 
Following LPS stimulation, however, preterm and term cord blood both express 
decreased IL10 and TGFβ compared to adult blood291. Further, when cord blood 
monocytes are supplemented with recombinant IL10 or TGFβ and are stimulated with 
TLR4, their inhibition of pro-inflammatory cytokine expression is impaired compared 
to adult monocytes. Anti-inflammatory cytokines limit inflammation through 
antagonising pro-inflammatory pathways and enhancing immunosuppressive 
mechanisms and tissue repair. The suppressive effects of anti-inflammatory cytokines 
are dependent on their ratios relative to pro-inflammatory mediators and the respective 
bioactivity of the molecules. Therefore, increased constitute cord blood IL10 levels may 
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Table 1.2. A summary of studies on preterm cord blood cytokine expression 
compared to term following immune stimulation in vitro. Cytokine expression may be 
increased (↑),decreased (↓) or comparable (↔) in preterm compared to term cord blood 
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1.4.5. Neonatal TLR Signalling 
Neonatal TLR signalling is immature compared to adults. In mice, TLR4 deficiency in 
mice leads to LPS hypo-responsiveness, resulting in increased microbial loads and 
higher rates of mortality295, 296. TLR2/TLR4-/- mice exposed to S. typhimurium are more 
susceptible to infection and show an increased bacterial load and rate of mortality. 
Similarly, IRAK1-/- animals are resistant to endotoxic shock because inflammatory 
signalling is downregulated297. In humans, IRAK4 deficiency is negatively correlated 
with age298, making children more vulnerable to higher incidences of infection and 
severe complications compared to adults299. The attenuated expression of these early 
signalling molecules could therefore place neonates at an increased risk of infection. 
Although there is a wealth of data which suggests that TLR expression is altered by 
preterm delivery48, 82, 288, 300, the largest body of literature has focused on TLR4. 
Seminal work by Forster-Waldl and colleagues found decreased expression of TLR4 in 
preterm cord blood of very low birth weight infants compared to term controls, with an 
associated decrease in pro-inflammatory cytokines following TLR4 stimulation288.  
Similarly, other studies have shown a positive correlation between gestational age and 
TNFα cytokine production following TLR4 stimulation, indicating increased immune 
responsiveness by preterm neonates with advancing gestational age at delivery35, 62, 82, 
288, 301. Conversely, constitutive expression of TLR2 does not appear to differ 
significantly across gestational age in isolated cord blood monocytes35. Preterm 
monocytes also show comparable expression of constitutive TLR2, TLR4 and TLR6 
compared to term and adult monocytes86. Alternately, other studies have shown that 
protein expression of TLR2 and TLR4 on monocytes and neutrophils is positively 
correlated with gestational age302. Deficient TLR4 expression could be analogous to 
mutations seen within the TLR4 gene itself, which lead to susceptibility to bacterial 
infection and decreased responsiveness to LPS288, 303, 304.  
Regulating TLR signalling is central to immune tolerance. For example, murine models 
show blocking NF-κB signalling in IECs decreases systemic inflammation while 
increasing local inflammation61. Other studies have also demonstrated NF-κB activation 
in IECS is protective against mucosal injury for this reason305, 306. Ultimately,  increased 
NF-κB and decreased IκBα contribute to severity of inflammation and increase the risk 
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of neonatal diseases such as NEC307. It is therefore unsurprising that breast milk 
stimulates intestinal epithelial cells’ expression of IκBα, resulting in reduced NF-κB 
translocation308. The very presence of this inhibitor in breastmilk highlights the 
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1.5. THE REGULATION OF INFLAMMATION 
Inflammation requires gradual down-regulation to avoid constant defensive signalling 
that leads to wide-spread tissue damage. Immune regulation can involve the expression 
of anti-inflammatory mediators, networks of genetic response signalling, and 
physiological feedback systems (e.g. via the HPA axis or secondary lymphoid 
organs)309. These mechanisms recruit Tregs, repress inflammatory genes and induce 
sickness-like behaviours that assist in the process of tissue healing. Notably, the down-
regulation of a pro-inflammatory response causes less tissue damage than increased 
anti-inflammatory mediator expression310, while uncontrolled inflammation causes 
more tissue damage than infection itself and can establish a fertile ground for pathogen 
growth or autoimmunity.  
As TLR signalling can be activated by both exogenous and endogenous ligands, it 
needs to be tightly regulated to avoid such pathological inflammation. Regulatory 
mechanisms active at different stages of the signalling pathway have distinct effects on 
inflammatory outcomes depending on the complexes they target. TLR signalling can be 
decreased in a temporal manner according to the gradual activation of inhibitors 
stimulated at various stages of the cascade. Examples of TLR regulation include the 
upregulation of direct inhibitors such as IκBα or post-transcriptional repressors of 
mRNA transcripts which control the signalling cascade. A key class of intracellular 
mediators induced by cytokines are inhibitory Suppressor of Cytokine Signalling 
(SOCS) proteins. These are proteins that regulate transcription of Janus Kinases (JAKs) 
that activate Signal Transducer and Activators of Transcription (STATs). SOCS 
proteins therefore inhibit the transcription of cytokines311. SOCS1-/- mice are therefore 
hyper-responsive to LPS exposure and produce higher levels of TNFα, IL12 and IFNγ 
than WT mice, resulting in decreased survival caused by excessive inflammation312-314. 
SOCS1 is also an important regulator of the p65 subunit, as it degrades this 
transcription factor and preventing cytokine expression315. SOCS proteins are 
responsive to cytokine production and are therefore important regulators of 
inflammation, impacting different components of the TLR signalling pathway. 
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Other regulators of inflammation target gene expression and can include microRNAs 
(miRs), gene promoters, inhibitory proteins and competitive binders. MiRs have 
emerged as master regulators of inflammation316 as they are responsive to different cues 
during inflammation and regulate gene expression post-transcriptionally. Dysregulated 
patterns of miR expression have also been associated with the development of chronic 
inflammatory conditions317. The role of miRs in regulating inflammation may therefore 
be critical to a better understanding of neonatal innate immunity. 
1.5.1. MicroRNAs 
MiRs are 18-22 nucleotide, single-stranded, non-coding RNAs which repress gene 
expression post-transcriptionally318. They are responsive to temporal and tissue-specific 
cues and therefore, regulate many cellular processes319, 320. The post-transcriptional 
action of miRs may explain the mechanisms behind differences in inflammatory gene 
and protein expression in studies of cord blood, and could be key to understanding 
dysregulated innate immune responses in preterm neonates.  
MiRs are ‘promiscuous’ as each can have hundreds of mRNA targets that impact 
networks of genes. In silico analyses of microarray expression data estimate that miRs 
regulate approximately 30% of the human genome321. As such, they are shown to 
influence fundamental cellular processes including cell differentiation, proliferation, 
migration and apoptosis. Regulation by miRs is complex because different miRs can 
have multiple mRNA targets, act on many pathways simultaneously or act on different 
components of a common pathway. Similarly, mRNAs or entire genetic pathways can 
be targeted by many miRs at once to achieve a single effect, such as the downregulation 
of inflammation. These effects are commonly explored using microarray analyses, and 
in vitro miR transfection or knockdown studies.  
MiRs are evolutionarily-conserved and encoded by the genome such that they are 
regulated by their own transcription factors and promoters319. They are encoded as 
primary transcripts or as introns alongside protein sequence exons322. MiRs are 
transcribed by RNA Polymerase II from long primary transcripts (pri-miRNAs), which 
are subsequently cut by the RNaseIII, Drosha, into 60 base-pair precursors also known 
as ‘pre-miRNAs’323, 324 (Fig 1.2). Another RNase III, Dicer, then cuts the pre-miR into 
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an asymmetrical 22bp miR duplex containing the mature miR and its star-form 
complement325. Mature single-stranded miRs are exported to the cytoplasm and loaded 
onto an RNA-inducing silencing complex (RISC), which guides their targeted 
recognition of mRNA transcripts. MiRs bind complementarily to the 3’ untranslated 
region (UTR) of their target mRNA transcript and therefore, silence translation or 
signal transcript degradation324. MiR binding results in the adenylation or reduction of 
mRNA stability to the point of degradation326, 327, indirectly repressing protein 
synthesis. MiRs can down-regulate protein synthesis by directly targeting mRNA or 
indirectly up-regulating protein expression through suppression of negative regulators. 
For example, miR-155 upregulates cytokine expression through repressing the 
suppressor of cytokine signalling SOCS1328, 329. 
Approximately 1800 human miRs have been identified330 and at least 150 of these have 
known immune implications331, though their functional roles are not fully 
characterised332. In the context of immunity, tissue-specific or temporal aspects of miR 
regulation allow for the strict control of inflammation. Inflammation itself upregulates 
factors that control the expression of miRs, including TGFβ and bone morphogenic 
protein (BMP), which induce pri-miR processing333. A more comprehensive 
understanding of the regulatory interactions between miRs and inflammation could 










Fig 1.2. A diagrammatic representation of miR synthesis and function. miRs are encoded in 
genomic DNA and transcribed as long primary transcripts (pri-miRNAs), which are then cut by 
Drosha (to form pre-miRNAs) and Dicer (to form a miR duplex consisting of the miR and its 
asymmetrical star-form partner). The mature miR transcript is then exported into the cytoplasm 
and loaded onto RISC, which guides its recognition of mRNA transcripts. This complex binds 
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1.5.1.1. MiRs that regulate TLR signalling 
TLR signalling and the induction of pro-inflammatory cytokines can be up- or down-
regulated through the actions of miRs (for review see335). Approximately 29% of 
genetic transcripts for cytokines and chemokines contain miR targets336. MiRs are also 
responsive to cytokines: for example, IL10 downregulates miR-155 release by bone 
marrow macrophages following LPS stimulation337. Human decidual cells stimulated 
with IL1β demonstrate differential expression of 428 transcripts (containing six miRs) 
which repress genes in TLR and MAPK signalling pathways338. In fact, a majority of 
miR regulation occurs downstream of TLR receptors to ‘dampen’ rather than eliminate 
TLR signalling. This allows for the elicitation of a balanced and appropriate immune 
response to a pathogen without prolonging inflammatory signalling.  
The temporal nature of miR induction means that miRs are expressed as part of early 
and late response mechanisms. As such, miR-155 induction occurs within two hours of 
LPS exposure, while miR-21 is induced after 8 hours335, 339. These temporal cues form a 
regulatory loop where miR-21 represses PDCD4, a repressor of IL10, and therefore 
delays an increase in IL10 expression needed to represses miR-155 later during 
inflammatory signalling337. When miR-155 is downregulated, it no longer represses 
SHIP1 or SOCS1 genes, allowing these proteins to downregulate the pro-inflammatory 
TLR4 response340. This network of signalling presents an antagonistic relationship 
between two miRs that rely on temporal cues during inflammatory signalling. As such, 
it highlights the role of miRs in ‘buffering’ rather than eliminating inflammation.  
TLR-induced inflammation consists of many adaptor molecules and transcription 
factors that can be regulated throughout the signalling cascade. TLRs themselves have 
few 3’UTRs, indicating the presence of conserved target sites for regulation by miRs335. 
At the receptor level, let-7e represses the expression of TLR4 mRNA, restricting 
signalling downstream of the receptor335, 341. let-7e is increased with LPS stimulation as 
demonstrated in macrophages in vitro, where silencing the gene upregulates cytokine 
expression following LPS stimulation. miR-9 is also upregulated by the activation of 
TLR2,4 and 7/8 in a MyD88- and NF-κB-dependent manner332. This is demonstrated by 
in vitro stimulation of human monocytes and neutrophils, where activation of NF-κB 
through TLR4 increases miR-9 expression and subsequently, miR-9 induces a negative-
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feedback response by downregulating NF-κB. It is therefore postulated that most TLR 
regulation occurs during or after transcription.  
1.1.1.1.4. miR-106a  
MiR-106a is an indirect pro-inflammatory regulator as it has a binding site on the anti-
inflammatory IL10 gene339. In human cell lines, transfection with an IL10 luciferase 
transporter gene results in decreased IL10 expression when miR-106a is increased342. 
Further, transfection of miR-106a into a bladder cancer cell-line increased p38 and JNK 
phosphorylation during TLR signalling343. Murine models of allergic airway 
inflammation have also demonstrated that the knockdown of miR-106a is associated 
with an upregulation of IL10 expression in the lung344. These mice also show increased 
airway inflammation in a dose-dependent manner to miR-106a expression. Together, 
these studies highlight miR-106a as an upregulator of TLR signalling through the 
repression of IL10. 
1.1.1.1.5. The miR-146 family 
The MiR-146 family are negative regulators of inflammation90, 323, 345, 346 consisting of 
miR-146a and miR-146b. Their expression is highest 24 hours following LPS exposure 
in human monocytes in vitro323, 346 and mice in vivo347. The miR146 family represses 
NF-κB, MAPK and downstream EGR transcription factors in the TLR signalling 
cascade348, 349. While miR-146a and miR-146b differ by two base-pairs, they are both 
associated with repression of IRAK1 and TRAF6323, 350, 351and are regulated by NF-
κB323, 352. 
miR-146a expression can be induced by LPS, TNFα and IL1β in a NF-κB-dependent 
manner323. It also shows cell-specific function, decreasing TRAF6 and IRAK1 in 
monocytes323 and STAT1 in Tregs353. In mice, miR-146a deficient Tregs are associated 
with the formation of autoimmune inflammatory lesions, indicating that the miR is 
crucial for these cells’ tolerogenic roles353. Human Langerhans cells also show 
increased constitutive expression of miR-146a compared to dendritic cells, which may 
be related to the induction of tolerance on the skin and mucosa towards the external, 
pathogen-rich environment354. In pDCs, TLR7 or TLR9 stimulation leads to increased 
miR-146a expression, which decreases NF-κB activation and therefore impairs TLR 
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signalling355. Overall, miR-146a clearly has context-dependent roles in inflammatory 
suppression.  
miR-146a may also have a role in conferring endotoxin tolerance, although the precise 
mechanisms remain unclear. miR-146a-/- mice are hyper-sensitive to LPS, developing 
acute vascular responses following exposure to the endotoxin353, 356. Further, neonatal 
mice upregulate miR-146a expression to establish enteric homeostasis in intestinal 
epithelia347. Extensive mucosal damage is observed in mice where miR-146a expression 
is ablated by anti-miR-146a antibodies347, particularly as miR-146a is also involved in 
the induction of gene sets central to cell survival, differentiation and homeostasis347, 351. 
Tolerance towards LPS through the down-regulation of IRAK1 remains evident in the 
murine gut until 3 weeks of age, when IRAK1 expression is restored347, 357. These 
findings highlight that miR-146a expression in the gut is age-specific and that miRs 
have many roles in supporting a tolerogenic neonatal immune system.  
1.1.1.1.6.  miR-155 
miR-155 is an important pro-inflammatory mediator that regulates many inflammatory 
targets and influences entire networks of inflammatory genes. The anti-inflammatory 
action of IL10 has been shown to repress miR-155 during LPS stimulation in human 
and murine cell lines337, 358, highlighting the significance of its role during 
inflammation. The best characterised target of miR-155 is SOCS1, where the over-
expression of miR-155 in mice directly down-regulates the expression of SOCS1 and 
therefore, upregulates cytokine synthesis328, 341, 359, 360. miR-155 expression is increased 
in mononuclear leukocytes following stimulation with Poly I:C and IFNβ, as it can be 
induced by both MyD88- and TRIF-dependent signalling pathways 323, 361. miR-155 
induction is also associated with increased TNFα expression and therefore, its over-
expression in mice makes them more vulnerable to septic shock than wild types362. 
Further, the knockdown of miR-155 is associated with decreased numbers of Th1 and 
Th17 cells and mild experimental autoimmune encephalitis in mice363.  
miR-155 expression is upregulated by TLR2, 3, 4 and 9 signalling (reviewed in335).  
Cancer and embryonic kidney cell lines have also shown that miR-155 targets MyD88 
during Helicobacter pylori exposure364. The knockdown of miR-155 therefore leads to 
_____________________________________________________________________________ 
Chapter One: 
Introduction & Literature Review  Page 76 
 
 
increased MyD88 expression in human macrophage cells in response to oxidised low 
density lipoprotein (representing oxidative stress). Downstream of MyD88, miR-155 
has also been shown to repress IKKε (an inhibitor of NF-κB binding) and is associated 
with upregulated cytokine expression. H. pylori infection of gastric epithelial cells and 
human embryonic kidney cells shows that the over-expression of miR-155 leads to 
decreased IKKε365. Overall, miR-155 is ubiquitously expressed and has multiple roles 
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1.6. MIR EXPRESSION IN THE PLACENTA 
Placentation is a complex process influenced by epigenetic regulation that is responsive 
to environmental cues throughout gestation. The placenta is a dynamic organ that 
requires temporal regulation as it develops and therefore, the differential expression of 
epigenetic regulators play a critical role during pregnancy. As miRs influence vast 
networks of cellular processes, it is unsurprising that they are emerging as key 
regulators of placental gene expression.  
Microarray analyses have revealed that the human placenta expresses approximately 
600 different miRs, including those exclusive to gestational tissues366-369. MiRs that are 
involved in proliferation, differentiation, cell death and metabolism are abundant in the 
placenta366, 370. Placental miR biogenesis was first confirmed in trophoblasts which 
demonstrated the expression of proteins specific to facilitating miR synthesis and 
function, including Argonaute2 and Dicer371, 372. In fact, the knockdown of Dicer in 
human placental explants is associated with the over-proliferation of cytotrophoblast 
cells due to the absence of regulation by miRs372. Murine models have also shown that 
the knockout of miR biogenesis machinery in the placenta causes impaired 
angiogenesis and compromised embryonic survival373. Together, these studies highlight 
the role of miRs in regulating placental development and function. 
Interestingly, the preterm placenta has a unique miR profile, showing differential 
expression of 20 placenta-specific miRs compared to term374. Further, placental and 
decidual miRs are differentially expressed in preterm compared to term deliveries with 
chorioamnionitis375, 376, suggesting that inflammatory regulation occurs differently at 
different gestational ages. Deep-sequencing has shown that preterm villous trophoblasts 
differentially express 7 inflammatory miRs with intra-amniotic infection compared with 
iatrogentic preterm birth377. Notably, there is no difference observed in the decidua of 
these placentae, highlighting the tissue-specific nature of miR-based regulation.  
Unique clusters of miRs are differentially expressed throughout gestation in the 
placenta378. MiRs associated with angiogenesis and cell survival are dominant in first 
trimester placentae, while those associated with cell differentiation are upregulated in 
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third trimester placentae378. A majority of placental miRs are encoded on the C19MC 
chromosomal cluster, comprising the largest known cluster of human miRs321, 378. These 
miRs become differentially expressed during pathological pregnancies including 
hypoxia-induced fetal growth restriction379, 380, pre-eclampsia374, 381 and preterm 
delivery374. A microarray targeting 762 miRs expressed in term and first trimester 
trophoblasts and cell lines has identified several miR clusters exclusive to the placenta 
and 27 miRs that are differentially expressed according to gestational age382. This 
suggests there are diverse miR ‘fingerprints’ which are unique to gestational age and 
can influence the phenotype of placental cells. 
The differential expression of placental miRs may contribute to altered placental 
function, however a majority of such evidence remains correlational. For example, 
decreased placental expression of miR-16 and miR-21 is positively correlated with 
IUGR and adverse pregnancy outcome383. These findings are extrapolated from 
previous studies which suggest that miR-21 regulates cell proliferation and migration384, 
and miR-16 is involved in apoptosis and the regulation of the cell cycle385. Such 
analysis is open to interpretation as miRs can have tissue-specific patterns of expression 
and function386 and the pathogenesis of IUGR is multifactorial. Studies which transfect 
or interfere with miRs are therefore required to elucidate precise bioactive pathways or 
pathological mechanisms. As such, though different placental miRs have been 
identified by array analyses, their specific function is yet to be elucidated and are 
currently limited to in silico analyses. Further, there are few studies on the involvement 
of miRs in regulating TLR signalling. As miRs have been demonstrated to play critical 
roles in regulating networks of inflammation, it is important to characterise their roles 
in the regulation of placental inflammation and how their expression many be 
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1.7. THE REGULATION OF NEONATAL INNATE IMMUNITY 
BY MIRS 
Our understanding of miR expression in neonatal tissue is limited, although it may be 
key to understanding differences in immune regulation compared to adults. The 
differential expression of miRs that regulate TLR signalling may also explain 
differences between term and preterm cord blood cytokine responses to immune 
stimulation (see section 1.5). In adults, miRs play an important role in the development 
and differentiation of different immune cells (for review see359) and given their 
influence on developmental processes (e.g. angiogenesis and cell differentiation), they 
are also likely contributors to immune ontogeny.  
Literature regarding neonatal expression of immune-regulatory miRs is particularly 
scarce. The decrease in TNFα expression demonstrated by cord blood monocytes 
following LPS stimulation compared to adult monocytes (with no difference in NF-
κBp65 expression) may result from post-transcriptional regulation by miRs387. In fact, 
decreased miR-125b is associated with increased TNFα in cord blood monocytes 
following in vitro LPS exposure, while overexpression of miR-125b represses TNFα387. 
Most other studies on cord blood miR expression lack such mechanistic insight. For 
example, Charrier et al. associated increased miR-146a and decreased miR-155 
expression in cord blood pDCs with dysfunctional responses to viral stimulation 
relative to adult pDCs388, but did not confirm any changes in target mRNA expression. 
Similarly, 20 differentially expressed miRs were reported by a study comparing cord 
blood and adult mononuclear cells389, but their functional effects were not defined.  
In a seminal study on cord blood miR responses to endotoxin, Lederhuber et al. found 
the constitutive expression of miR-146a and miR-146b was comparable between cord 
blood and adult blood242. Following LPS stimulation, they observed a time-dependent 
upregulation of miR-146a and miR-146b in cord and adult blood, however, at 24 hours 
post-LPS exposure, there was a significant, two-fold upregulation of miR-146a in cord 
blood compared to adult blood. miR-146a therefore appears to be essential for the 
negative regulation of TLR4 signalling in both adults and neonates. This extended 
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period of increasing miR-146a expression observed in neonates may suggest an 
increased reliance on tolerogenic mechanisms. Notably, this study only characterised 
TLR4 expression alongside miR-146a/b and saw no difference between adult and cord 
blood responses, which is contrary to previous literature on stimulated TLR4 responses 
(Table 1.1). Further, known targets of miR-146a/b, IRAK1 or TRAF6 were not 
characterised.  
Microarrays of peripheral neonatal blood has shown that inflammation such as 
chorioamnionitis alters the preterm transcriptome, including miR expression390. Preterm 
neonates exposed to chorioamnionitis differentially express 488 genes compared to 
unexposed preterm neonates, with one of the top pathway regulators being miR-155 
(which was upregulated). Similarly, exposure to maternal smoking during pregnancy 
has been associated with increased cord blood miR-223 expression and decreased Treg 
numbers compared to cord blood from non-smoking mothers391. As miR-223 is mainly 
expressed on leukocytes and has roles in granulocyte development and function, it may 
directly repress Treg development. Further, the concentration of cigarette smoke toxins 
in maternal urine is associated with a dose-dependent decrease in cord blood miR-155 
expression. This suggests pro-inflammatory insults during pregnancy may alter post-
natal immune regulation, at least as mediated by miRs. Together, these findings begin 
to clarify a role for miRs in top-down regulatory networks of inflammatory gene 
regulation in neonates, though they require validation studies to confirm their 
mechanistic influence. 
1.7.1. REGULATION OF PRETERM NEONATAL INNATE IMMUNITY 
BY MIRS 
Currently, there is no literature assessing the impact of preterm delivery on immune 
miR expression in neonates. Differential expression of miRs according to gestational 
age could be a key factor contributing to differences between the preterm and term 
neonates’ immune function. Given that LPS-stimulated TLR4 expression is correlated 
with gestational age35, 288, it is likely that the expression of let-7e is also age-dependent. 
Existing studies on miRs expressed by preterm peripheral blood or placenta use 
microarray techniques that are more exploratory for the sake of establishing biomarkers 
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(for review see392). For example, peripheral blood from neonates with BPD shows 
increased miR-152, miR-30a, miR-133b and miR-7 expression compared to healthy 
neonates393. These findings could, however, be part of a more generalised inflammatory 
response.  
Though studies have provided observational insights into differential miR cluster 
expression in preterm tissues, none have offered mechanistic evidence as to how these 
miRs are altered in preterm neonates and what impact this has on innate immune 
function. For example, Rogers et al. identified differential expression of the miR14~92 
gene cluster in autopsies of preterm infants who died from severe BPD394. The cluster is 
typically associated with normal lung development395 but in the lung tissue of deceased 
infants with BPD, it was downregulated394. The controls for this study were deceased 
term infants that did not suffer from non-respiratory mortalities, which questions the 
validity of their use as a control group. To consolidate their findings, the authors 
showed decreased miR-17 and miR-19b in serum from preterm infants who later 
developed BPD. They postulated that because these miRs typically downregulate TGFβ 
expression, their downregulation would predispose preterm neonates to the aberrant 
inflammation observed in BPD sufferers. While it authors suggest these miRs could be 
used as biomarkers for screening BPD in vulnerable preterm infants, these findings do 
not confirm a precise mechanism for their role in aberrant respiratory inflammation. 
Identifying such mechanisms is critical, because it is likely that whole networks of 
inflammatory genes are impacted by the pathogenesis of BPD. Although miRs can be 
correlated with particular disease states or increased under experimental conditions, 
there often remains the need to demonstrate causality396.  
The difficulty in identifying miRs that regulate neonatal innate immunity is that miR 
expression can influence entire networks of genes. Preterm birth encompasses multiple 
phenotypes and in the context of inflammation, genetic alterations affect entire 
networks of physiology with both scientific and clinical implications. MiRs that are 
differentially expressed between term and preterm neonates may contribute to perturbed 
maturity of this system. Currently, knowledge of miR expression and the regulation of 
inflammatory responses by neonates remains in its infancy. Characterising differential 
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miR expression could therefore improve diagnostic and prognostic phenotyping or 
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1.8. SYNOPSIS 
Preterm neonates are at higher risk of developing inflammatory morbidities compared 
to their term-born counterparts. TLR signalling is a critical component of inflammation 
and in vitro cord blood studies have shown that it is impaired in preterm neonates. As 
such, decreased expression of TLRs and cytokines following innate immune stimulation 
is observed in preterm compared to term cord blood. Preterm neonates are also more 
susceptible to developing neutropenia and demonstrate decreased phagocytic and cell-
mediated killing capacities compared to term neonates. Such attenuation of innate 
immune function typically increases the likelihood of contracting infection. Preterm 
neonates are, however, also susceptible to developing conditions characterised by 
aberrant inflammation including neonatal sepsis, RDS and NEC. The mechanisms 
underlying these paradoxes in innate immune dysfunction remain unclear, but may 
relate to immature regulatory signalling. 
MiRs have recently emerged as critical regulators of inflammation, but their expression 
remains poorly characterised in the context of neonatal immunity. Differences in miR 
expression between preterm and term neonates could contribute to immune 
dysregulation. To address this gap in immunological research, this thesis will assess the 
impact of preterm delivery on the expression of miRs and other genes associated with 
TLR signalling in placenta and cord blood. The identification of mechanisms that 
predispose preterm neonates to inflammatory conditions could lead to more targeted 





Introduction & Literature Review  Page 84 
1.9. AIMS & HYPOTHESES 
The aim of this thesis is to investigate TLR signalling pathways in cord blood and 
placenta to understand factors that may contribute to inflammatory dysregulation in 
preterm neonates. Specifically, the studies contained in this thesis aim to: 
 Characterise the expression of genes associated with TLR signalling, including 
miRs and their targets (mRNAs) in preterm and term placenta at birth; 
 Characterise the expression of miRs and their mRNA targets, and cytokines in 
preterm and term cord blood at birth; 
 Characterise the expression of miRs and mRNAs in preterm and term cord 
blood following TLR stimulation to mimic exposure to common neonatal 
pathogens; 
o Identify how this response changes over time in vitro; and 
 Conduct a bioinformatics-based analysis of TLR signalling molecules to identify 
network-level alterations in preterm neonates’ peripheral blood and identify 
novel mechanisms and/or targets for further research.  
In the context of genes associated with TLR signalling, it is hypothesised that: 
 Preterm placenta will show a pro-inflammatory gene expression profile, 
including decreased anti-inflammatory miRs and increased inflammatory genes; 
 Preterm cord blood will show decreased anti-inflammatory miR expression and 
increased inflammatory gene expression compared to term at birth; 
 Following in vitro stimulation with TLR2, 3 and 4 agonists, preterm cord blood 
will show: 
o decreased expression of anti-inflammatory regulators including let-7e, 
miR-146a and SOCS1 compared to term; 
o increased expression of pro-inflammatory mediators including miR-155, 
miR-106a and IL6 compared to term; 
o increased pro-inflammatory gene expression over time compared to 
term cord blood; and 
 Preterm neonates with infection will demonstrate an inflammatory gene 
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2.1. SUBJECT RECRUITMENT 
Pregnant women (n= 152) presenting and delivering at term (control group; ≥ 37 weeks 
gestation), late preterm (32-37 weeks) or early preterm (≤ 32 weeks) gestation were 
recruited to this study by the researcher, research midwife or consulting neonatologist. 
All participants delivered at either the Lyell McEwin Hospital (LMH) or the Women’s 
and Children’s Hospital (WCH) between 2012 and 2016 in Adelaide, South Australia.  
All participants provided informed written consent for participation in this study. 
Neonates with known congenital malformations were excluded from this study. Clinical 
data were collected from health records including obstetric history, delivery details and 
neonatal health outcomes. Birth weight centiles were calculated using the GROW v6.7 
Customised Centile Calculator397. Intra-uterine growth restriction (IUGR) was defined 
as birth weight below the 3rd centile, while small for gestational age (SGA) was defined 
as birth weight below the 10th centile. Chorioamnionitis was confirmed using 
histopathological reports. Ethical approval for this study was provided by the human 
research ethics committees of the Lyell McEwin Hospital (Approval: 
HREC/14/TQEHLMH/158), Women’s and Children’s Hospital (Approval: 
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2.2. SAMPLE PROCESSING 
All reagents and materials are listed in Appendix I. 
All cord blood samples (n=152) were analysed for baseline gene expression (Chapter 4) 
and a subset of matched placentae (n=60) were analysed for baseline gene expression 
(Chapter 3). A subset of cord blood samples were also stimulated with TLR agonists in 
vitro for analysis in Chapter 5 (n=61). A smaller subset of samples from this group was 
used for a time course study of in vitro TLR stimulation in Chapter 6 (n=49). 
Limitations in cord blood volume were the determinants for sample size in each 
experimental chapter.  
2.2.1. CORD BLOOD 
Umbilical cord blood was collected in lithium heparin vials at delivery and processed 
within one hour of collection. Samples consisted of a mixture of arterial and venous 
cord blood. One aliquot of whole blood (300µL) was stored at -80°C for baseline 
analysis of RNA expression. Approximately 6mL of cord blood was used for in vitro 
culture. Remaining cord blood was centrifuged (10 minutes at 3,500 rpm, 4°C) and 
separated serum was removed and frozen at -20°C for cytokine analysis (section 2.4). 
2.2.2. PLACENTAL TISSUE 
Placentas were collected within one hour of delivery. Approximately 5mm of surface 
tissue from the maternal surface was removed prior to sampling to maximise genetic 
sampling of placental rather than maternal tissue. Samples were dissected from five 
cotyledons and pooled together. Dissection avoided obvious major vessels, blood clots 
and calcified or fibrous tissue. Aliquots of the pooled placental tissue (50mg) were 
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2.3. CORD BLOOD CULTURE AND STIMULATION 
2.3.1. WHOLE CORD BLOOD IN VITRO TLR STIMULATION  
Previous studies have highlighted the importance of cellular cross-talk and plasma-
based factors during an immune response (see 1.5.2). Further, previous findings from 
our laboratory have indicated that CBMCs do not respond as robustly to TLR 
stimulation as whole cord blood153. Whole cord blood was therefore used to investigate 
gene and protein expression in this thesis.  
Replicates of cord blood (100µL) were cultured in flat-bottomed 96-well cell culture 
plates at 37°C and 5% CO2. Cultures were rested overnight prior to TLR stimulation to 
minimise any potential effect of labouring delivery.  
TLR agonists were provided as lyophilised powders. PGN from the cell wall 
component of S. aureus and synthetic Poly I:C were reconstituted in sterile water, and 
LPS derived from E. coli was reconstituted in sterile DPBS, as per manufacturer’s 
instructions. 
Following an overnight resting period, cord blood was stimulated with PGN (10ng/mL; 
10μL), Poly I:C (50ng/mL; 10μL) or LPS (100ng/mL; 10μL). TLR agonist 
concentrations were determined from existing studies52, 256 and optimised in our 
laboratory. Both time and agonist concentration optimisation studies were performed, 
determining the peak synthesis phase of IL6 and TNFα production according to agonist 
dose and over time following TLR stimulation153.  TNFα and IL6 production both 
peaked and plateaued 6 hours following TLR stimulation. The 6 hour time point was 
therefore chosen for the analysis of TLR signalling pathways. Cord blood was removed 
from culture following 2, 6 or 24 hours stimulation, and triplicates were pooled (to 
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2.3.1.1. Stimulation of Diluted Cord Blood for Cytokine Analysis 
Whole cord blood was diluted in sterile saline (1:4) and plated (100μL) for cytokine 
analyses. Diluted blood was used in these experiments due to limitations in cord blood 
volumes available for analysis from preterm deliveries. Cord blood was cultured in 96 
well, flat bottom cell culture plates at 37°C and 5% CO2 and rested overnight prior to 
agonist exposure. Following resting, cord blood was stimulated with either PGN 
(100ng), Poly I:C (5μg) or LPS (1μg). Following stimulation, duplicate wells were 
pooled and collected at 2, 6 or 24 hours. Pooled samples were centrifuged at 10,000rpm 
for 5 minutes at 4°C for the separation of supernatant from haemocytes. Supernatant 
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2.4. ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) 
A select panel of pro- and anti-inflammatory cytokines and chemokines were 
investigated using ELISA. These targets have well-defined roles in TLR signalling (see 
1.3-5).  
2.4.1. Single-target ELISA 
Single target ELISAs (Human Duo Sets) were used to measure TNFα, IL6 and IL8 in 
cord blood serum to account for their typically increased serum concentration. The 
lower detection limit for TNFα was 15.625pg/mL, and the lower detection limit for both 
IL6 and IL8 was 31.25pg/mL. Samples being assayed for IL6 and IL8 were diluted 1:20 
in the appropriate reagent diluent prior to analysis. All inter-assay and intra-assay 
coefficients were below 10%. 
2.4.2. Multi-panel ELISA  
Multi-panel ELISA was used to determine the concentration of 7 cytokines and 
chemokines in cord blood serum (Milliplex MAP Kit). These consisted of GM-CSF, 
IL1α, IL1β, IL1RA, IL10, IL12p70 and MCP1. These cytokines are well-established as 
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Table 2.1. Detection Specifications for the Milliplex MAP Kit used for this thesis. 
Minimum limit of detection (pg/mL), intra-assay %CV and inter-assay %CV for 
cytokines measured using the Milliplex MAP Kit. 
Target Minimum Limit 
of Detection 
(pg/mL) 
Intra-assay %CV Inter-assay %CV 
GM-CSF 7.5 3.1 10.1 
IL1α 9.4 3.3 12.8 
IL1β 0.8 2.3 6.7 
IL1RA 8.3 2.1 10.7 
IL10 1.1 1.6 16.8 
IL12p70 0.6 2.2 16.7 
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2.5. RNA EXTRACTION AND PURIFICATION  
2.5.1. RNA Extraction from Pooled Placental Tissue 
RNA extraction from placenta was performed as previously described using 
TRIzol®398. Frozen pooled placental tissue (50mg) was homogenised in TRIzol using 
2.8mm Precellys Zirconium Oxide Beads and a Precellys Tissue Homogeniser (2x 20 
second cycles at 5,500rpm). Chloroform (300µL) was added to homogenised samples 
and tubes were manually agitated for 15 seconds. Samples were incubated at room 
temperature for 10 minutes and then centrifuged (10 minutes at 10,000rpm, 4°C). The 
upper, clear aqueous phase was transferred into a new RNase-free tube and cold 
isopropanol (4°C, 1mL) was added. Samples were incubated for 10 minutes at room 
temperature. RNA was pelleted by centrifugation (10 minutes at 10,000rpm, 4°C) and 
supernatant was discarded. The pellet was resuspended in cold RNase-free ethanol 
(1.5mL) and centrifuged (5 minutes at 7,500rpm, 4°C). Supernatant was discarded and 
the pellet was eluted in RNase-free water (100μL). 
RNA was purified using the miRNeasy Mini Kit and RNase-Free DNase Set, according 
to manufacturer’s protocol. Purified RNA was eluted in RNase-free water (50µL) and 
its concentration was determined using a Nanophotometer. RNA integrity was 
determined using a RNA 6000 Nano kit and Bioanalyser.  
Placental RNA with RNA integrity numbers (RINs) ≥ 5 were used for analysis. Low 
RINs are typically obtained from placental tissue due to the increased density of RNA 
in these samples which produces a high level of background fluorescence during 
electropherogram analysis on microfluidic chips. However, placental RNA integrity ≥ 5 
has been shown to be sufficient for reliable qPCR analysis399, 400. 
2.5.2. RNA Extraction from Cord Blood 
RNA was extracted from whole cord blood using TRIzol LS® Reagent and purified 
using a miRNeasy Mini Kit, which extracts all RNA transcripts longer than 18 
nucleotides. Three volumes of TRIzol LS were added to one volume of cord blood and 
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room temperature for 5 minutes to allow for dissociation of nuclear contents. 
Chloroform (200μL) was added to each sample and agitated for 15 seconds. The RNA 
extraction and purification procedure from this stage onwards was identical to that 
previously described for placental tissue (see section 2.5.1.). Cord blood RNA with 





General Methods  Page 94 
 
2.6. QUANTITATIVE REAL TIME REVERSE TRANSCRIPTION 
POLYMERASE CHAIN REACTION (qRT-RT-PCR) 
2.6.1. qRT-RT-PCR for miRNA  
Purified miRNA (10ng) was reverse transcribed using a Taqman MicroRNA Reverse 
Transcription Kit. The manufacturer’s protocol was modified slightly to accommodate 
for five RT primer targets per reverse transcription reaction. This was performed to 
enable consistency and the efficient use of reagents. Samples were amplified in 
reactions containing RNA in Nuclease-free water (10ng in a 5μL volume). Pooled 
reverse transcription contained a mixture of dNTP mix (0.19µL), Multiscribe enzyme 
(1.25μL), 10xRT buffer (1.25μL), RNase inhibitor (0.24μL), five RT primers (1.12μL 
each) and RNA in nuclease-free water (5μL). Seven miR primers were used for cDNA 
synthesis (let-7e, miR-155, miR-146a, miR-146b, miR-106a, RNU6B and RNU48 (see 
Table 2.2)).  The reaction mixture was adjusted to a total volume of 13.77μL using 
nuclease-free water. The reaction was incubated on a Thermal Cycler at 16°C for 
30min, 42°C for 30min and 85°C for 5min, and terminated at 4°C.  
Relative miRNA expression was quantified using Taqman MicroRNA Assays. Each 
20µL reaction contained the cDNA template (10ng in 1.33 µL), RNase-free water 
(7.67μL), the relevant Taqman gene microRNA expression assay (1µL) and Taqman 
Universal PCR Master Mix II without UNG (10µL). Relative miR expression was 
determined using the comparative cycle threshold (2-ΔCT) method using the QuantStudio 
12K Flex PCR machine. As miRs are short, non-coding RNA transcripts, endogenous 
snoRNAs are often used as comparative controls during PCR. The snoRNAs RNU48 
and RNU6B were therefore identified as candidate housekeeping genes from previous 
literature investigating cord blood242 and placental miR expression386. The PCR 
consisted of two holding stages (2 min at 50°C and 10min at 95°C) and two 
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Table 2.2. A summary of miR primers used for this thesis. The miR assay name and 
assay ID for primers used in this thesis.  
miR Assay name Manufacturer’s Assay ID 
let-7e hsa-let-7e-5p 002406 
miR-155 hsa-miR-155 002623 
miR-146a hsa-miR-146a 000468 
miR-146b hsa-miR-146b 001097 
miR-106a hsa-miR-106a-5p 002169 
RNU6B NR_002752 001093 
RNU48 NR_002745 001006 
2.6.2. qRT-RT-PCR for mRNA Targets 
Purified RNA was reverse transcribed using a SuperScript™ III First-Strand Synthesis 
SuperMix for qRT-PCR according to manufacturer’s protocol. Briefly, samples were 
amplified in 20µL reactions containing RNA (50ng) in RNase-free water, 2xRT 
enzyme mix (10µL) and RT Enzyme mix (2µL), constituted in RNAse-free water. The 
cDNA synthesis reaction was performed on a Thermal Cycler at 25°C for 10 minutes, 
50°C for 30 minutes and 85°C for 5 minutes. Samples were cooled to 4°C and E.coli 
RNase H (1µL) was added to degrade any remaining RNA. Samples were reheated and 
held at 37°C for 20min. Converted cDNA was stored at -20°C until qPCR.  
The PCR reaction was performed using TaqMan® Gene Expression Assays. Each 20µL 
reaction contained the cDNA template in RNasefree water (100ng in 2µL), the relevant 
Taqman gene expression assay (1μL each) and 2X Taqman® Gene Expression Fast 
Master Mix (10µL). Taqman gene expression assays included β-actin (Human ACTB, 
Hs99999903_m1), IL6 (Hs00985639_m1), IL10 (Hs00961622_m1), IRAK1 
(Hs01018347_m1), MyD88 (Hs00182082_m1), NF-κB1 (Hs00765730_m1), SOCS1 
(Hs00705164_s1), TLR2 (Hs00610101_m1), TLR3 (Hs01551078_m1), TLR4 
(Hs01061963_m1) and TRAF6 (Hs00377558_m1). Relative mRNA expression was 
determined using the QuantStudio 12K Flex PCR machine. The PCR consisted of two 
holding stages (2 minutes at 50°C and 20 seconds at 95°C) and an amplification stage 
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to determine mRNA abundance relative to the appropriately determined housekeeping 
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2.7. BIOINFORMATICS  
2.7.1. TLR SIGNALLING PATHWAY ANALYSIS 
In silico bioinformatics and statistical analyses were used to examine networks of gene 
expression in preterm neonatal TLR signalling pathways. We analysed two publicly 
available custom RNA-sequencing (RNA-seq) datasets profiling whole blood from 
early and late preterm neonates published by other authors390, 402, 403. One of these 
datasets utilised an Illumina HT12 platform validated using the CodeLink gene 
platform to perform an array on whole peripheral blood collected from neonates 
admitted to the neonatal unit who were having their blood sampled for clinical reasons 
including maternal thyroid disease, jaundice or suspected infection403. The second 
dataset was from a study that sought to characterise neonatal sepsis using blood from 
neonates with suspected sepsis. Gene expression was analysed using an Affymetrix 
GeneChip GGh3 Transcriptome Array390, 402. 
The NCBI Gene Expression Omnibus (GEO) is a public repository of high-throughput 
experimental data404. The software package GEOquery was used to download the 
relevant datasets from the GEO repository (GSE69686 and GSE25504). The GEO2R 
web application was then used to analyse differentially expressed genes within these 
microarray datasets. Data were normalised using log transformation before analysis. 
Bioinformatics analyses were performed in collaboration with Dr Jimmy Breen 
(Bioinformatics core-facility manager, Robinson Research Institute, University of 
Adelaide) using the R software package, limma. Limma is a library used to analyse gene 
expression microarray data by making simultaneous, multiple comparisons between 
RNA targets405. This software package was utilised as it employs empirical Bayesian 
methods that provide robust analyses where array numbers are low406. The R software 
package was then used to generate heat maps to represent gene expression in counts per 
million (cpm). 
The Kyoto Encyclopaedia of Genes and Genomes (KEGG) is a standardised reference 
for the definition of biological pathways that uses information from large-scale 
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expressed genes within the TLR signalling pathway (KEGG ID: hsa04620) were 
identified from the datasets extracted from GEO and these were generated as a heat-
map. The top 20 KEGG pathways differentially expressed according to neonatal 
bacterial infection and neonatal sepsis.  
2.7.2. CELL TYPE ENRICHMENT ANALYSIS 
The Immuno-Navigator database408 as used to query target genes in the TLR signalling 
pathway (defined by KEGG) to identify correlation scores of gene co-expression in 
specific adult tissues (sorted by significance of enrichment). The correlation network 
hub prediction tool was used to determine how many networks the listed genes were 
involved in, for specific immune cell types. The sub-functionalisation of these genes 
was isolated in healthy, unstimulated adult peripheral blood immune cells. Publicly 
available data from adult whole blood was used to explore the expression of these genes 
in specific immune cell types, as there is currently no data derived from neonates. Heat-
maps were generated according to the expression of inflammatory genes within the data 
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2.8. STATISTICAL ANALYSES 
Data were analysed using the Statistical Package for Social Sciences (SPSS v24). 
Graphs were generated using GraphPad Prism software v6.00 (GraphPad Software, 
Inc.). Where normally distributed, data regarding clinical characteristics were analysed 
using t-tests or ANOVAs and presented as mean ± SD, unless otherwise indicated. 
Where data were not normally distributed, clinical data were analysed using Mann-
Whitney U or Kruskal-Wallis tests. qPCR data were logarithmically transformed (log10) 
to normalise data for analysis. Raw data were presented as median (25th-75th centile), 
unless otherwise indicated. All data reporting frequencies were analysed using 
Pearson’s Chi-squared tests. ANCOVAs or MANCOVAs were used to analyse log-
transformed qPCR data, with pre-eclampsia, labouring delivery, maternal smoking 
during pregnancy, birthweight centile, neonatal sex, chorioamnionitis and antenatal 
betamethasone exposure used as covariates where relevant. Post-hoc comparisons were 
conducted using t-tests or ANOVAs where appropriate. An a priori Bonferroni 
correction was made to the critical alpha level for post-hoc comparisons. Spearman’s 
correlations were used to assess the relationship between the matched sample 
expression of untransformed miR and mRNA data. An alpha level of 0.05 was 
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3.1. ABSTRACT 
Background 
Preterm birth is commonly associated with an inflammatory aetiology. Markers of placental 
inflammation, such as genes associated with TLR signalling, may therefore be associated 
with innate immune immaturity in the preterm neonate. TLR signalling is regulated post-
transcriptionally by miRs and the expression of these genes may be critical in regulating the 
in utero environment. Intrauterine perturbations caused by maternal physiology such as pre-
eclampsia, smoking and growth restriction also affect placental inflammation. This study 
aimed to characterise the expression of miRs and mRNAs in the TLR signalling cascade in 
term and preterm placenta. 
Methods and Results 
Term and preterm placenta were collected and homogenised at delivery. The expression of 
miRs and mRNAs was quantified using qPCR. There was no difference in the expression of 
the miRs or mRNAs assessed between term and preterm placenta. Term, but not preterm, 
placental miR-155 and miR-146a expression were correlated with their respective targets 
SOCS1 (p=0.015) and IRAK1 (p=0.005). Maternal smoking during pregnancy was 
associated with decreased let-7e (p=0.039) and increased TLR2, MyD88, IRAK1, NF-κB1, 
SOCS1, IL6 and IL10 expression (all p<0.05).  
Conclusion 
An association between miRs and their mRNA targets was evident in term but not preterm 
placenta, suggesting TLR signalling may not be regulated in the same manner throughout 
gestation. Further, maternal smoking during pregnancy was associated with decreased 
regulatory let-7e expression and increased expression of genes in the TLR signalling 
cascade. Together, these data suggest that the regulation of the TLR signalling pathway may 
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3.2.  INTRODUCTION 
Intrauterine inflammation (IUI) is the most common known cause of preterm birth10, 110, 145. 
Acute or prolonged IUI (pathogen driven or sterile) is associated with poor fetal outcomes 
such as IUGR409 and fetal death130, 131. Despite the increased prevalence of these adverse 
outcomes, the impact of IUI on the neonatal innate immune system remains poorly 
characterised.  
In animal models of infection, IUI ‘programs’ the postnatal immune response. Rodents 
exposed to endotoxin in utero show attenuated pro-inflammatory cytokine responses when 
re-exposed as neonates101, 103. These mice also demonstrate decreased leukocyte recruitment 
and TNFα and IL1β production. In humans, intrauterine infection increases inflammation in 
the placenta, cord blood and neonatal peripheral blood139, 409. It is therefore commonly 
associated with inflammatory morbidities including sepsis410, NEC411 and CLD412. Other 
inflammatory insults such as maternal smoking during pregnancy have also been associated 
with increased numbers of pro-inflammatory M1 macrophages in the placenta413 and 
subsequently, an increased incidence of childhood atopy amongst offspring414. Overall, 
increased inflammatory signalling in utero may contribute to adverse pregnancy and 
neonatal health outcomes. 
TLRs are key drivers of an inflammatory response. Their activation by class-specific ligands 
elicits a cascade of intracellular signalling through adaptor molecules, resulting in increased 
cytokine production. Increased TLR activation has been associated with parturition in 
humans415 and murine models where administering TLR agonists to the uterine horn induces 
delivery416. As such, studies in mice have also demonstrated that inhibiting TLR4 signalling 
arrests preterm birth normally induced by endotoxin417, 418.  TLR signalling can be regulated 
by negative or positive feedback loops involving cytokines, transcription factors and 
epigenetic regulators, including miRs. MiRs are non-coding mRNAs that repress gene 
translation post-transcriptionally, and can therefore regulate different stages of TLR 
signalling. For example, let-7e targets and represses the TLR4 transcript to dampen TLR 
signal activation, while indirect regulators such as miR-155 repress SOCS1 and therefore 
increase cytokine signalling. Overall, the regulation of TLR signalling in the placenta 
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Previous studies highlight the key role of miRs during placentation366, 370. Altered signatures 
of miR expression in the placenta and fetal membranes have been associated with poor 
pregnancy outcomes including preterm birth374, 377. Preterm placenta demonstrate increased 
pro-inflammatory419, 420 miR-210 and miR-223 expression in the amnion compared to 
term421. Additionally, pregnancies conceived by assisted reproductive technology that 
deliver preterm show increased placental TLR4 signalling and NF-κB activation, and 
decreased miR-146a expression compared to term placenta422. Notably, a majority of these 
studies on placental miR expression have only found associations between miRs and poor 
pregnancy outcomes, without characterising target genes directly. As such, the impact of 
differential miR expression on placental TLR signalling pathways remains poorly 
understood, particularly in association with preterm delivery. 
This study aimed to profile components of the TLR signalling cascade (both miRs and their 
mRNA targets) in term and preterm placenta. Due to previously reported impacts on 
inflammatory signalling, betamethasone exposure423, maternal smoking424, pre-eclampsia425 
and IUGR426 were also considered in this analysis. It was hypothesised that preterm placenta 
would show increased expression of pro-inflammatory genes associated with TLR signalling 
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3.3. METHODS 
3.3.1. PARTICIPANTS & SAMPLE COLLECTION 
60 pregnant women presenting at the LMH and WCH, who delivered at term (≥ 37 weeks) 
or preterm (<37 weeks) gestation were recruited to this study. Clinical data were obtained 
from maternal and neonatal health records, including obstetric history and neonatal 
outcomes (see section 2.1). Following delivery, placenta were immediately collected and 
tissue was pooled from five cotyledons. 
3.3.2. WHOLE RNA EXTRACTION 
TRIzol® reagent was used to extract RNA from pooled placental tissue (see section 2.5.1). 
Briefly, three volumes of TRIzol were added to one volume of placenta and samples were 
mechanically homogenised. Lysates were separated by centrifugation with chloroform to 
retrieve the interphase for subsequent washing with isopropanol and ethanol. RNA was 
eluted in RNase free water and purified using a miRNeasy Mini Kit and DNAse I treatment 
as per manufacturers’ protocol. RINs were assessed using a bioanalyser, where a RIN≥ 5 
was considered sufficient for PCR analysis. 
3.3.3. qRT-PCR ANALYSIS OF miRNA EXPRESSION  
RNA (10ng) was reverse transcribed using a Taqman® MicroRNA Reverse Transcription 
Kit according to manufacturer’s protocol that was slightly modified for optimal cDNA 
output (see section 2.6.1). This involved pooling a maximum of five RT primers per batch in 
a single RT mixture. Reverse transcription targeted seven primer sequences: let-7e, miR-
155, miR-146a, miR-146b, miR-106a, RNU6B and RNU48. Relative miRNA expression was 
quantified using Taqman® MicroRNA Assays in 20µL reactions containing 1.33µL of 
cDNA. qRT-PCR utilised the comparative cycle threshold (2-ΔCT) method to determine miR 
abundance relative to the reference genes RNU48 and RNU6B. 
3.3.4. qRT-PCR ANALYSIS OF mRNA EXPRESSION 
Purified RNA (100ng) was reverse transcribed using a SuperScript™ III First-Strand 
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PCR was used to quantify the relative expression of miR targets including TLR2, TLR3, 
TLR4, MyD88, IRAK1, TRAF6, NF-κB1, IL6, IL10 and SOCS1 relative to the housekeeping 
gene, β-actin. qRT-PCR was performed using TaqMan® Gene Expression Assays and each 
20µL reaction contained 2μL of the cDNA template.  
3.3.5. STATISTICAL ANALYSES 
Data were analysed using SPSS v24. Demographic and clinical data are presented as mean ± 
SD, unless otherwise indicated. Frequency data were analysed using Chi-squared tests. T-
tests and Mann-Whitney U tests were used to compare continuous data according to 
gestational age groups. Gene expression data are presented as median (25th-75th centile), 
unless otherwise indicated. Data were logarithmically transformed (log10) for subsequent 
parametric analysis. ANCOVAs or MANCOVAs were used to analyse qPCR data, with pre-
eclampsia, labouring delivery, neonatal sex, maternal smoking during pregnancy, 
birthweight centile, chorioamnionitis and antenatal betamethasone exposure used as 
covariates. Post-hoc comparisons were made using t-tests where appropriate, with an a 
priori Bonferroni correction made to the critical alpha level. Spearman’s correlations were 
used to assess the relationship between matched sample expression of miR and mRNA data. 
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3.4. RESULTS 
3.4.1. PARTICIPANT CHARACTERISTICS 
Clinical and demographic characteristics of the term (n=38) and preterm (n=22) deliveries 
included in this analysis are shown in Table 3.1. Maternal age, BMI, ethnicity, gravidity, 
parity, cigarette smoking during pregnancy, mode of delivery and the incidence of multiple 
pregnancy were not significantly different between preterm and term deliveries. The 
incidence of pre-eclampsia was more frequently associated with preterm (36%) than term 
delivery (5%; χ2(1)=9.703, p=0.002). Preterm deliveries had a lower gestational age than 
term neonates (t(58)=12.636, p<0.001) and were more frequently exposed to antenatal 
betamethasone compared to term neonates (58% vs 8%, respectively; χ2(1)=18.675, 
p<0.001). Birthweight was lower in preterm compared to term neonates (t(58)=7.060, 
p<0.001), but birthweight centile, and incidence of SGA and IUGR was comparable 
between the groups. Birth length and head circumference were lower in preterm compared to 
term neonates (t(29.631)=6.901, p<0.001; and t(31.519)=6.578, p<0.001, respectively). 
Preterm neonates had lower APGAR scores at 1 (U=273, p=0.009) and 5 minutes compared 
to term neonates (U=245, p<0.001). Placental weight was lower in preterm compared to 
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Table 3.1. Maternal demographic and neonatal characteristics for preterm and term 
deliveries of placenta analysed in Chapter 3. Values are given as mean± SD or n (%), 
unless otherwise indicated. P-values were calculated using Chi-square tests, t-tests or Mann-
Whitney U tests, p≤ 0.05. 
 Term Preterm p value 
n=38 n=22 
Gestational age (completed weeks), median 
(min-max) 
39 (37-41) 35 (30-36) <0.001 
Maternal demographics: 
           Age, years 
           BMI, kg/m2 
           Gravidity, median (min-max) 
           Parity, median (min-max) 
           Smoking during pregnancy 
           Ethnicity: 
                          Caucasian 
                          Indigenous 









































Multiple pregnancy 1 (3) 2 (9) 0.269 
Labouring delivery 
Mode of delivery: 
 Emergency Caesarean section  
 Elective Caesarean section  
















 Weight, g 













Birth centile, % 
SGA 
IUGR 
Birth length, cm 


























Antenatal Betamethasone 3 (8) 13 (58) <0.001 
APGARS, median (min-max): 
           1 min 
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3.4.2. THE EXPRESSION OF HOUSEKEEPING GENES 
Two snoRNAs (RNU48 and RNU6B) were identified from the literature as candidate 
housekeeping genes242, 386. Both snoRNAs were expressed in placenta. RNU48 was more 
consistently expressed in placenta (median CT 28.6 (IQR=27-30)) compared to RNU6B (CT 
32.5 (IQR=31-34)). As RNU48 was less variable than RNU6B and did not differ between 
gestational age groups, it was deemed the most appropriate housekeeping gene for this 
study.  
3.4.3. THE EXPRESSION OF GENES INVOLVED IN TLR SIGNALLING 
IN THE PLACENTA  
There was no difference in the expression of miRs (let-7e, miR-155, miR-146a, miR-146b or 
miR-106a) or mRNAs associated with TLR signalling (TLR2, TLR4, MyD88, IRAK1, NF-
κB1, SOCS1, IL6 or IL10) between term and preterm placenta, when adjusting for the 
covariates pre-eclampsia, birthweight centile, neonatal sex, labouring delivery, maternal 
smoking, chorioamnionitis and antenatal betamethasone (Fig. 3.1-5).  
Only 57% of term placentas and 73% of preterm placentas expressed detectable levels of 
TLR3 mRNA. The expression of TRAF6 was not detected in the placenta (Table 3.2). 
 
Fig. 3.1. Placental let-7e and TLR4 expression following term and preterm delivery. 
Placental expression of let-7e relative to RNU48 (A), and TLR4 expression relative to β-





The Expression of Genes Associated with TLR signalling in the Placenta 
  Page 109 
 
Fig. 3.2. Placental miR-155, MyD88 and SOCS1 expression following term and preterm 
delivery. Placental expression of miR-155 relative to RNU48 (A), and MyD88 (B) and 
SOCS1 expression relative to β-actin (C), following term and preterm delivery. Note: y-axes 
are presented on a logarithmic scale.  
 
Fig. 3.3. Placental miR-146a, miR-146b and IRAK1 expression following term and 
preterm delivery. Placental expression of miR-146a (A) and mir-146b (B) relative to 
RNU48, and IRAK1 expression relative to β-actin (C), following term and preterm delivery. 
Note: y-axes are presented on a logarithmic scale.  
 
Fig. 3.4. Placental miR-106a and IL10 expression following term and preterm delivery. 
Placental expression of miR-106a relative to RNU48 (A), and IL10 expression relative to β-
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Fig. 3.5. Placental TLR2, NF-κB1 and IL6 expression following term and preterm 
delivery. Placental expression of TLR2 (A), NF-κB1 (B) and IL6 (C) relative to β-actin, 
following term and preterm delivery. Note: y-axes are presented on a logarithmic scale.  
Table 3.2. The frequency of expression for genes associated with TLR signalling in term 
and preterm placenta. The frequency of expression of genes (mRNA) in term and preterm 
placenta. Data are expressed as the frequency (n, %), p≤ 0.05. 








TLR2 21 (100%) 14 (93%) 0.456 
TLR3 12 (57%) 11 (73%) 0.402 
TLR4 21 (100%) 15 (100%) 0.422 
MyD88 21 (100%) 14 (93%) 0.420 
IRAK1 21 (100%) 14 (93%) 0.420 
TRAF6 0 (0%) 0 (0%) - 
NF-κB1 21 (100%) 15 (100%) 0.422 
IL10 18 (86%) 13 (87%) 0.450 
IL6 21 (100%) 14 (93%) 0.420 
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Within our statistical model, the contribution of maternal smoking was identified as having a 
significant, independent effect on let-7e expression. Post-hoc analyses showed that maternal 
smoking was associated with decreased placental let-7e expression (p=0.017), but there was 
no associated change in the expression of its target, TLR4 (Fig.3.6). Maternal smoking was 
also associated with increased placental TLR2 (p=0.033), MyD88 (p<0.001), IRAK1 
(p<0.001), NF-κB1 (p=0.001), SOCS1 (p<0.001), IL6 (p=0.014) and IL10 expression 
(p=0.043; Fig.3.7). There was no effect of maternal smoking on the expression of any other 
miRs examined. 
 
Fig. 3.6. Placental let-7e and TLR4 expression according to maternal smoking during 
pregnancy. Placental expression of let-7e relative to RNU48 (A), and TLR4 expression 
relative to β-actin (B) in mothers who smoked and mothers who did not smoke cigarettes 











Fig. 3.7. The expression of genes associated with TLR signalling in the placenta according to maternal smoking during pregnancy. The 
expression of TLR2 (A), MyD88 (B), IRAK1 (C), NF-κB1 (D), SOCS1 (E), IL6 (F) and IL10 (G) relative to β-actin in placenta from mothers who 
smoked and mothers who did not smoke during pregnancy, independently of gestational age. Note: the y-axes are presented on a logarithmic 





The Expression of Genes Associated with TLR signalling in the Placenta Page 113 
 
3.4.4. THE CORRELATION BETWEEN PLACENTAL miR AND TARGET 
mRNA EXPRESSION  
Placental miR-155 and SOCS1 expression were positively correlated (ρ=0.377, p=0.028). 
When data were split by gestational age, the correlation was significant in term (ρ=0.535, 
p=0.015), but not preterm placenta (Fig. 3.8).  
 
Fig. 3.8. A scatterplot of SOCS1 and miR-155 expression in term and preterm placenta. 
The relative expression of miR-155 correlated with its target, SOCS1 in preterm and term 
placenta. Note: y-axis presented on a logarithmic scale, *p<0.05. 
Placental miR-146a and IRAK1 expression were positively correlated (ρ=0.37, p=0.031). 
When data were split by gestational age, the correlation was significant in term (ρ=0.584, 
p=0.005) but not preterm placenta (Fig 3.9).  
Placental let-7e, miR-146b and miR-106a were not correlated with the expression of their 
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Fig 3.9. A scatterplot of IRAK1 and miR-146a expression in term and preterm placenta. 
The relative expression of miR-146a correlated with its target IRAK1, in preterm and term 
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3.5. DISCUSSION 
This study sought to characterise the expression of miRs that regulate the TLR signalling 
cascade and their targets in term and preterm placenta. No difference in miR or mRNA 
expression was observed between term and preterm placenta. Correlational relationships 
between miR and target mRNA expression were identified more frequently in term 
compared to preterm placenta. The presence of these relationships begins to suggest the 
post-translational regulation of mRNAs by miRs may be more mature in term compared to 
preterm placenta. Additionally, maternal smoking was associated with decreased regulatory 
let-7e and increased TLR2, MyD88, IRAK1, NF-κB1, SOCS1, IL6 and IL10 expression 
independently of gestational age, suggesting a pro-inflammatory placental phenotype. 
The current study assessed gene expression using homogenised term and preterm placenta. 
A homogenous cell population was used to provide a more accurate reflection of in utero 
conditions, as others have shown cytotrophoblasts from first trimester placenta express 
TLR2 and TLR4, while syncytiotrophoblasts do not427. Similarly, our analysis of 
homogenised tissue found no difference between term and preterm placental expression of 
TLR2, TLR4 or TLR4’s regulator, let-7e at birth. These findings are in line with previous 
studies that have shown second428 and third trimester placental trophoblasts express 
comparable TLR1-10 mRNA429. These authors have also shown that following TLR 
stimulation, third trimester trophoblasts from preterm placenta expressed decreased IL6 and 
TNFα expression compared to term429. They therefore postulated that differences in term 
and preterm placental immunity may be due to post-transcriptional regulation, which is 
supported by our correlational analyses. 
Relationships between miRs and their targets provide preliminary insights into active 
inflammatory regulation. As such, we found a positive correlation between miR-146a and 
IRAK1 in term, but not preterm placenta. miR-146a typically downregulates MyD88-
dependent signalling through targeting IRAK1 and TRAF6 in trophoblast cell lines, 
ultimately decreasing IL6 and IL10 production422. This also supports other authors’ 
observations that preterm trophoblast cytokine expression is decreased compared to term 
trophoblasts429. Overall, these findings suggest that during inflammation, the preterm 
placenta has diminished regulatory capacity on inflammatory gene expression. Inflammatory 
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regulation is, however, a complex process that involves networks of gene signalling and 
therefore these findings should be interpreted with caution. Ultimately, the relationship 
between these placental miRs and their targets needs to be confirmed using tissue explant 
stimulation, knockdown cell-lines or luciferase assays.  
Term placenta also showed a positive correlation between miR-155 and its target SOCS1, 
while preterm placenta did not. This again suggests immune-regulatory relationships may be 
immature in the preterm placenta or that other genes play a more important role in regulating 
SOCS1 expression. miR-155 is associated with increased cytokine signalling through the 
repression of its target, SOCS1341. Early TLR signalling is typically associated with 
decreased let-7e to allow for the upregulation of TLR4. As inflammation proceeds, miR-155 
is then upregulated to repress SOCS1, indirectly increasing cytokine signalling341. Later 
during inflammation, IL10 increases to form a negative feedback loop and dampen the 
immune response, which includes the targeted suppression of miR-155337 to restore SOCS1 
expression and decrease cytokine signalling. While TLR signalling is poorly characterised in 
studies on placental tissue, it has been demonstrated that placental SOCS1 expression 
exceeds that of the spleen430. It is therefore postulated that placental expression of SOCS1 is 
integral to maintaining a tolerogenic state in utero. As our analysis preliminarily shows no 
association between miRs and their targets in the preterm placenta, this could indicate a 
predisposition towards IUI.  
Maternal smoking during pregnancy impairs cytotrophoblast development431 and is also 
associated with increased oxidative stress432 and inflammation413. Smoking therefore has the 
potential to affect immunomodulation at the feto-maternal interface. The present study 
shows that maternal smoking was associated with decreased let-7e expression and increased 
expression of TLR2, MyD88, IRAK1, NF-κB1, SOCS1, IL6 and IL10. This increase in 
inflammatory signalling molecules alongside decreased (let-7e) or unchanged regulatory 
miR expression (miR-155, miR-146a and miR-106a) suggests smoking alters the 
inflammatory profile of the placenta. These findings could indicate perturbed immune 
regulation in association with maternal smoking, which supports other studies’ evidence of a 
pro-inflammatory in utero environment driven by increased ROS production and cellular 
apoptosis154, 433. In a sample of term placentae, Maccani et al. found an association between 
maternal smoking and decreased miR-146a expression, but did not confirm the expression of 
its target, IRAK1434. Conversely, our data did not observe any association between smoking 
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and placental miR-146a expression, but confirmed an increase in IRAK1 expression. 
Maternal smoking during pregnancy is also a risk factor for preterm birth435, which is 
commonly associated with premature inflammatory activation in utero436. While we could 
not determine a direct interaction between gestational age and maternal smoking, increased 
inflammatory gene expression in conjunction with increased anti-inflammatory IL10 and 
SOCS1 expression in our sample could be evidence of the placenta attempting to restore the 
tolerogenic cytokine balance in utero. Ultimately this requires further investigation using a 
larger sample size recruited with maternal smoking as a primary outcome, though it remains 
evident maternal smoking is associated with altered inflammatory gene expression.  
Glucocorticoids are immunosuppressive and have been shown to decrease placental 
cytokine expression in vitro437. However, the same authors found no difference in placental 
explants’ baseline cytokine production between asthmatic mothers who did and did not use 
inhaled glucocorticoids438. Similarly, our sample did not find any difference in placental 
inflammatory gene expression according to antenatal glucocorticoid exposure. We also 
observed no change in the expression of these genes in association with pre-eclampsia or 
chorioamnionitis, which have previously been associated with the differential miR 
expression in the context of microarrays374, 376. Although these conditions are typically 
associated with inflammation, it is likely we did not observe any effect because these 
exposures co-occur within our sample. Further studies are therefore required to separate 
their independent effects.  
Interestingly, we found no difference in the expression of the genes measured according to 
neonatal sex. Previous studies have identified sex-specific expression of both the placental 
glucocorticoid receptor439 and cytokines437. Notably, these studies were conducted using 
asthmatic mothers, which indicates that the fetus responds differently to an inflammatory in 
utero environment depending on its sex. Others have confirmed that trophoblasts from 
pregnancies carrying a male fetus increased pro-inflammatory and decreased anti-
inflammatory cytokine production in response to LPS in vitro440. The authors postulated this 
response could be a mechanism for the increased incidence of males being born preterm441. 
Our results, however, do not indicate any significant interaction between fetal sex and 
unstimulated gene expression in homogenised placental tissue samples, irrespective of 
gestational age. A different cohort may therefore be necessary to investigate sex-differences 
in placental TLR signalling.  
 
Chapter 3: 
The Expression of Genes Associated with TLR signalling in the Placenta Page 118 
 
A major strength of the current study is that it is the first to use qPCR to assess miR 
expression and the expression of previously validated targets in the preterm and term 
placenta. Although our findings are limited by a lack of functional studies, they have 
indicated associations between miRs and their targets in term but not preterm placental 
tissue. These data are important as they suggest different modes of TLR regulation across 
gestational age. While previous studies have looked at differential miR expression during 
pathological pregnancies, they present variable results that may be due to differences in 
experimental protocol. For example, miR-20a and miR-17 were be upregulated in pre-
eclamptic placentas when analysed using qPCR, but the same study observed no change in 
their expression when they used microarray methods442. This supports the idea that 
microarray analyses should be used as explorative tools and reinforced by subsequent qPCR, 
experimental animal or cell line models once targets are identified.   
Although preterm delivery is frequently associated with pathological inflammation, our data 
have shown that preterm placenta shows similar constitutive expression of genes associated 
with TLR signalling compared to the term placenta. Notably, we found term placenta 
showed significant correlations between miRs and their mRNA targets, while preterm did 
not. In addition to this, maternal smoking, as a risk factor for preterm birth itself, was 
associated with increased inflammatory gene expression. Overall, the potential lack of a 
relationship between miR regulators and their targets found in the preterm placenta could 
suggest an inability to regulate inflammation on immune challenge, though this requires 
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4.1. ABSTRACT 
Background 
Preterm delivery accounts for 75% of neonatal deaths, half of which are related to 
inflammatory conditions. Studies on preterm neonates demonstrate decreased expression of 
Toll-like Receptors (TLRs) and pro-inflammatory cytokines, which does not explain their 
susceptibility to developing these morbidities. This study aimed to characterise the 
expression of genes associated with TLR signalling, including microRNAs (miRs), 
according to gestational age at delivery.  
Methods and Results 
Term and preterm cord blood was collected at delivery. miR and mRNA expression was 
quantified using qPCR. Cord blood serum cytokine expression was analysed using ELISA. 
let-7e and miR-155 expression was decreased in early preterm compared to late preterm and 
term cord blood (p=0.046 and p=0.018, respectively). There was no difference in the 
expression of genes associated with TLR signalling (mRNAs) or cytokines between early 
and late preterm, and term cord blood. However, maternal smoking was associated with 
decreased miR-146b and increased TLR2, TLR4, MyD88, IRAK1, NF-κB1, SOCS1, IL6 and 
IL10 expression (all p<0.05). 
Conclusion 
These findings suggest early preterm neonates have reduced immuno-regulatory capacity, as 
influenced by attenuated miR expression. Further, maternal smoking was associated with 
decreased expression of regulatory miR-146b and increased expression of inflammatory 
TLR-signalling genes. This may predispose neonates to upregulated inflammatory pathways 
at birth. Overall, the decreased constitutive expression of regulatory miRs by preterm cord 
blood may contribute to altered innate immune function in early preterm neonates. 
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4.2. INTRODUCTION 
Preterm birth is associated with an increased risk of neonatal morbidity. A majority of these 
conditions are characterised by aberrant inflammation, including NEC100, CLD222 and 
neonatal sepsis443. This suggests preterm neonates are unable to localise or appropriately 
regulate inflammatory signalling. Previous studies have found decreased numbers of 
leukocytes284 and shown decreased opsonophagocytic capacity in preterm compared to term 
blood82. Though these findings suggest preterm neonates are immunosuppressed, others 
have also demonstrated increased phagocytic capacity in preterm compared to term blood 
following exposure to whole bacteria in vitro284, 285. Nonetheless, previous literature 
supports there are definite differences in preterm immune system function compared to term 
infants.  
TLRs are ubiquitously expressed innate immune receptors that activate pro-inflammatory 
signalling. When TLRs are ligated by different classes of pathogen-associated molecular 
patterns, they signal through adaptor molecules including MyD88, TRAF6 and IRAK1. This 
leads to the translocation of transcription factors, such as NF-κB, into the nucleus to induce 
pro-inflammatory cytokine transcription. MiRs are post-transcriptional regulators of the 
TLR signalling that can repress the translation of TLRs, signalling molecules, cytokines and 
transcription factors. For example, let-7e interacts with the TLR4 mRNA 3’UTR during LPS 
stimulation, resulting in the down-regulation of TLR activity341. Neonatal mice increase 
miR-146a/b expression in the gut to down-regulate excessive and damaging inflammatory 
responses to harmless commensal bacteria347. This occurs because the miR146 family 
downregulates TLR signalling through repressing IRAK1 and TRAF6323, 444. Additionally, 
human cord blood constitutively expresses increased miR-146a and miR-146b compared to 
adult blood242, 445, suggesting the neonatal immune system maintains a tolerogenic state ex 
utero. Other miRs regulate inflammation by repressing inhibitory molecules. An example is 
miR-155, which is increased with NF-κB induction, and binds to the 3’ UTR of Suppressor 
of Cytokine Signalling-1 (SOCS1) gene transcript to indirectly upregulate inflammation341. 
Despite evidence of altered inflammatory regulation relative to adults, miR expression 
remains sparsely characterised in neonatal immunity.  
Cord blood provides a snapshot of the state of immune system at birth. Investigating the 
TLR signalling pathway in cord blood therefore offers valuable insight into neonatal 
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immunity. Existing studies on preterm cord blood have yielded inconsistent results on the 
constitutive expression of TLRs, signalling co-factors and inflammatory cytokines48, 82, 288. 
Some have shown that TLR4 mRNA is comparable between term and preterm cord blood82, 
86, while others show that both protein and mRNA are decreased in preterm cord blood288, 
302. The discrepancy between data examining mRNA and protein expression could therefore 
be related to post-transcriptional regulation.  
This study aims to examine the expression of miRs that regulate TLR signalling and their 
mRNA targets in term and preterm cord blood. Cytokine production was also characterised 
in cord blood serum from these deliveries to determine post-translational differences in 
inflammatory gene expression. It was hypothesised that preterm cord blood would show 
decreased anti-inflammatory miRs and increased inflammatory gene expression compared to 
term neonates at birth.  
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4.3.  METHODS 
4.3.1. PARTICIPANTS & SAMPLE COLLECTION 
Pregnant women presenting at the LMH and WCH (n=152), who delivered at early preterm 
(<32 weeks), late preterm (32-36 weeks) or term gestation (≥ 37 weeks) were recruited to 
this study. Clinical data were obtained from maternal and neonatal health records, including 
obstetric history and neonatal outcomes (see section 2.1). Cord blood was collected into 
lithium heparin vials at delivery and stored at -80°C for subsequent analysis.  
4.3.2. WHOLE RNA EXTRACTION 
TRIzol LS® reagent was used to extract RNA from cord blood (see section 2.5.2). Briefly, 
three volumes of TRIzol LS were added to one volume of cord blood and samples were 
mechanically agitated. Lysates were separated by centrifugation with chloroform to retrieve 
the interphase for subsequent washing with isopropanol and ethanol. RNA was eluted in 
RNase free water and purified using a miRNeasy Mini Kit and DNAse I treatment as per 
manufacturers’ protocol. RINs were assessed using a bioanalyser, where a RIN≥ 9 was 
considered sufficient for PCR analysis. 
4.3.3. qRT-PCR ANALYSIS OF miRNA EXPRESSION  
RNA (10ng) was reverse transcribed using a Taqman® MicroRNA Reverse Transcription 
Kit according to manufacturer’s protocol that was slightly modified for optimal cDNA 
output (see section 2.6.1). This involved pooling a maximum of five RT primers per batch in 
a single RT mixture. Reverse transcription targeted seven primer sequences: let-7e, miR-
155, miR-146a, miR-146b, miR-106a, RNU6B and RNU48. Relative miRNA expression was 
quantified using Taqman® MicroRNA Assays in 20µL reactions containing 1.33µL of 
cDNA. qRT-PCR utilised the comparative cycle threshold (2-ΔCT) method to determine miR 
abundance relative to the reference genes, RNU6B and RNU48. 
4.3.4. qRT-PCR ANALYSIS OF mRNA EXPRESSION 
Purified RNA (50ng) was reverse transcribed using a SuperScript™ III First-Strand 
Synthesis Kit for qRT-PCR according to manufacturer’s protocol (see section 2.6.2). qRT-
PCR was used to quantify the relative expression of miR targets including TLR2, TLR3, 
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TLR4, MyD88, IRAK1, TRAF6, NF-κB1, IL6, IL10 and SOCS1 relative to the endogenous 
house-keeping gene, β-actin. qRT-PCR was performed using TaqMan® Gene Expression 
Assays and each 20µL reaction contained 2μL of the cDNA template.  
4.3.5. CORD BLOOD SERUM PROTEIN ANALYSES 
Single-target ELISAs were used to measure TNFα, IL6 and IL8 (Human Duo Sets, R&D 
Systems) in cord blood serum, as per manufacturer’s instructions (see section 2.4.1). The 
lower detection limit for TNFα was 15.625pg/mL, and the lower detection limit for both IL6 
and IL8 was 31.25pg/mL. All inter-assay and intra-assay coefficients were below 10%. 
Multi-panel ELISA was used to determine the concentration of 7 cytokines and chemokines 
in cord blood serum according to manufacturer’s instructions (see section 2.4.2). These 
included GM-CSF, IL1α, IL1β, IL1RA, IL10, IL12p70 and MCP1. The limitations and 
sensitivities of these analytes are listed in Table 2.1.  
4.3.6. STATISTICAL ANALYSES 
Data were analysed using SPSS v24. Demographic and clinical data are presented as mean ± 
SD, unless otherwise indicated. Frequency data were analysed using Chi-squared tests. 
Kruskal-Wallis tests or ANOVAs were used to compare continuous data according to 
gestational age groups. Post-hoc analyses of this data were conducted using Mann-Whitney 
U tests or t-tests as required. Gene expression and cytokine data are presented as median 
(25th-75th centile), unless otherwise indicated, and were logarithmically transformed (log10) 
to normalise data for parametric analysis. ANCOVAs or MANCOVAs were used to analyse 
qPCR and ELISA data, with pre-eclampsia, labouring delivery, maternal smoking during 
pregnancy and birthweight centile used as covariates for term and preterm cord blood 
analyses; and chorioamnionitis and antenatal betamethasone were used as additional 
covariates where separate preterm cord blood analyses were conducted. Post-hoc 
comparisons were made using t-tests where appropriate. An a priori Bonferroni correction 
was made to the critical alpha level for post-hoc comparisons. Spearman’s correlations were 
used to assess the relationship between matched sample expression of miR and mRNA data. 
An alpha level of 0.05 was considered statistically significant.   
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4.4. RESULTS 
4.4.1. PARTICIPANT CHARACTERISTICS 
Clinical characteristics from term (n=78), late preterm (n=54) and early preterm (n=20) 
deliveries are shown in Table 4.1. Gestational age was significantly different between the 
groups (F(2,151)=574.028, p<0.001). Maternal age, BMI, cigarette smoking during 
pregnancy, gravidity and ethnicity were not significantly different according to these 
gestational age groups. Parity was significantly different between the gestational age groups 
(χ2(2)=10.104, p=0.006), with post-hoc tests indicating that it was lower in mothers who 
delivered late preterm compared to term (p=0.006). Pre-eclampsia was more frequently 
observed in late (17%) and early preterm deliveries (35%) compared to term (8%; 
χ2(2)=11.845, p=0.003). Multiple pregnancies delivered more frequently at early (15%) or 
late preterm (11%) than term gestation (3%; χ2(2)=7.133, p=0.028). Mode of delivery was 
significantly different between the groups (χ2(3)=23.624, p<0.001): emergency Caesarean 
sections were more frequent in early preterm (40%) and late preterm (31%) compared to 
term deliveries (9%); while term deliveries (64%) were more frequently delivered via 
elective Caesarean section compared to early (50%) and late preterm deliveries (30%; 
χ2(4)=23.624, p<0.001). Labour was more frequently associated with late preterm delivery 
(56%) compared to early preterm (25%) or term delivery (31%; χ2(2)=9.360, p=0.009). 
Early preterm neonates (85%) were exposed to antenatal betamethasone more frequently 
than late preterm (57%) and term neonates (10%; χ2(2)=54.994, p<0.001). Birthweight was 
significantly different between the gestational age groups (F(2,150)=136.03, p<0.001). Post-
hoc tests showed that it was lower in early compared to late preterm (p<0.001), early 
preterm compared to term (p<0.001), and late preterm compared to term neonates (p<0.001). 
Birthweight centile was significantly different between the groups (F(2,150)=9.335, 
p<0.001). Post-hoc analyses showed it was lower in early preterm compared to term 
(p<0.001) and in late preterm compared to term neonates (p=0.007). The incidence of SGA 
and IUGR were more frequent in early preterm compared to late preterm and term neonates 
(χ2(2)=14.962, p=0.001; and χ2(2)=22.872, p<0.001, respectively). Birth length was 
significantly different between the groups (F(2,143)=139.922, p<0.001) and post-hoc 
analyses revealed that it was lower in early compared to late preterm, early preterm 
compared to term and late preterm compared to term neonates (all p<0.001). Head 
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circumference was significantly different between the groups (F(2,143)=36.912, p<0.001) 
and post-hoc analyses showed it was lower in early compared to late preterm (p=0.001), 
early preterm compared to term (p<0.001) and late preterm compared to term neonates 
(p=0.001). APGARS at one minute were significantly different between the groups 
(χ2(2)=20.160, p<0.001) and post-hoc analyses showed they were lower in early compared 
to late preterm (p=0.01), early preterm compared to term (p<0.001) and late preterm 
compared to term neonates (p=0.016). APGARS at five minutes were significantly different 
between the groups (χ2(2)=27.808, p<0.001) and post-hoc analyses showed they were lower 
in early compared to late preterm (p=0.005), early preterm compared to term (p<0.001) and 
late preterm compared to term neonates (p=0.002).  
Placental weight was significantly different between the gestational age groups 
(F(2,137)=58.135, p<0.001) and post-hoc analyses showed it was lower in early compared 
to late preterm, early preterm compared to term and late preterm compared to term neonates 
(all p<0.001). The incidence of chorioamnionitis was more frequent in early and late 
preterm deliveries compared to term (10% vs 6% and 0%, respectively; χ2(2)=22.872, 
p<0.001).  
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Table 4.1. Maternal demographics and neonatal characteristics of term, late and early 
preterm deliveries for cord blood analysed in Chapter 4. Values are given as mean± SD or 
n (%), unless otherwise indicated. p-values presented in the table were calculated using 
ANOVAs or Kruskal-Wallis tests. Post-hoc tests were conducted using t-tests or Mann-
Whitney U tests and are represented within each gestational age group column using the 
following symbols: *p≤ 0.05 compared to both other groups; #p≤ 0.05 compared to term. 
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4.4.2. CORD BLOOD GENE EXPRESSION 
Due to limitations in available volumes of cord blood, gene expression analyses were 
conducted in a subset of samples (n=53 term, n=32 late preterm and n=7 early preterm). 
The low frequency of chorioamnionitis meant that its independent contribution to gene 
expression could not be analysed, however expression data for neonates exposed to 
chorioamnionitis were within the IQRs for their respective gestational age groups. 
Chorioamnionitis remained in the final analysis as a covariate when analysing preterm gene 
expression.  
4.4.3. THE EXPRESSION OF HOUSEKEEPING GENES 
Two snoRNAs (RNU48 and RNU6B) were identified from the literature as candidate 
reference genes242, 386. Both snoRNAs were expressed in cord blood. RNU48 was expressed 
more consistently (median CT 27.5 (IQR=27-28)) compared to RNU6B (median CT 31.6 
(IQR=30-34)). As RNU48 was less variable than RNU6B and did not differ between 
gestational age groups, it was deemed the most appropriate reference gene for miR 
characterisation in this study.  
4.4.4. THE EXPRESSION OF miRs THAT REGULATE TLR SIGNALLING 
IN CORD BLOOD  
Cord blood let-7e expression was significantly different between term, late preterm and 
early preterm deliveries after adjusting for labouring delivery, maternal smoking, pre-
eclampsia and birthweight centile (F(2,78)=3.200, p=0.046; Fig. 4.1A). Post-hoc analyses 
showed let-7e expression was increased in term compared to early preterm cord blood 
(p=0.021) and late preterm compared to early preterm cord blood (p=0.015), with no 
difference between late preterm and term cord blood expression.  
Cord blood miR-155 expression was significantly different between term, late preterm and 
early preterm deliveries (F(2,78)=4.225 p=0.018; Fig. 4.2A). Post-hoc analyses revealed 
miR-155 expression was increased in term compared to early preterm cord blood (p=0.005) 
and in late preterm compared to early preterm cord blood (p=0.022), with no difference 
between late preterm and term cord blood expression. 
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There was no significant difference between early preterm, late preterm and term cord blood 
expression of miR-146a (Fig.4.3A), miR-146b (Fig.4.3.B) or miR-106a (Fig. 4.4A). No 
significant independent contribution of antenatal betamethasone exposure or 
chorioamnionitis was observed in early or late preterm cord blood miR expression. 
Within the MANCOVA model, maternal smoking was identified as having a significant, 
independent effect on gene expression. This was assessed further using post-hoc ANOVAs, 
with gestational age groups and smoking status included as independent factors. We found 
no main effect between gestational age group and smoking, however, a significant main 
effect of smoking was found in association with increased miR-146b expression in cord 
blood from mothers who smoked during pregnancy (p=0.022; Fig.4.6A).  
4.4.5. THE EXPRESSION OF mRNAs INVOLVED IN TLR SIGNALLING IN 
CORD BLOOD  
The expression of mRNA associated with TLR signalling was assessed in a smaller subset 
of samples due to the low volumes of early preterm cord blood available. The analysis was 
split according to term (n=18) and preterm cord blood (a pooled group consisting of n=14 
late preterm and n=2 early preterm deliveries). Only 13% of preterm cord blood expressed 
detectable levels of TRAF6 and the expression of TLR3 was not detected in any cord blood 
(Table 4.2). 
There was no difference between term and preterm TLR2 (Fig.4.5A), TLR4 (Fig.4.1B), 
MyD88 (Fig.4.2B), IRAK1 (Fig.4.3C), NF-κB1 (Fig.4.5B), IL6 (Fig.4.5C), IL10 (Fig.4.4B) 
or SOCS1 (Fig.4.2C) expression in cord blood after adjusting for the effect of pre-eclampsia, 
antenatal betamethasone, birthweight centile, chorioamnionitis and labour.  
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Fig. 4.1. Cord blood let-7e and TLR4 expression following term and preterm delivery. 
Cord blood expression of let-7e relative to RNU48 (A), and TLR4 expression relative to β-
actin (B), following term and preterm delivery. Note: y-axes are presented on a logarithmic 
scale, *p<0.05. 
 
Fig. 4.2. Cord blood miR-155, MyD88 and SOCS1 expression following term and preterm 
delivery. Cord blood expression of miR-155 relative to RNU48 (A), and MyD88 (B) and 
SOCS1 (C) expression relative to β-actin, following term and preterm delivery. Note: y-axes 
are presented on a logarithmic scale, *p<0.05.  
 
Fig. 4.3. Cord blood miR-146a, miR-146b and IRAK1 expression following term and 
preterm delivery. Cord blood expression of miR-146a (A) and miR-146b (B) relative to 
RNU48, and IRAK 1 expression relative to β-actin (C), following term and preterm delivery. 
Note: y-axes are presented on a logarithmic scale.  
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Fig. 4.4. Cord blood miR-106a and IL10 expression following term and preterm delivery. 
Cord blood expression of miR-106a relative to RNU48 (A), and IL10 expression relative to 
β-actin (B), following term and preterm delivery. Note: y-axes are presented on a 
logarithmic scale.  
 
Fig.4.5. Cord blood TLR2, NF-κB1 and IL6 expression following term and preterm 
delivery. Cord blood expression of TLR2 (A), NF-κB1 (B) and IL6 (C) relative to β-actin, 
following term and preterm delivery. Note: y-axes are presented on a logarithmic scale.  
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Table 4.2. The frequency of expression of genes associated with TLR signalling in term 
and preterm cord blood. The frequency of detectable mRNA expression (n, %) in term and 






TLR2 15 (83%) 14 (88%) 0.413 
TLR3 0 (0%) 0 (0%) - 
TLR4 17 (94%) 16 (100%) 0.375 
MyD88 16 (89%) 15 (94%) 0.419 
IRAK1 14 (78%) 15 (94%) 0.281 
TRAF6 0 (0%) 2 (13%) - 
NF-κB1 17 (94%) 15 (94%) 0.419 
IL10 8 (44%) 6 (38%) 0.343 
IL6 6 (33%) 8 (50%) 0.387 
SOCS1 17 (94%) 15 (94%) 0.420 
A post-hoc ANOVA was used to analyse the effect of gestational age group and maternal 
smoking on cord blood mRNA expression. This analysis showed no interaction between 
gestational age group and smoking. Maternal smoking was associated with increased cord 
blood TLR2 (p=0.010), TLR4 (p=0.007), MyD88 (p=0.010), IRAK1 (p=0.012), NF-κB1 
(p=0.038) and SOCS1 expression (p=0.006; Figs.4.6B and 4.7).  
 
Fig. 4.6. Cord blood miR-146b and IRAK1 expression according to maternal smoking 
during pregnancy. Placental expression of miR-146b relative to RNU48 (A) and IRAK1 
relative to β-actin (B), from mothers who smoked and mothers who did not smoke cigarettes 




Fig 4.7. The expression of genes associated with TLR signalling in cord blood according to maternal smoking during pregnancy. The 
expression of TLR2 (A), TLR4 (B), MyD88 (C), NF-κB1 (D) and SOCS1 (E) relative to β-actin in cord blood from mothers who smoked and 
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4.4.6. CORRELATIONS BETWEEN miRs AND THEIR TARGET mRNAs IN 
CORD BLOOD 
The expression of let-7e, miR-155, miR-146a, miR-106a and their respective targets: TLR4, 
SOCS1, IRAK1 and TRAF6 or IL10 were not correlated in term or preterm cord blood. NF-
κB1 was not correlated with the expression of any miRs.  
4.4.7. CORRELATIONS BETWEEN CORD BLOOD AND PLACENTAL 
miRs AND mRNAs  
A subset of matched placenta and cord blood samples were analysed for correlating miR 
expression within gestational groups (n=31 term and n=18 preterm deliveries).  
4.4.7.1. Correlations between Matched Genes in Cord Blood and Placenta 
The expression of let-7e, miR-155, miR-146a, miR-146b and miR-106a was not correlated 
between matched cord blood and placental tissue (Table 4.3). 
Table 4.3. The correlation between cord blood and placental miR expression following 
term and preterm delivery. The correlation (ρ) between miR expression in cord blood and 
placenta according to term and preterm delivery calculated using untransformed (raw) data 







ρ p-value ρ p-value 
let-7e 0.246 0.183 0.117 0.645 
miR-155 -0.100 0.614 -0.003 0.990 
miR-146a 0.151 0.417 -0.102 0.687 
miR-146b 0.204 0.629 0.000 1.000 
miR-106a -0.127 0.626 0.151 0.715 
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A subset of matched samples were analysed using Spearman’s correlations to determine the 
relationship between mRNA expression in cord blood and placenta within gestational groups 
(n=11 term and n=7 preterm deliveries). Placental and cord blood MyD88 expression 
showed a positive correlation following preterm but not term delivery (ρ=0.886, p=0.019; 
Fig. 4.8). The expression of TLR2, TLR4, IRAK1 or NF-κB1were not correlated in matched 
cord blood and placental tissue, following term or preterm delivery (Table 4.4). There were 
insufficient data points to match correlations for the expression of IL6, IL10, TRAF6 or 
TLR3 split according to gestational age. 
 
Fig. 4.8. A scatterplot of cord blood and placental MyD88 expression following term and 
preterm delivery. The correlated expression of MyD88 between matched placenta and cord 
blood following term and preterm delivery. Note: y-axis presented on a logarithmic scale, 
*p≤ 0.05. 
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Table 4.4 The correlation between cord blood and placental mRNA expression following 
term and preterm delivery. The correlation (ρ) between mRNA expression in cord blood 
and placenta according to term and preterm delivery calculated using untransformed (raw) 







ρ p-value ρ p-value 
TLR2 -0.481 0.190 0.029 0.957 
TLR4 -0.318 0.340 0.055 0.908 
MyD88 0.213 0.555 0.886 0.019 
IRAK1 -0.370 0.327 -0.657 0.156 
NF-κB1 0.321 0.365 0.600 0.208 
SOCS1 0.218 0.519 0.250 0.589 
4.4.7.2. Correlations between miRs and their target mRNAs in Cord Blood 
and Placenta 
Matched samples were used to analyse whether the expression of placental miRs was 
correlated with the expression of their respective targets in cord blood. This analysis was 
repeated according to the expression of cord blood miRs and their mRNA targets’ 
expression in matched placenta. Within term and preterm groups, the expression of let-7e 
and its target, TLR4 were not correlated between cord blood and placental tissue (Table 4.5). 
The expression of miR-155 and its targets, SOCS1 or MyD88 was not correlated between 
cord blood and placental tissues (Tables 4.6-7). The expression of miR-146a and its target, 
IRAK1 was not correlated between cord blood and placental tissues (Table 4.8). The 
expression of miR-106a and its target, IL10 was not correlated between cord blood and 
placental tissues (Table 4.9). 
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Table 4.5. The correlation between cord blood and placental let-7e and TLR4 expression 
in matched samples following term and preterm delivery. The correlation (ρ) between cord 
blood let-7e and placental TLR4 expression, and between placental let-7e and cord blood 
TLR4 expression according to term and preterm delivery calculated using untransformed 





Cord blood let-7e 0.246 0.173 
TLR4 0.573 -0.318 
Preterm 
Cord blood let-7e 0.117 0.173 
TLR4 -0.595 0.055 
Table 4.6. The correlation between cord blood and placental miR-155 and SOCS1 
expression in matched samples following term and preterm delivery. The correlation (ρ) 
between cord blood miR-155 and placental SOCS1 expression, and between placental miR-
155 and cord blood SOCS1 expression according to term and preterm delivery calculated 





Cord blood miR-155 -0.100 -0.433 
SOCS1 -0.067 0.218 
Preterm 
Cord blood miR-155 -0.003 0.464 
SOCS1 0.107 0.250 
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Table 4.7. The correlation between cord blood and placental miR-155 and MyD88 
expression in matched samples following term and preterm delivery. The correlation (ρ) 
between cord blood miR-155 and placental MyD88 expression, and between placental miR-
155 and cord blood MyD88 expression according to term and preterm delivery calculated 





Cord blood miR-155 -0.100 0.310 
MyD88 0.417 0.218 
Preterm 
Cord blood miR-155 -0.003 0.357 
MyD88 0.600 0.250 
Table 4.8. The correlation between cord blood and placental miR-146a and IRAK1 
expression in matched samples following term and preterm delivery. The correlation (ρ) 
between cord blood miR-146a and placental IRAK1 expression, and between placental miR-
146a and cord blood IRAK1 expression according to term and preterm delivery calculated 





Cord blood miR-146a 0.151 -0.373 
IRAK1 0.084 -0.370 
Preterm 
Cord blood miR-146a -0.102 -0.600 
IRAK1 0.107 -0.657 
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Table 4.9. The correlation between cord blood and placental miR-106a and IL10 
expression in matched samples following term and preterm delivery. The correlation (ρ) 
between cord blood miR-106a and placental IL10 expression, and between placental miR-
106a and cord blood IL10 expression according to term and preterm delivery calculated 
using untransformed (raw) data for relative gene expression. Note: there were no significant 





Cord blood miR-106a -0.127 0.075 
IL10 -0.086 0.000 
Preterm 
Cord blood miR-106a 0.151 0.000 
IL10 0.000 1.000 
4.4.8. CYTOKINE EXPRESSION IN CORD BLOOD SERUM 
Cytokine protein expression was measured in a subset of samples (n=49 term, n=37 late 
preterm and n=14 early preterm), as determined by the volume of cord blood available. The 
number of cord blood samples that showed detectable cytokine production was varied 
(Table 4.10). There was no difference in cord blood cytokine expression between the 
gestational age groups (Fig. 4.9-10).  
The effects of gestational age group and maternal smoking on cord blood cytokine 
expression were also analysed. There was no main effect of gestational age group or 
maternal smoking on cord blood GMCSF, IL10, IL12p70, IL1α, IL1β, IL6, IL8, MCP1 or 
TNFα production.  
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Table 4.10. The frequency of detection of cytokines in cord blood serum. The frequency of 
detection of cytokines in term, late preterm and early preterm cord blood serum (n, %).  
 Term 
n= 55 
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Fig. 4.9. Cytokine production in cord blood serum from term, and late and early preterm deliveries. The production of GMCSF (A), 
IL10 (B), IL12p70 (C), IL1α (D), IL1β (E) and MCP1 (F) in cord blood serum from term, and late and early preterm deliveries. Note: the 
y-axes are presented on a logarithmic scale. 
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Fig. 4.10. TNFα, IL6 and IL8 production in cord blood serum from term, and late and 
early preterm deliveries. The production of TNFα(A), IL6 (B) and IL8 (C) in cord blood 
serum from term, and late and early preterm deliveries. Note: the y-axes are presented on a 
logarithmic scale. 
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4.5. DISCUSSION 
This study investigated miRs that regulate TLR signalling in preterm cord blood. Early 
preterm cord blood showed increased let-7e and miR-155 expression compared to late 
preterm and term. Interestingly, there was no difference in the expression of miR-146a, miR-
146b, miR-106a, mRNAs associated with TLR signalling or cytokine production between 
early preterm, late preterm and term cord blood. These findings begin to suggest the absence 
of a regulatory relationship between miRs and mRNA in early preterm cord blood.   
Early preterm cord blood expressed decreased let-7e with no difference in its target, TLR4 
compared to late preterm and term. The otherwise comparable expression of TLR2 and TLR4 
mRNA across the gestational age groups agrees with other studies that have measured both 
mRNA and surface protein expression of these receptors on neonatal monocytes and 
neutrophils82, 85, 86. The decrease in let-7e we observed could be associated with the 
continued upregulation of TLR4 during inflammation and requires confirmation using in 
vitro stimulation studies. Murine embryos have shown increased let-7 transcription at 10.5 
days gestation, however, these transcripts are not processed by the enzyme Drosha and 
therefore, remain in their precursory, stem-loop form446. Other pre-miRs, including those 
encoded by the Chromosome 19 cluster, are also highly expressed in human embryonic stem 
cells without being transcribed447. Additionally, activity of the secondary miR processing 
molecule, Dicer is decreased in undifferentiated murine embryonic cell lines compared to 
differentiated cells448. Alternately, mechanisms that inhibit pre-miR transcription may be an 
attempt at maintaining an undifferentiated state in fetal cells449. As such, Lin28b is another 
negative regulator of let-7e and is highly expressed in fetal T cells449. As we did not measure 
pre-miRs (as they are biologically inactive), either of these mechanisms could be an 
underlying cause for decreased let-7e and miR-155 expression in early preterm cord blood.   
MiRs often exert their effects in the context of gene networks or signalling pairs. Although 
let-7e and miR-155 do not interact directly, they regulate the TLR signalling pathway in 
opposite directions and are shown to be involved in similar feedback loops. For example, the 
protein kinase, Akt, is activated by LPS exposure to upregulate let-7e and downregulate 
miR-155 simultaneously341. The overexpression of let-7e accompanied by miR-155 
repression in Akt-/- murine macrophages therefore leads to LPS tolerance during repeated 
LPS stimulation341. As we found decreased let-7e and miR-155 expression in early preterm 
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cord blood, this suggests regulatory feedback loops could be disturbed and that miR-
mediated regulation may be attenuated in early preterm neonates. The state of these TLR 
signalling feedback loops could be investigated using time course studies on inflammatory 
stimulation in cord blood.  
Placental and cord blood MyD88 expression were correlated in association with preterm but 
not term delivery. This could indicate underlying inflammatory activation leading to preterm 
parturition, though it would typically be associated with the co-expression of other 
inflammatory genes450 and therefore, requires more direct investigation. Our analysis did not 
observe any other correlations in gene expression between matched miRs or their targets in 
and between cord blood and placental tissue. Although ovine studies have found placental 
exosomes contain miRs which can regulate gene targets in cord blood451, this cannot be 
confirmed using the current experimental paradigm. Future studies using murine models and 
radiolabelled miRs during pregnancy may therefore be useful in determining whether 
placental miRs regulate neonatal immunity at delivery.  
Irrespective of gestational age, cord blood serum cytokine production was inconsistent. 
Previous studies have also reported between 30-70% of cord blood samples (n=370) do not 
express detectable IL6, IL8 or IL10452, 453. Similarly, those that have detected cytokine 
expression, reported no difference in the constitutive expression of IL6, IL8 and IL10 in 
monocytes, lymphocytes and granulocytes between preterm and term cord blood204. Overall, 
as we found no difference in IL6 or IL10 mRNA expression, it is not surprising that a 
difference in cytokine expression was not seen.  
Maternal smoking during pregnancy is a recognised risk factor for preterm delivery14 and 
growth restriction155. Our analysis showed maternal smoking was associated with decreased 
miR-146b expression in cord blood and increased TLR2, TLR4, MyD88, IRAK1, NF-κB1, 
IL6, IL10 and SOCS1, indicating increased inflammatory activation. This agrees with 
previous studies432, 433 and findings from Chapter 3 that show smoking during pregnancy 
contributes to a pro-inflammatory in utero environment. In contrast to this, others have 
observed that term CBMCs from mothers who smoke express decreased constitutive IL6, 
TNFα and IL10 compared to non-smokers161. These findings may differ with ours because 
of post-transcriptional regulation or the use of isolated cell populations. Alternately, it is 
possible that in utero inflammation programs neonatal tolerance in an attempt to adapt to a 
pro-inflammatory environment as perceived by the fetus. A limitation of the current cohort 
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is our inability to separate the effects of gestational age and smoking, while we observed no 
apparent interaction between these factors, it is likely this occurred due to a smaller sample 
size. Overall, it is apparent that maternal smoking during pregnancy alters neonatal 
immunity and our support that dysregulated expression of genes the TLR signalling pathway 
may contribute to this.  
In summary, the current data show early preterm cord blood expresses decreased 
constitutive let-7e and miR-155, while the expression of the miRs’ mRNA targets remains 
comparable to late preterm and term cord blood. Decreased regulatory miR expression 
suggests that late preterm and term neonates may have a more mature innate immune system 
that better regulates inflammation during infection. Notably, our findings provide a snapshot 
of neonatal innate immunity at delivery and it remains unclear whether these differences 
affect their ability to respond to inflammatory challenge. Further research is therefore 
required to assess the impact of these differences on functional responses in cord blood.  
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A majority of health conditions affecting preterm neonates have an inflammatory 
aetiology. However, in vitro studies on preterm cord blood show decreased expression 
of inflammatory mediators following immune stimulation compared to term. Toll-like 
Receptor (TLR) signalling results in inflammation and can be regulated by microRNAs 
(miRs). This study therefore aimed to determine the expression of miRs and mRNAs in 
cord blood following TLR stimulation.  
Methods and Results 
Cord blood was collected from term (n=29), late preterm (n=17) and early preterm 
deliveries (n=15) and stimulated in vitro with ligands for TLR2 (PGN), TLR3 (Poly 
I:C) and TLR4 (LPS). The expression of miRs and mRNA in the TLR signalling 
pathway was quantified using qPCR. Term cord blood increased mir-155 in response to 
PGN (p=0.031), and increased let-7e (p=0.008), miR-155 (p<0.001), miR-106a 
(p=0.05), NF-κB1 (p=0.023) and IL6 (p=0.007) in response to LPS. Late preterm cord 
blood increased let-7e (p=0.008), TLR2 (p=0.008) and SOCS1 (p=0.024) in response to 
LPS. Early preterm cord blood only increased NF-κB1 (p=0.029) and IL6 (p=0.01) in 
response to LPS. There was no difference observed in the expression genes associated 
with TLR signalling by cord blood in response to Poly I:C stimulation. 
Conclusion 
This study suggests an absence of miR expression may contribute to diminished 
regulation of TLR signalling during inflammation in early preterm cord blood in vitro. 
Dysregulated innate immune signalling could underlie a susceptibility towards 
uncontrolled inflammation in early preterm neonates.  
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5.2. INTRODUCTION 
Preterm neonates are more susceptible to developing severe inflammatory conditions 
than their term counterparts4, 25. These conditions are characterised by a bias towards 
unresolved inflammation and increased expression of pro-inflammatory mediators. 
Inflammation can be driven by innate immune TLR signalling. TLRs are activated by 
the ligation to specific classes of PAMPs. TLR2 recognises PGN that forms the cell 
wall of gram-positive bacteria; TLR3 recognises viral PAMPs including synthetic Poly 
I:C; and TLR4 recognises LPS, which is a component of the gram-negative bacterial 
membrane. TLRs activate a series of intracellular adaptor molecules (e.g. MyD88 and 
IRAK1) to initiate the translocation of nuclear factors that induce inflammatory 
cytokine transcription (e.g. NF-κB). The expression of these genes can be regulated at 
different levels of signalling by miRs. Inflammation must be tightly regulated to avoid 
prolonged or aberrant tissue damage.   
MiRs have important roles in regulating TLR signalling during inflammation. They 
respond to physiological cues and act post-transcriptionally, resulting in a ‘dampening’ 
of the inflammatory response. In response to inflammatory cues, the miR, let-7e, 
inhibits TLR4 expression, while miR-146a inhibits expression of the signalling 
molecule IRAK1, and both miRs therefore down-regulate TLR signalling. Other miRs 
increase inflammatory activation, including miR-155, which represses the suppressor of 
cytokine signalling (SOCS1) gene, and miR-106a that represses IL10.  
Preterm neonates show decreased leukocyte counts207 and attenuated expression of pro-
inflammatory cytokines following LPS stimulation compared to their term-born 
counterparts288. Specifically, preterm cord blood expresses decreased IL6 and TNFα 
following stimulation with TLR agonists82, 213, 288 or whole bacteria compared to term252, 
289. Other aspects of TLR signalling have, however, demonstrated comparable 
responses to immune stimulation in vitro. For example, preterm CBMCs exhibit 
comparable86, 302 or increased454 phosphorylation of NF-κB following stimulation with 
whole bacteria compared to term. As NF-κB phosphorylation results in pro-
inflammatory cytokine transcription76, this suggests inflammatory cytokine expression 
is either be comparable or increased between term and preterm cord blood. 
Discrepancies between NF-κB phosphorylation and cytokine expression in cord blood 
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studies may be explained by differences in post-transcriptional regulation of TLR 
signalling.  
Alterations in the regulation of TLR signalling may also explain preterm neonates’ 
susceptibility to developing inflammatory morbidities. Currently, little is known about 
miR-related regulation of neonatal immunity. Studies to date have focused on miR 
arrays that explore patterns of miR expression in association with preterm delivery374. 
Even fewer studies have validated miR expression in cord blood. Charrier et al., 
demonstrated increased miR-146a and decreased miR-155 expression in cord blood 
pDCs that expressed decreased IRAK1 and MyD88 compared to adult pDCs following 
TLR9 stimulation388. Similarly, cord blood monocytes are shown to increase miR-146a 
expression after 24 hours LPS stimulation in vitro compared to adult monocytes242. 
These data support that term neonates exhibit a tolerogenic immune bias during LPS 
stimulation compared to adults.  
It is unclear whether miRs are differentially expressed in preterm compared to term 
neonates, which could contribute to the differential responses to TLR stimulation 
observed between them (see Table 1.2). This study therefore aimed to characterise 
expression of miRs and their gene targets following TLR stimulation in term and 
preterm cord blood. Previous findings from our laboratory have shown increased IL6 
expression with TLR stimulation, without any change in anti-inflammatory 
cytokines153. It was therefore hypothesised that preterm cord blood would exhibit 
decreased expression of anti-inflammatory let-7e, miR146a and SOCS1 and increased 
expression of pro-inflammatory miR-155, miR-106a and IL6 compared to term cord 
blood following TLR stimulation.  
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5.3. METHODS 
5.3.1. PARTICIPANTS AND SAMPLE COLLECTION  
Pregnant women presenting at the LMH and WCH (n=61), who delivered at early 
preterm (<32 weeks), late preterm (32-36 weeks) or term gestation (≥ 37 weeks) were 
recruited to this study. Clinical data were obtained from maternal and neonatal health 
records, including obstetric history and neonatal outcomes (see section 2.1). Cord blood 
was collected into lithium heparin vials at delivery for in vitro culture. 
5.3.2. CORD BLOOD CULTURE AND TLR STIMULATION 
Whole cord blood was plated in volumes of 100µL in flat-bottomed 96-well cell culture 
plates and cultured at 37°C and 5% CO2 overnight. Following this ‘resting’ period, one 
set of wells were left unstimulated (untreated ‘controls’) and remaining wells were 
stimulated with either PGN (TLR2 agonist; 100pg), Poly I:C (TLR3 agonist; 500pg), or 
LPS (TLR4 agonist; 1ng). Wells were collected and pooled in triplicate after 6 hours in 
vitro. 
5.3.3. WHOLE RNA EXTRACTION 
TRIzol LS® reagent was used to extract RNA from cord blood (see section 2.5.2). 
Briefly, three volumes of TRIzol LS were added to one volume of cord blood and 
samples were mechanically agitated. Lysates were separated by centrifugation with 
chloroform to retrieve the interphase for subsequent washing with isopropanol and 
ethanol. RNA was eluted in RNase free water and purified using a miRNeasy Mini Kit 
and DNAse I treatment as per manufacturers’ protocol. RINs were assessed using a 
bioanalyser, where a RIN≥ 9 was considered sufficient for PCR analysis. 
5.3.4. qRT-PCR ANALYSIS OF miRNA EXPRESSION  
RNA (10ng) was reverse transcribed using a Taqman® MicroRNA Reverse 
Transcription Kit according to manufacturer’s protocol, that was slightly modified for 
optimal cDNA output (see section 2.6.1). This involved pooling a maximum of five RT 
primers per batch in a single RT mixture. Reverse transcription targeted five primer 
sequences: let-7e, miR-155, miR-146a, miR-106a and RNU48. Relative miRNA 
Chapter Five:  
Cord Blood Gene Expression Following TLR Stimulation    Page 151 
 
expression was quantified using Taqman® MicroRNA Assays in 20µL reactions 
containing 1.33µL of cDNA. qRT-PCR utilised the comparative cycle threshold (2-ΔCT) 
method to determine miR abundance relative to the housekeeping gene RNU48. 
5.3.5. qRT-PCR ANALYSIS OF mRNA EXPRESSION 
Purified RNA (50ng) was reverse transcribed using a SuperScript™ III First-Strand 
Synthesis Kit for qRT-PCR according to manufacturer’s protocol. qRT-PCR was used 
to quantify the relative expression of miR targets including TLR2, TLR4, MyD88, 
IRAK1, NF-κB1, IL6, IL10 and SOCS1 relative to the reference gene, β-actin. qRT-PCR 
was performed using TaqMan® Gene Expression Assays and each 20µL reaction 
contained 2μL of the cDNA template.  
5.3.6. STATISTICAL ANALYSES 
Data were analysed using SPSS v24. Demographic and clinical data are presented as 
mean ± SD, unless otherwise indicated. Frequency data were analysed using Chi-
squared tests. Kruskal-Wallis tests or ANOVAs were used to compare continuous data 
according to the gestational age groups. Post-hoc analysis was conducted using Mann-
Whitney U tests or t-tests where necessary. Gene expression data are presented as 
median (25th-75th centile), unless otherwise indicated, and were logarithmically 
transformed (log10) to normalise data for parametric analysis. ANCOVAs or 
MANCOVAs were used to analyse qPCR data, with pre-eclampsia, labouring delivery, 
maternal smoking during pregnancy and birthweight centile used as covariates for term 
and preterm cord blood analyses; and chorioamnionitis and antenatal betamethasone 
were used as additional covariates for analyses concerning preterm cord blood. Post-hoc 
comparisons were made using t-tests where appropriate. An a priori Bonferroni 
correction was made to the critical alpha level for post-hoc comparisons. Spearman’s 
correlations were used to assess the relationship between matched sample expression of 
miR and mRNA data. An alpha level of 0.05 was considered statistically significant. 
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5.4. RESULTS 
5.4.1. PARTICIPANT CHARACTERISTICS 
Clinical characteristics from term (n=29), late preterm (n=17) and early preterm (n=15) 
deliveries are shown in Table 5.1. Maternal age, BMI, smoking during pregnancy, 
ethnicity and gravidity were not significantly different between the gestational age 
groups. Gestational age at delivery (completed weeks) was significantly different 
between the groups (F(2,60)=297.701, p<0.001). Parity showed a trend towards being 
different between the gestational age groups, but this did not reach statistical 
significance (p=0.056). Pre-eclampsia was more frequently associated with early 
preterm deliveries (33%) compared to late preterm (12%) and term (7%; χ2(2)=7.861, 
p=0.020). Mode of delivery was significantly different between the groups 
(χ2(3)=9.687, p=0.046), where emergency Caesarean sections were more frequent in 
early preterm (47%) and late preterm (33%) compared to term deliveries (10%); and 
both early preterm (60%) and term deliveries (62%) were more frequently delivered via 
elective Caesarean section compared to late preterm deliveries (35%). The frequency of 
labouring deliveries did not differ between the groups.  
Early (87%) and late preterm neonates (82%) were more frequently exposed to 
antenatal betamethasone compared to term neonates (3%; χ2(2)=40.182, p<0.001). 
Birthweight was significantly different between the gestational age groups 
(F(2,60)=116.08, p<0.001) and post-hoc analyses showed that it was lower in early 
preterm compared to term, early preterm compared to late preterm and late preterm 
compared to term neonates (p<0.001 for all). Birthweight centile was significantly 
different between the groups (F(2,60)=11.057, p<0.001) and post-hoc analyses showed 
that it was lower in early preterm compared to term (p<0.001) and early preterm 
compared to late preterm neonates (p=0.04). The incidence of SGA and IUGR occurred 
more frequently in early preterm compared to late preterm and term neonates 
(χ2(2)=15.822, p<0.001; and χ2(2)=19.028, p<0.001, respectively). Birth length was 
significantly different between the groups (F(2,54)=94.461, p<0.001) and post-hoc 
analyses showed it was lower in early preterm compared to term, early preterm 
compared to late preterm and late preterm compared to term neonates (p<0.001 for all). 
Head circumference was significantly different between the groups (F(2,54)=14.875, 
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p<0.001) and post-hoc analyses showed that it was lower in early preterm compared to 
term (p<0.001) and late preterm compared to term neonates (p=0.014). APGARS at 1 
minute were significantly different between the groups (U=76, p=0.001) and post-hoc 
tests showed they were lower in early preterm compared to term (p=0.001) and early 
preterm compared to late preterm neonates (p=0.04). APGARS at 5 minutes were 
significantly different between the groups (U=81.5, p=0.002) and post-hoc tests showed 
that they were lower in early preterm compared to term (p=0.002) and early preterm 
compared to late preterm (p=0.024). 
Placental weight was significantly different between the gestational age groups 
(F(2,47)=32.112, p<0.001) and post-hoc analyses showed that it was lower following 
early preterm compared to late preterm (p=0.003), early preterm compared to term 
(p<0.001) and late preterm compared to term delivery (p=0.003). The incidence of 
chorioamnionitis was higher in early preterm deliveries (20%) compared to late preterm 
(12%) and term (0%; χ2(2)=13.866, p=0.001).  
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Table 5.1. Maternal demographics and neonatal characteristics of term, late and 
early preterm deliveries for cord blood analysed in Chapter 5. Values are given as 
mean± SD or n (%), unless otherwise indicated. p-values presented in the table were 
calculated using ANOVAs or Kruskal-Wallis tests. Post-hoc tests were conducted using 
t-tests or Mann-Whitney U tests and are represented within each gestational age group 
column by the following symbols: *p≤ 0.05 compared to both other groups; #p≤ 0.05 
compared to term.  





n=29 n=17 n=15 
Gestational age (completed weeks), 
median (min-max) 




Gravidity, median (min-max) 
Parity, median (min-max)            

























































2 (7) 4 (24) 3 (20) 0.130 
Labouring delivery 
Mode of delivery: 
          Emergency Caesarean section  
          Elective Caesarean section  
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Birth centile, % 
SGA 
IUGR 
Birth length, cm 




































1 (3) 14 (89) 13 (87) <0.001 
APGARS, median (min-max): 
           1 min 
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5.4.2. CORD BLOOD miR EXPRESSION FOLLOWING PGN (TLR2) 
STIMULATION 
PGN stimulation significantly increased miR-155 expression compared to controls 
(unstimulated samples) in term cord blood after adjusting for the covariates pre-
eclampsia, labouring delivery, maternal smoking during pregnancy and birthweight 
centile (Fig. 5.1, F(1,48)=4.910, p=0.031). There was a trend towards increased miR-
106a expression with PGN stimulation compared to controls in term cord blood, 
however, this did not reach statistical significance (p=0.094; Fig. 5.4). Term cord blood 
showed no difference in let-7e or miR-146a expression between unstimulated and PGN 
stimulated samples (Figs. 5.2-3).    
Late and early preterm cord blood showed no difference in the expression of any miR 
between PGN stimulated and unstimulated samples after adjusting for the covariates 
pre-eclampsia, labouring delivery, maternal smoking during pregnancy, birthweight 
centile, chorioamnionitis and antenatal betamethasone exposure (Figs. 5.1-4). 
There was no difference in the magnitude of let-7e, miR-155, miR-146a or miR-106a 
expression with PGN treatment between early preterm, late preterm and term cord 
blood.  
 
Fig. 5.1. Cord blood miR-155 expression with and without PGN stimulation. The 
expression miR-155 relative to RNU48 in (A) term, (B) late preterm and (C) early 
preterm cord blood at 6 hours in vitro following PGN stimulation or under control 
conditions. Note: the y-axes are presented on a logarithmic scale, *p<0.05. 
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Fig. 5.2. Cord blood let-7e expression with and without PGN stimulation. The 
expression let-7e relative to RNU48 in (A) term, (B) late preterm and (C) early preterm 
cord blood at 6 hours in vitro following PGN stimulation or under control conditions. 
Note: the y-axes are presented on a logarithmic scale, *p<0.05. 
 
Fig. 5.3. Cord blood miR-146a expression with and without PGN stimulation. The 
expression miR-146a relative to RNU48 in (A) term, (B) late preterm and (C) early 
preterm cord blood at 6 hours in vitro following PGN stimulation or under control 
conditions. Note: the y-axes are presented on a logarithmic scale, *p<0.05. 
 
Fig. 5.4. Cord blood miR-106a expression with and without PGN stimulation. The 
expression miR-106a relative to RNU48 in (A) term, (B) late preterm and (C) early 
preterm cord blood at 6 hours in vitro following PGN stimulation or under control 
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5.4.3. CORD BLOOD miR EXPRESSION FOLLOWING Poly I:C (TLR3) 
STIMULATION 
There was a trend towards increased let-7e expression with Poly I:C stimulation 
compared to unstimulated conditions in late preterm cord blood after adjusting for pre-
eclampsia, labouring delivery, maternal smoking, birthweight centile, chorioamnionitis 
and antenatal betamethasone, however this trend did not reach statistical significance 
(p=0.072; Fig. 5.5). There was no difference in let-7e expression in term or early 
preterm cord blood between control and Poly I:C stimulated samples. No difference 
was observed in miR-155, miR-146a or miR-106a expression with Poly I:C stimulation 
in term, late preterm or early preterm cord blood (Fig. 5.6-8).  
There was no difference in the magnitude of let-7e, miR-155, miR-146a or miR-106a 
expression induced by Poly I:C stimulation between early preterm, late preterm and 
term cord blood.   
 
Fig. 5.5. Cord blood let-7e expression with and without Poly I:C stimulation. The 
expression let-7e relative to RNU48 in (A) term, (B) late preterm and (C) early preterm 
cord blood at 6 hours in vitro following Poly I:C stimulation or under control 
conditions. Note: the y-axes are presented on a logarithmic scale, *p<0.05. 
 
Fig. 5.6. Cord blood miR-155 expression with and without Poly I:C stimulation. The 
expression miR-155 relative to RNU48 in (A) term, (B) late preterm and (C) early 
preterm cord blood at 6 hours in vitro following Poly I:C stimulation or under control 
conditions. Note: the y-axes are presented on a logarithmic scale, *p<0.05. 
Chapter Five:  
Cord Blood Gene Expression Following TLR Stimulation    Page 158 
 
 
Fig. 5.7. Cord blood miR-146a expression with and without Poly I:C stimulation. The 
expression miR-146a relative to RNU48 in (A) term, (B) late preterm and (C) early 
preterm cord blood at 6 hours in vitro following Poly I:C stimulation or under control 
conditions. Note: the y-axes are presented on a logarithmic scale, *p<0.05. 
 
Fig. 5.8. Cord blood miR-106a expression with and without Poly I:C stimulation. The 
expression miR-106a relative to RNU48 in (A) term, (B) late preterm and (C) early 
preterm cord blood at 6 hours in vitro following Poly I:C stimulation or under control 
conditions. Note: the y-axes are presented on a logarithmic scale, *p<0.05.
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5.4.4. CORD BLOOD miR EXPRESSION FOLLOWING LPS (TLR4) 
STIMULATION 
LPS stimulation significantly increased term cord blood let-7e (F(1,47)=7.653, 
p=0.008; Fig. 5.9A), miR-155 (F(1,47)=25.143, p<0.001; Fig. 5.9D) and miR-106a 
expression (F(1,47)=4.040, p=0.050; Fig. 5.9J) compared to control term cord blood 
samples, after adjusting for the covariates pre-eclampsia, labouring delivery, maternal 
smoking during pregnancy and birthweight centile. No change in miR-146a expression 
was observed between LPS-stimulated and control samples in term cord blood. 
Late preterm cord blood increased let-7e expression with LPS stimulation compared to 
unstimulated samples (F(1,24)=5.816, p=0.024; Fig. 5.9B). There was no difference 
observed in miR-155, miR-146a or miR-106a expression by late preterm cord blood 
between control and LPS-stimulated samples (Fig. 5.9 E, H, K).  
There was no difference in expression of any of the miRs in early preterm cord blood 
between control and LPS-stimulated samples (Fig. 5.9 C, F, I, L).  
There was no significant difference observed in the magnitude of LPS-stimulated miR-
155 and miR-146a responses between gestational age groups, however a trend towards 
increased mir-155 expression (p=0.067) and mir-146a expression (p=0.085) was 
observed in term cord blood compared to both preterm groups. There was no difference 
observed in the magnitude of let-7e or miR-106a expression with LPS stimulation 
between the groups.   
 
  
Chapter Five:  
Cord Blood Gene Expression Following TLR Stimulation    Page 160 
 
 
Fig. 5.9. Cord blood miR expression with and without LPS stimulation. The 
expression of let-7e (A-C), miR-155 (D-F), miR-146a (G-I) and miR-106a (J-L) relative 
to RNU48 in term (A, D, G, J), late preterm (B, E, H, K) and early preterm (C, F, I, L) 
cord blood at 6 hours in vitro following LPS stimulation or under control conditions. 
Note: the y-axes are presented on a logarithmic scale, *p<0.05.  
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5.4.5. CORD BLOOD mRNA EXPRESSION FOLLOWING LPS 
(TLR4) STIMULATION  
The expression of genes associated with TLR signalling (mRNA) was collected for a 
smaller subset of samples and the analysis was split according to term (n= 15), late 
preterm (n= 10) and early preterm (n= 10) cord blood. Based on the miR results 
following LPS stimulation compared to PGN or Poly I:C, our analysis of mRNA 
expression focused only on responses to LPS stimulation. This strategy prioritised 
experiments based on limited blood and therefore RNA volumes available following 
preterm delivery.  
The frequency of mRNA expression by LPS-stimulated cord blood was not 
significantly different according to the gestational age groups (Table 5.2).  
Table 5.2. The frequency of gene expression (mRNA) in LPS-stimulated cord blood. 
The frequency (n, %) of TLR-associated gene expression (mRNA) in LPS-stimulated 
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Late preterm cord blood showed increased TLR2 expression following LPS stimulation 
after adjusting for covariates pre-eclampsia, labouring delivery, maternal smoking 
during pregnancy and birthweight centile (F(1,10)= 10.582, p=0.008; Fig. 5.10). There 
was a trend towards increased TLR2 expression in term cord blood following LPS 
stimulation compared to unstimulated samples, however, this did not reach statistical 
significance (p=0.077). Early preterm cord blood showed no change in TLR2 
expression following LPS stimulation. 
 
Figure 5.10. The expression of TLR2 in cord blood with and without LPS 
stimulation. The expression of TLR2 relative to β-actin in in (A) term, (B) late preterm 
and (C) early preterm cord blood in control samples and following LPS stimulation at 6 
hours. Note: the y-axes are presented on a logarithmic scale, *p<0.05. 
NF-κB1 expression was increased in term cord blood (F(1,21)= 5.968, p=0.023; Fig. 
5.11) and early preterm cord blood following LPS stimulation (F(1,12)= 6.145, 
p=0.029). Late preterm cord blood showed no difference in NF-κB1 expression 
following LPS stimulation.  
 
Figure 5.11. The expression of NF-κB1 in cord blood with and without LPS 
stimulation. The expression of NF-κB1 relative to β-actin in in (A) term, (B) late 
preterm and (C) early preterm cord blood in control samples and following LPS 
stimulation at 6 hours. Note: the y-axes are presented on a logarithmic scale, *p<0.05. 
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IL6 expression was increased following LPS stimulation in term cord blood (F(1,22)= 
13.120, p=0.002), late preterm (F(1,10)=99.283, p<0.001) and early preterm cord blood 
(F(1,11)= 14.693, p=0.003; Fig.5.12).  
 
Fig. 5.12. The expression of IL6 in cord blood with and without LPS stimulation. The 
expression of IL6 relative to β-actin in in (A) term, (B) late preterm and (C) early 
preterm cord blood following 6 hours in control samples and following LPS stimulation 
at 6 hours. Note: the y-axes are presented on a logarithmic scale, *p<0.05. 
Late preterm cord blood increased SOCS1 expression following LPS stimulation 
(F(1,11)=6.861, p=0.024; Fig.5.13). Term and early preterm cord blood showed no 
difference in SOCS1 expression following LPS stimulation. 
 
Fig. 5.13. The expression of SOCS1 in cord blood with and without LPS stimulation. 
The expression of SOCS1 relative to β-actin in in (A) term, (B) late preterm and (C) 
early preterm cord blood following 6 hours in control samples and following LPS 
stimulation at 6 hours. Note: the y-axes are presented on a logarithmic scale, *p<0.05. 
There was no difference observed in TLR4, MyD88, IL10 or IRAK1 expression 
following LPS stimulation within the gestational age groups (Fig. 5.14-17). 
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Fig. 5.14. The expression of TLR4 in cord blood with and without LPS stimulation. 
The expression of TLR4 relative to β-actin in in (A) term, (B) late preterm and (C) early 
preterm cord blood following 6 hours under control conditions and following LPS 
stimulation. Note: the y-axes are presented on a logarithmic scale, *p<0.05. 
 
Fig. 5.15. The expression of MyD88 in cord blood with and without LPS stimulation. 
The expression of MyD88 relative to β-actin in in (A) term, (B) late preterm and (C) 
early preterm cord blood following 6 hours under control conditions and following LPS 
stimulation. Note: the y-axes are presented on a logarithmic scale, *p<0.05. 
 
Fig. 5.16. The expression of IRAK1 in cord blood with and without LPS stimulation. 
The expression of IRAK1 relative to β-actin in in (A) term, (B) late preterm and (C) 
early preterm cord blood following 6 hours under control conditions and following LPS 
stimulation. Note: the y-axes are presented on a logarithmic scale, *p<0.05. 
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Fig. 5.17. The expression of IL10 in cord blood with and without LPS stimulation. 
The expression of IL10 relative to β-actin in in (A) term, (B) late preterm and (C) early 
preterm cord blood following 6 hours under control conditions and following LPS 
stimulation. Note: the y-axes are presented on a logarithmic scale, *p<0.05. 
There were no correlations between the expression of let-7e, miR-155, miR-146a, miR-
106a and their respective targets: TLR4, SOCS1, IRAK1 and TRAF6 or IL10 in term, 
late preterm or early preterm cord blood. As a common regulator of miRs, NF-κB1 was 
not associated with miR expression in these samples. 
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5.5. DISCUSSION 
This study is the first to show there is a disparity in TLR-stimulated miR expression 
between term, late preterm and early preterm cord blood. Further, IL6 was the only 
gene investigated that was consistently increased in cord blood following LPS 
stimulation by all gestational age groups. In term cord blood, LPS or PGN exposure 
increased miR-155. LPS stimulation also increased let-7e, miR-106a and NF-κB1 
expression in term cord blood. Similarly, late preterm cord blood increased let-7e, TLR2 
and SOCS1 with LPS stimulation. In contrast to this, early preterm cord blood 
stimulated with LPS increased NF-κB1 without any change in miR expression. No 
changes in cord blood gene expression were observed in any gestational age group 
following Poly I:C stimulation. These data demonstrate an absence of miR expression 
following TLR stimulation in early preterm cord blood despite increased expression of 
pro-inflammatory NF-κB1 and IL6. 
The lack of a miR response to TLR stimulation in early preterm cord blood may be 
associated with immature miR transcript processing. A previous study analysed 2,108 
term cord blood samples for the expression of the miR processing complex, Dicer455. 
Interestingly, Dicer mRNA expression was decreased in cord blood from neonates who 
later developed severe RSV infections during the neonatal period compared to healthy 
neonates. The authors of this study postulated that in this scenario, decreased Dicer 
expression led to an increased viral load, as it has previously been associated with the 
inhibition of viral expression in the context of Influenza A456. While our findings are 
not specific to viral immunity, decreased Dicer expression could contribute to the 
absence of a miR response to TLR stimulation in early preterm cord blood. This would 
not only predispose early preterm neonates to contracting viral infections, but also 
underlie an inability to control the inflammatory response to other pathogens. 
Both term and late preterm cord blood increased let-7e expression in response to TLR 
stimulation. let-7e is best known for targeting TLR4 and therefore, downregulating TLR 
signalling341. Term and late preterm cord blood therefore show evidence of a capacity to 
regulate inflammatory gene expression, while early preterm cord blood does not. Our  
study showed simultaneous increases in inflammatory and regulatory genes as we 
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investigated the peak synthesis phase of cytokine expression (6 hours201). Increased 
expression of the pre-miR, let7 has been associated with decreased IL10 and IL6 
expression in human and murine macrophages stimulated in vitro with Salmonella and 
E. coli457. We therefore postulate that as TLR signalling progresses, term and late 
preterm neonates eventually express enough regulatory let-7e to downregulate cytokine 
expression. In contrast, early preterm neonates do not show this regulatory miR 
response, at least with respect to the TLR ligands we used for this study. 
Interestingly, we observed no difference in miR expression following TLR3 stimulation 
with Poly I:C in any gestational age group. These results are unsurprising as TLR3 
mRNA was undetectable in cord blood at birth (Chapter 4). Others have also found 
CBMCs do not express cytokines in response to Poly I:C78 or TLR7/8 viral agonist 
stimulation48. The only studies that have been able to demonstrate a cytokine response 
to viral stimulation have used high concentrations of Poly I:C in conjunction with 
IFNγ254, which is normally decreased in cord blood compared to adult blood201. It is 
likely the absence of cytokine expression following viral stimulation in vitro also 
reflects an increased susceptibility by neonates towards viral infections such as RSV277.  
The expression of IRAK1 and MyD88 did not change following LPS stimulation in term 
or preterm cord blood, and neither did IRAK1’s negative regulator, miR-146a323. Others 
have observed increased miR-146a expression after 24 hours LPS stimulation in vitro in 
term cord blood monocytes242. While their findings support previous evidence that miR-
146a is regulated by NF-κB expression during terminal TLR signalling458, we 
characterised an earlier time-point which may exclude these effects. In fact, miR-146a 
expression is typically shown to increase up to 100 fold between 24-48 hours in vitro in 
association with decreased IRAK1 and cytokine expression89, 90. The effect of increased 
NF-κB1 expression on miR-146a expression in term and early preterm cord blood are 
not evident in the current analysis.  
Increased NF-κB1 expression in term and early preterm cord blood stimulated with LPS 
suggests active inflammatory cytokine transcription. Interestingly, preterm cord blood 
monocytes have shown increased NF-κB phosphorylation following bacterial 
stimulation compared to term454. Additionally, intestinal epithelial cells from preterm 
neonates also show increased NF-κB activation and cytokine expression in response to 
flagellin (a TLR5 agonist), and decreased expression of anti-inflammatory IκB, 
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compared to adults459. Similarly, rodent models of NEC show increased NF-κB 
activation and decreased IκB expression307, leading to inflammatory injury that 
precedes NEC61. Together, these studies indicate that over-expression of NF-κB by 
TLR-stimulated early preterm cord blood, in the absence of miR expression, could be a 
contributing mechanism to uncontrolled inflammation in these neonates.  
Although miR-106a is known to target IL10339, term cord blood showed increased miR-
106a expression and no difference in IL10 with LPS stimulation. Conversely, early 
preterm cord blood showed no change in the expression of miR-106a, but increased 
IL10 with LPS stimulation. The concurrent increase in IL10 and IL6 in early preterm 
cord blood suggests a ‘genomic storm’ scenario, where inflammatory transcription is 
increased without resolving inflammation. While IL10 is an anti-inflammatory 
cytokine, its increased expression has been associated with septic shock where patients 
increase the expression of both pro- and anti- inflammatory genes460. Furthermore, 
peripheral blood from term neonates with sepsis expresses increased IL10 and pro-
inflammatory IL8, IL6 and IL1β461. Therefore, the increase in IL10 and IL6 without any 
change in regulatory miRs could be evidence of a system that is hyper-responsive to 
inflammatory stimulation.  
Neonatal immune development is shaped by the in utero environment (see section 
1.3.2). For example, transcriptome-wide analyses of neonatal peripheral blood have also 
shown that exposure to chorioamnionitis is associated with a unique pattern of 
inflammatory gene expression compared to unexposed neonates390. Maternal smoking 
during pregnancy has also been associated with altered inflammatory signalling in cord 
blood, where CBMCs show decreased IL6, TNFα and IL10 expression following TLR 
stimulation in vitro compared to non-smoking mothers162, 163. We therefore used these 
factors as covariates in our analysis to adjust for the potential influence they may have 
on stimulated immune responses. In the current study, we observed no significant 
interaction effects between smoking and gestational age. The ability to discriminate the 
independent effects of these exposures would be interesting, however, would require a 
larger sample size. Further, many in utero insults can increase the risk of preterm birth 
and co-occur with different clinical management strategies. This would make it difficult 
to isolate the impact of these exposures, even in a larger sample size. Animal studies 
and in vitro modelling may be the best way to understand these independent effects.  
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A major strength of our study is that we stimulated whole cord blood. This method 
allowed for a holistic insight into neonatal immune function. Further, previous findings 
from our laboratory have shown that isolated CBMCs do not respond as robustly to 
TLR stimulation over time or increasing doses of TLR agonists153. Cord blood 
leukocytes are immature compared to adults and likely require support from other 
factors in whole blood to mount effective immune responses. Whole blood also 
contains platelets, which express TLRs and can contribute to inflammatory 
signalling462. Notably, miRs show cell-specific function which is a limitation of the 
current study. As such, we cannot determine whether specific cells are responsible for 
the upregulation of certain genes that could explain the observed gestational age-
specific responses to TLR stimulation. For example, Tregs numbers are increased in 
preterm cord blood compared to term463, 464. The FOXP3 protein is specific to Tregs and 
ensures their survival and proliferation465 and has been shown to suppress miR-155 
expression in Tregs466. Therefore, if preterm cord blood has increased numbers of 
Tregs, they may be suppressing any increases in TLR-induced miR-155 expression in 
early preterm cord blood. Future studies could confirm this using flow cytometry 
targeting cell-specific miR expression. 
In summary, the coordinated increase in pro-inflammatory and anti-inflammatory genes 
observed in term but not preterm cord blood suggests the key miRs we measured may 
not regulate inflammation as effectively in preterm neonates. This deficiency in miR-
based immune regulation could contribute to chronic inflammatory signalling that 
precedes inflammatory disease. Overall, our novel findings support that preterm 
neonatal inflammatory responses are not intrinsically immature, rather, their 
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6.1.  ABSTRACT 
Background 
The process of inflammation changes over time under the influence of genetic regulators 
such as microRNAs (miRs). MiRs exhibit time-sensitive expression, forming feedback loops 
with other genes involved in inflammatory Toll-like Receptor (TLR) signalling. In Chapter 
5, term and late preterm cord blood increased miR expression following TLR stimulation in 
vitro while early preterm cord blood did not; however, this finding was limited by the 
analysis of a single time-point. This study therefore aimed to identify temporal differences 
in TLR signalling between term and preterm cord blood to characterise potential disruptions 
in inflammatory feedback mechanisms.  
Methods and Results 
Term, late and early preterm whole cord blood were collected and rested in vitro overnight. 
A rested sample was collected as a control measure and then cord blood was stimulated with 
TLR2, 3 or 4 agonists for 2, 6 or 24 hours before collection. Expression of miRs and mRNA 
associated with TLR signalling was quantified using qPCR. Cord blood cytokine production 
was quantified using ELISA. There was no change in the expression of any miRs or mRNAs 
over time in control cultures. In response to PGN, preterm cord blood increased IL6 
(p=0.004) and TNFα production over time (p=0.002). In response to LPS, preterm cord 
blood increased IL6 (p=0.002) and TNFα over time (p<0.001). Term cord blood increased 
TNFα in response to PGN (p<0.001) and LPS (p=0.004) over time. 
Conclusion 
Preterm cord blood upregulates pro-inflammatory cytokine expression over time following 
TLR stimulation without changing the expression of anti-inflammatory genes associated 
with TLR signalling. The lack of a temporal response to inflammatory stimulation by 
preterm cord blood may contribute to uncontrolled inflammation in preterm neonates.  
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6.2. INTRODUCTION 
Inflammation involves a dynamic series of processes which change in response to gene 
expression over time. It begins with the recruitment of leukocytes to the site of antigen 
recognition followed by pathogen killing, inflammatory resolution and repair of host tissues. 
These processes require regulation so they occur sequentially to avoid prolonged, 
pathological inflammation. Inflammatory signalling is therefore increased or decreased 
through positive and negative feedback loops created by genetic regulators such as miRs.  
TLR signalling is a key inflammatory mechanism that involves the sequential recruitment of 
adaptor molecules over time. This process can be coordinated by miRs, which repress 
inflammatory gene expression over time. For example, approximately two hours after LPS 
stimulation in vitro, murine macrophages decrease TLR4 mRNA expression, which leads to 
decreased expression of the pro-inflammatory cytokine, TNFα296, 490.  At a similar time 
point, an increase in SOCS1 expression is observed467, which contributes to the 
downregulation of cytokine signalling through NF-κB inhibition313.  These sequential 
processes highlight time-dependent changes in gene expression that regulate inflammation. 
In the context of TLR signalling, miR-146a and miR-155 play important roles. miR-146a 
forms part of a negative feedback loop as it targets IRAK1 and TRAF6, therefore 
contributing to decreased signalling along the TLR cascade. The expression of miR-146a is 
NF-κB-dependent, as its promoter region is located downstream of NF-κB binding sites. 
miR-146a expression is therefore upregulated with NF-κB signalling and peaks later during 
the inflammatory response (approximately 8 hours following pathogen exposure)323. This 
delayed timing is critical to allow the initial inflammatory response to occur. miR-155 also 
exhibits time-specific expression, which has implications for expression of its target, 
SOCS1341. Murine macrophages show increased miR-155 expression as early as 30 minutes 
following TNFα exposure, followed by a decrease in miR-155 at 1 hour in vitro362.  The 
expression of miR-155 is repressed by both NF-κB468 and IL10337. Further, IL10 mRNA is 
regulated by miR-106a, highlighting the intricate network of temporal regulation of the TLR 
signalling cascade at miR, mRNA and protein levels.  
Chapter 5 demonstrated concurrent increases in pro- and anti-inflammatory genes by term 
cord blood at 6 hours following LPS stimulation and we suggested term neonates exhibit 
inflammatory regulation through miRs. Alternately, the lack of a response by early preterm 
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cord blood suggests its miR expression is unresponsive to inflammatory stimuli. Previous 
studies have characterised temporal responses to LPS stimulation in cord blood, showing 
that neonates exhibit a delayed, but increased response in miR-146a expression over 24 
hours compared to adults242. This chapter therefore aimed to assess a time-course of miR 
and mRNA expression following TLR stimulation to examine if and when these genes were 
inducted by term and preterm cord blood. It was hypothesised that preterm cord blood would 
show increased pro-inflammatory and decreased anti-inflammatory gene expression over 
time.  
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6.3.  METHODS 
6.3.1. PARTICIPANTS & SAMPLE COLLECTION 
Pregnant women (n=49) presenting at the LMH and WCH, who delivered at early preterm 
(<32 weeks), late preterm (32-36 weeks) or term gestation (≥ 37 weeks) were recruited to 
this study. Clinical data were obtained from maternal and neonatal health records, including 
obstetric history and neonatal outcomes (see section 2.1). Cord blood was collected into 
lithium heparin vials at delivery for in vitro culture. 
6.3.2. CORD BLOOD CULTURE AND TLR STIMULATION 
Whole cord blood was plated in volumes of 100µL in flat-bottomed 96-well cell culture 
plates and cultured at 37°C and 5% CO2 overnight. Following this ‘resting’ period, one set 
of wells were left unstimulated (the untreated ‘control’) and remaining wells were 
stimulated with either PGN (TLR2 agonist; 100pg), Poly I:C (TLR3 agonist; 500pg), or LPS 
(TLR4 agonist; 1ng). Wells were collected and pooled in triplicate after 2, 6 or 24 hours in 
vitro.  
Additional replicates of whole cord blood were diluted in sterile saline (1:4) and plated 
(100µL) for subsequent cytokine analyses. Following resting, wells were stimulated with 
either PGN (100ng), Poly I:C (5μg) or LPS (1μg). Wells were collected and pooled in 
duplicate following 2, 6 or 24 hours in vitro. Replicates were centrifuged to extract culture 
supernatant. 
6.3.3. WHOLE RNA EXTRACTION 
TRIzol LS® reagent was used to extract RNA from cord blood (see section 2.5.2). Briefly, 
three volumes of TRIzol LS were added to one volume of cord blood and samples were 
mechanically agitated. Lysates were separated by centrifugation with chloroform to retrieve 
the interphase for subsequent washing with isopropanol and ethanol. RNA was eluted in 
RNase free water and purified using a miRNeasy Mini Kit and DNAse I treatment as per 
manufacturers’ protocol. RINs were assessed using a bioanalyser, where a RIN ≥ 9 was 
considered sufficient for PCR analysis. 
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6.3.4. qRT-PCR ANALYSIS OF miRNA EXPRESSION  
RNA (10ng) was reverse transcribed using a Taqman® MicroRNA Reverse Transcription 
Kit according to manufacturer’s protocol, that was slightly modified for optimal cDNA 
output (see section 2.6.1). This involved pooling a maximum of five RT primers per batch in 
a single RT mixture. Reverse transcription targeted five primer sequences: let-7e, miR-155, 
miR-146a, miR-106a and RNU48. Relative miRNA expression was quantified using 
Taqman® MicroRNA Assays in 20µL reactions containing 1.33µL of cDNA. qRT-PCR 
utilised the comparative cycle threshold (2-ΔCT) method to determine miR abundance relative 
to the reference gene RNU48. 
6.3.5. qRT-PCR ANALYSIS OF mRNA EXPRESSION 
Purified RNA (50ng) was reverse transcribed using a SuperScript™ III First-Strand 
Synthesis Kit for qRT-PCR according to manufacturer’s protocol. qRT-PCR was used to 
quantify the relative expression of miR targets including TLR2, TLR4, MyD88, IRAK1, NF-
κB1, IL6, IL10 and SOCS1 relative to the house-keeping gene, β-actin. qRT-PCR was 
performed using TaqMan® Gene Expression Assays and each 20µL reaction contained 2μL 
of the cDNA template.  
6.3.6. CORD BLOOD SERUM PROTEIN ANALYSES 
Single-target ELISAs were used to measure TNFα and IL6 in cord blood supernatant, as per 
manufacturer’s instructions (see section 2.4.1). The lower detection limit for TNFα was 
15.625pg/mL and the lower detection limit for IL6 was 31.25pg/mL. All inter-assay and 
intra-assay coefficients were below 10%. 
6.3.7. STATISTICAL ANALYSES 
Data were analysed using SPSS v24. Demographic and clinical data are presented as mean ± 
SD, unless otherwise indicated. Frequency data were analysed using Chi-squared tests. 
Kruskal-Wallis tests or ANOVAs were used to analyse continuous data. Post-hoc analyses 
were conducted using Mann-Whitney U tests or t-tests as required, using the Bonferroni 
adjustment to the critical alpha level. Gene and cytokine expression are presented as median 
(25th-75th centile), unless otherwise indicated, and were logarithmically transformed (log10) 
to normalise data for parametric analysis. 
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Repeated measures ANCOVAs were used to interpret transformed data, using pre-
eclampsia, labouring delivery, maternal smoking during pregnancy, chorioamnionitis and 
antenatal betamethasone as covariates where required. Where assumptions of sphericity 
were violated, degrees of freedom were corrected using the Greenhouse Geisser estimates. 
Post-hoc comparisons were made using t-tests where appropriate. An a priori Bonferroni 
correction was made to the critical alpha level for post-hoc comparisons. An alpha level of 
<0.05 was considered statistically significant.  
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6.4. RESULTS 
6.4.1. PARTICIPANT CHARACTERISTICS 
Clinical characteristics from term (n=26), late preterm (n=13) and early preterm (n=10) 
deliveries are shown in Table 6.1. Maternal age, BMI, cigarette smoking during pregnancy, 
pre-eclampsia, gravidity and ethnicity were not significantly different between gestational 
age groups. Gestational age at delivery (completed weeks) was significantly different 
between the gestational age groups (F(2,48)=319.239, p<0.001). Parity was significantly 
different between the groups (χ2(2)= 21.127, p=0.009). Post-hoc tests showed that parity was 
higher in mothers who delivered late preterm compared to term (p=0.009) and between 
mothers who delivered late preterm compared to early preterm (p=0.011). Mode of delivery 
and labour were equally distributed between the groups.  
Early (90%) and late preterm neonates (77%) were more frequently exposed to antenatal 
betamethasone compared to term neonates (12%; χ2(2)=24.446, p<0.001). Birthweight was 
significantly different between the gestational age groups (F(2,48)=97.995, p<0.001) and 
post-hoc tests showed it was lower in early preterm compared to late preterm and term, and 
between late preterm compared to term (p<0.001 for all). Birthweight centile was also 
significantly different between the groups (F(2,48)=9.021, p<0.001), with post-hoc tests 
showing it was lower in early preterm compared to term (p=0.001). The incidence of SGA 
and IUGR was more frequent among early preterm neonates compared to late preterm and 
term (χ2(2)=12.772, p=0.002; and χ2(2)=14.763, p=0.001, respectively). Birth length was 
significantly different between the groups (F(2,44)=93.539, p<0.001) and post-hoc tests 
revealed it was significantly lower between early preterm and term, early preterm and late 
preterm, and late preterm and term neonates (p<0.001 for all). Neonatal head circumference 
was significantly different between the groups (F(2,44)=13.142, p<0.001). Post-hoc tests 
showed it was significantly lower in early preterm compared to term (p<0.001) and late 
preterm compared to term (p=0.035). APGARS at 1 and 5 minutes were significantly 
different between the gestational age groups (χ2(2)=11.007, p=0.004; and χ2(2)=13.783, 
p=0.001, respectively). Post-hoc tests showed APGARS at one minute (p=0.002) and at five 
minutes (p=0.006) were lower in early preterm compared to term neonates.  
Placental weight was significantly different between the gestational age groups 
(F(2,38)=34.384, p<0.001). Post-hoc tests showed it was lower in early preterm compared to 
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term (p<0.001), early preterm compared to late preterm (p=0.016) and late preterm 
compared to term deliveries (p=0.001). The incidence of chorioamnionitis was more 
frequent in early preterm deliveries (30%) compared to late preterm (8%) and term (0%; 
χ2(2)=8.676, p=0.013).   
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Table 6.1. Maternal demographics and neonatal characteristics of term, late and early 
preterm deliveries for cord blood analysed in Chapter 6.  Values are given as mean± SD or 
n (%), unless otherwise indicated. p-values presented in the table were calculated using 
ANOVAs or Kruskal-Wallis tests. Post-hoc tests were conducted using t-tests or Mann-
Whitney U tests and are represented within each gestational age group column by the 
following symbols: *p≤ 0.05 compared to both other groups; #p≤ 0.05 compared to term.  
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Multiple pregnancy  
 
1 (4) 3 (23) 2 (20) 0.158 
Labouring delivery 
Mode of delivery: 
 Emergency Caesarean section 
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Antenatal betamethasone, n (%) 
 
3 (12) 10 (77) 9 (90) <0.001 
APGARS, median, (min-max): 
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6.4.2. THE EXPRESSION OF GENES ASSOCIATED WITH TLR 
SIGNALLING IN CORD BLOOD OVER TIME 
To ensure that time alone did not alter gene expression, miR expression was compared in 
matched unstimulated samples of term and late preterm cord blood. Early preterm samples 
were not used for this analysis due to limitations in available cord blood. Although whole 
blood was cultured over 24 hours, RNA integrity was lost by the 24 hour time point. RNA 
integrity was, however, maintained at 2 and 6 hours (RIN ≥ 9). This meant that only qPCR 
data from 0, 2 and 6 hour time-points were available for analysis. No change was observed 
in miR or mRNA expression in unstimulated cultures over time (Figs. 6.1-10). There were 
insufficient data points on IL6 and IL10 expression in rested cultures, which may relate to 
the previously discussed issue of inconsistent constitutive cytokine gene expression (see 
section 4.5) 
 
Figure 6.1. The expression of let-7e in term and late preterm cord blood over time in 
vitro. The expression of let-7e relative to RNU48 in term (A) and late preterm cord blood 
(B) over time in vitro (hours). Note: the y-axes are presented on a logarithmic scale, 
*p<0.05. 
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Figure 6.2. The expression of miR-155 in term and late preterm cord blood over time in 
vitro. The expression of miR-155 relative to RNU48 in term (A) and late preterm cord blood 
(B) over time in vitro (hours). Note: the y-axes are presented on a logarithmic scale, 
*p<0.05. 
 
Figure 6.3. The expression of miR-146a in term and late preterm cord blood over time in 
vitro. The expression of miR-146a relative to RNU48 in term (A) and late preterm cord 
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Figure 6.4. The expression of miR-106a in term and late preterm cord blood over time in 
vitro. The expression of miR-106a relative to RNU48 in term (A) and late preterm cord 
blood (B) over time in vitro (hours). Note: the y-axes are presented on a logarithmic scale, 
*p<0.05. 
 
Figure 6.5. The expression of TLR2 in term and late preterm cord blood over time in 
vitro. The expression of TLR2 relative to β-actin in term (A) and late preterm cord blood (B) 
over time in vitro (hours). Note: the y-axes are presented on a logarithmic scale, *p<0.05. 
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Figure 6.6. The expression of TLR4 in term and late preterm cord blood over time in 
vitro. The expression of TLR4 relative to β-actin in term (A) and late preterm cord blood (B) 
over time in vitro (hours). Note: the y-axes are presented on a logarithmic scale, *p<0.05. 
 
Figure 6.7. The expression of IRAK1 in term and late preterm cord blood over time in 
vitro. The expression of IRAK1 relative to β-actin in term (A) and late preterm cord blood 
(B) over time in vitro (hours). Note: the y-axes are presented on a logarithmic scale, 
*p<0.05. 
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Figure 6.8. The expression of MyD88 in term and late preterm cord blood over time in 
vitro. The expression of MyD88 relative to β-actin in term (A) and late preterm cord blood 
(B) over time in vitro (hours). Note: the y-axes are presented on a logarithmic scale, 
*p<0.05. 
 
Figure 6.9. The expression of NF-κB1 in term and late preterm cord blood over time in 
vitro. The expression of NF-κB1 relative to β-actin in term (A) and late preterm cord blood 
(B) over time in vitro (hours). Note: the y-axes are presented on a logarithmic scale, 
*p<0.05. 
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Figure 6.10. The expression of SOCS1 in term and late preterm cord blood over time in 
vitro. The expression of SOCS1 relative to β-actin in term (A) and late preterm cord blood 
(B) over time in vitro (hours). Note: the y-axes are presented on a logarithmic scale, 
*p<0.05. 
6.4.2.1. TLR2 (PGN) Stimulation Over Time 
MiR expression was analysed in term, late preterm and early preterm cord blood over time 
(between rested cultures, and 2 and 6 hours following PGN stimulation). There was no 
interaction between time and gestational age group in our analysis of cord blood let-7e, miR-
155 or miR-146a expression after adjusting for pre-eclampsia, maternal smoking, labour, 
chorioamnionitis and betamethasone exposure (Figs. 6.11-13). Similarly, no significant 
interaction effect of gestational age and time was observed for expression of miR-106a 
following stimulation, however a non-significant trend towards increased miR-106a 
expression in term cord blood was observed at 6 hours (p=0.058; Fig. 6.14). 
 
Figure 6.11. The expression of let-7e in term and late preterm cord blood over time 
following PGN stimulation. The expression of let-7e relative to RNU48 in term (A) and late 
preterm cord blood (B) over time following PGN stimulation in vitro (hours). Note: the y-
axes are presented on a logarithmic scale, *p<0.05. 
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Figure 6.12. The expression of miR-155 in term and late preterm cord blood over time 
following PGN stimulation. The expression of miR-155 relative to RNU48 in term (A) and 
late preterm cord blood (B) over time following PGN stimulation in vitro (hours). Note: the 
y-axes are presented on a logarithmic scale, *p<0.05. 
 
Figure 6.13. The expression of miR-146a in term and late preterm cord blood over time 
following PGN stimulation. The expression of miR-146a relative to RNU48 in term (A) and 
late preterm cord blood (B) over time following PGN stimulation in vitro (hours). Note: the 
y-axes are presented on a logarithmic scale, *p<0.05. 
 
Figure 6.14. The expression of miR-106a in term and late preterm cord blood over time 
following PGN stimulation. The expression of miR-106a relative to RNU48 in term (A) and 
late preterm cord blood (B) over time following PGN stimulation in vitro (hours). Note: the 
y-axes are presented on a logarithmic scale, *p<0.05. 
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6.4.2.2. TLR3 (Poly I:C) Stimulation over time  
There was no interaction between time and gestational age in cord blood miR 
expression following Poly I:C stimulation over time after adjusting for pre-
eclampsia, labour, maternal smoking, chorioamnionitis and antenatal 
betamethasone (Figs. 6.15-18). 
 
Figure 6.15. The expression of let-7e in term and late preterm cord blood over 
time following Poly I:C stimulation. The expression of let-7e relative to RNU48 
in term (A) and late preterm cord blood (B) over time following Poly I:C 
stimulation in vitro (hours). Note: the y-axes are presented on a logarithmic 
scale, *p<0.05. 
 
Figure 6.16. The expression of miR-155 in term and late preterm cord blood 
over time following Poly I:C stimulation. The expression of miR-155 relative to 
RNU48 in term (A) and late preterm cord blood (B) over time following Poly I:C 
stimulation in vitro (hours). Note: the y-axes are presented on a logarithmic 
scale, *p<0.05. 
  
Chapter 6:  
Temporal Changes in Cord Blood Gene Expression Following TLR Stimulation Page 188 
 
Figure 6.17. The expression of miR-146a in term and late preterm cord blood 
over time following Poly I:C stimulation. The expression of miR-146a relative 
to RNU48 in term (A) and late preterm cord blood (B) over time following Poly 




Figure 6.18. The expression of miR-106a in term and late preterm cord blood 
over time following Poly I:C stimulation. The expression of miR-106a relative 
to RNU48 in term (A) and late preterm cord blood (B) over time following Poly 
I:C stimulation in vitro (hours). Note: the y-axes are presented on a logarithmic 
scale, *p<0.05. 
6.4.2.3. TLR4 (LPS) Stimulation Over Time 
There was no interaction between time and gestational age in cord blood miR 
expression following LPS stimulation over time after adjusting for pre-
eclampsia, labour, maternal smoking, chorioamnionitis and antenatal 
betamethasone (Figs. 6.19-22). 
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Figure 6.19. The expression of let-7e in term and late preterm cord blood over 
time following LPS stimulation. The expression of let-7e relative to RNU48 in 
term (A) and late preterm cord blood (B) over time following LPS stimulation in 
vitro (hours). Note: the y-axes are presented on a logarithmic scale, *p<0.05. 
 
Figure 6.20. The expression of miR-155 in term and late preterm cord blood 
over time following LPS stimulation. The expression of miR-155 relative to 
RNU48 in term (A) and late preterm cord blood (B) over time following LPS 
stimulation in vitro (hours). Note: the y-axes are presented on a logarithmic 
scale, *p<0.05. 
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Figure 6.21. The expression of miR-146a in term and late preterm cord blood 
over time following LPS stimulation. The expression of miR-146a relative to 
RNU48 in term (A) and late preterm cord blood (B) over time following LPS 




Figure 6.22. The expression of miR-106a in term and late preterm cord blood 
over time following LPS stimulation. The expression of miR-106a relative to 
RNU48 in term (A) and late preterm cord blood (B) over time following LPS 
stimulation in vitro (hours). Note: the y-axes are presented on a logarithmic 
scale, *p<0.05. 
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6.4.2.3.1. The expression of genes associated with TLR signalling (mRNA) 
following LPS stimulation over time 
A subset of samples were analysed for mRNA expression associated with TLR4 
signalling in term (n=6) and late preterm (n=8) cord blood.  
Late preterm cord blood increased IL6 expression over time (F(2,2)=121.312, 
p=0.008; Fig. 6.23). Post-hoc analyses revealed that IL6 expression was increased 
between baseline and 6 hours (p=0.038), but not between baseline and 2 hours or 
2 and 6 hours in preterm cord blood following LPS stimulation. Term cord blood 
did not show any change in IL6 expression over time following LPS stimulation.  
 
Figure 6.23. The expression of IL6 in term and late preterm cord blood over 
time following LPS stimulation. The expression of IL6 relative to β-actin in term 
(A) and late preterm cord blood (B) following LPS stimulation over time in vitro 
(hours). Note: the y-axes are presented on a logarithmic scale, *p<0.05. 
There was no interaction between time and gestational age group in cord blood 
TLR2 (Fig.6.24), TLR4 (Fig.6.25), MyD88 (Fig.6.26), IRAK1 (Fig.6.27), NF-κB1 
(Fig.6.28), IL10 (Fig.6.29) or SOCS1 expression (Fig.6.30) following LPS 
stimulation after adjusting for the covariates.  
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Figure 6.24. The expression of TLR2 in term and late preterm cord blood 
following LPS stimulation over time. The expression of TLR2 relative to β-actin 
in term (A) and preterm cord blood (B) following LPS stimulation over time in 
vitro (hours). Note: the y-axes are presented on a logarithmic scale, *p<0.05. 
 
Figure 6.25. The expression of TLR4 in term and late preterm cord blood 
following LPS stimulation over time. The expression of TLR4 relative to β-actin 
in term (A) preterm cord blood (B) following LPS stimulation over time in vitro 
(hours). Note: the y-axes are presented on a logarithmic scale, *p<0.05. 
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Figure 6.26. The expression of MyD88 in term and late preterm cord blood 
following LPS stimulation over time. The expression of MyD88 relative to β-
actin in term (A) and preterm cord blood (B) following LPS stimulation over time 
in vitro (hours). Note: the y-axes are presented on a logarithmic scale, *p<0.05. 
 
Figure 6.27. The expression of IRAK1 in term and late preterm cord blood 
following LPS stimulation over time. The expression of IRAK1 relative to β-actin 
in term (A) and preterm cord blood (B) following LPS stimulation over time in 
vitro (hours). Note: the y-axes are presented on a logarithmic scale, *p<0.05. 
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Figure 6.28. The expression of NF-κB1 in term and late preterm cord blood 
following LPS stimulation over time. The expression of NF-κB1 relative to β-
actin in term (A) and preterm cord blood (B) following LPS stimulation over time 
in vitro (hours). Note: the y-axes are presented on a logarithmic scale, *p<0.05. 
 
Figure 6.29. The expression of IL10 in term and late preterm cord blood 
following LPS stimulation over time. The expression of IL10 relative to β-actin 
in term (A) and preterm cord blood (B) following LPS stimulation over time in 
vitro (hours). Note: the y-axes are presented on a logarithmic scale, *p<0.05. 
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Figure 6.30. The expression of SOCS1 in term and late preterm cord blood 
following LPS stimulation over time. The expression of SOCS1 relative to β-actin 
in term (A) and preterm cord blood (B) following LPS stimulation over time in 
vitro (hours). Note: the y-axes are presented on a logarithmic scale, *p<0.05. 
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6.4.3. CORD BLOOD CYTOKINE PRODUCTION FOLLOWING TLR 
STIMULATION OVER TIME  
TNFα and IL6 production following TLR stimulation was assessed in a subset of term 
(n=17) and late preterm (n=17) cord blood samples due to limitations in volumes available.  
6.4.3.1. Cord Blood Cytokine Expression Following PGN Stimulation 
Preterm cord blood IL6 production showed a significant interaction with time following 
PGN stimulation (F(2,24)=6.922, p=0.004; Fig. 6.31B). Post-hoc analyses revealed IL6 
expression was increased between 2 and 24 hours (p=0.001), but not between 2 and 6 or 6 
and 24 hours in preterm cord blood. Term cord blood IL6 production did not show an 
interaction with time following PGN stimulation (Fig. 6.31A.  
 
Fig. 6.31. Cord blood IL6 production in term and preterm cord blood following PGN 
stimulation over time. IL6 production by term (A) and late preterm (B) cord blood 
stimulated with PGN over time in vitro (hours), *p<0.05. 
Term cord blood TNFα production increased significantly over time following PGN 
stimulation (F(2,53)=8.811, p<0.001; Fig. 6.32A). Post-hoc analyses revealed TNFα 
expression was increased between 2 and 6 hours (p=0.001), and 2 and 24 hours (p<0.001) 
but not between 6 and 24 hours in term cord blood. Late preterm cord blood TNFα showed a 
significant increase over time following PGN stimulation (F(2,34)=7.219, p=0.002; Fig. 
6.32B). Post-hoc analyses revealed TNFα expression was increased between 2 and 6 hours 
(p=0.023) and 2 and 24 hours (p=0.001), but not between 6 and 24 hours in preterm cord 
blood. 
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Fig. 6.32. Cord blood TNFα production in term and preterm cord blood following PGN 
stimulation over time. TNFα production by term (A) and preterm (B) cord blood stimulated 
with PGN over time in vitro (hours), *p<0.05.  
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6.4.3.2. Cord Blood Cytokine Expression Following Poly I:C Stimulation 
There was no change in IL6 or TNFα production over time in vitro following Poly I:C 
stimulation in term or preterm cord blood (Figs. 6.33-4).  
 
Fig. 6.33. Cord blood IL6 production in term and preterm cord blood following Poly I:C 
stimulation over time. IL6 production by term (A) and late preterm (B) cord blood 
stimulated with Poly I:C over time in vitro (hours), *p<0.05. 
 
Fig. 6.34. Cord blood TNFα production in term and preterm cord blood following Poly 
I:C stimulation over time. TNFα production by term (A) and preterm (B) cord blood 
stimulated with Poly I:C over time in vitro (hours), *p<0.05. 
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6.4.3.3. Cord Blood Cytokine Expression Following LPS Stimulation 
Term cord blood IL6 did not increase over time following LPS stimulation (Fig.6.35A). 
Preterm cord blood IL6 showed a significant increase over time following LPS stimulation 
(F(2,21)=8.095, p=0.002; Fig. 6.35B). Post-hoc analyses revealed IL6 expression was 
increased between 2 and 24 hours (p=0.001), and 6 and 24 hours (p=0.046), but not between 
2 and 6 hours in preterm cord blood.  
 
Fig. 6.35. Cord blood IL6 in term and preterm cord blood following LPS stimulation over 
time. IL6 production by term (A) and preterm (B) cord blood stimulated with LPS over time 
in vitro (hours), *p<0.05. 
Term cord blood TNFα production increased over time following LPS stimulation 
(F(2,43)=6.383, p=0.004; Fig. 6.36A). Post-hoc analyses revealed TNFα expression was 
increased between 2 and 6 hours (p=0.011) and 2 and 24 hours (p=0.002), but not between 6 
and 24 hours in term cord blood. Preterm cord blood TNFα production increased over time 
following PGN stimulation (F(2,34)=11.162, p<0.001; Fig. 6.36B). Post-hoc analyses 
revealed TNFα expression was increased between 2 and 6 hours (p=0.001) and 2 and 24 
hours (p<0.001), but not between 6 and 24 hours in preterm cord blood. 
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Fig. 6.36. Cord blood TNFα production in term and preterm cord blood following LPS 
stimulation over time. TNFα production by term (A) and preterm (B) cord blood stimulated 
with LPS over time in vitro (hours), *p<0.05  
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6.5. DISCUSSION 
We observed no change in cord blood miR expression between rested cultures, 2 and 6 
hours following TLR2, 3 or 4 stimulation. However, preterm cord blood showed time-
dependent increases in IL6 mRNA and cytokine expression following LPS stimulation. We 
also observed increases in IL6 and TNFα protein following PGN and LPS stimulation in 
preterm cord blood over 24 hours. Conversely, term cord blood did not change gene 
expression over time following TLR stimulation, but increased TNFα production following 
LPS and PGN stimulation. These findings do not support the presence of time-dependent 
gene regulation in cord blood over the first 6 hours following TLR stimulation. However, 
the difference between preterm and term cytokine responses suggests differential regulation 
of the innate immune response may occur between 6 and 24 hours post stimulation. Whether 
this can be explained by differential miR regulation is beyond the scope of the current data, 
given that we were unable to assess miR expression at 24 hours due to low RNA integrity.  
Previous studies have assessed miR expression in immortalised human monocyte cell lines 
(THP-1 cells) and shown TNFα expression increases 4-6 hours following LPS stimulation 
and then decreases when miR-146a starts to increase 8 hours following stimulation323. miR-
146a expression then peaks at 18 hours following LPS stimulation, when TNFα is not 
detected, which the authors suggest is a mechanism for endotoxin tolerance. Our data may 
also support this, demonstrating a plateau in TNFα expression 6 hours following PGN and 
LPS stimulation, although we were unable to confirm any change in miR-146a expression 
between 6 and 24 hours. In a similar study to ours, Lederhuber et al. observed a two-fold 
increase in miR-146a expression by LPS-stimulated term cord blood monocytes after 24 
hours in vitro (exceeding adult levels), but not any earlier during the first 12 hours in 
vitro242. These findings suggest miR transcripts accumulate gradually to dampen 
inflammation, which may be the reason our data did not demonstrate changes in gene 
expression between rested cultures and 2 and 6 hours following TLR stimulation in vitro.  
The current data shows TNFα production was increased until 6 hours, without any change in 
TLR4 expression, but an increase in NF-κB1 (see Chapter 5). This could suggest the lack of 
an effective feedback loop during TLR signalling. Typically, TNFα is classed as an early-
response cytokine. In murine macrophages, its expression decreases 2 hours after LPS 
stimulation due to an associated decrease in TLR4 expression and NF-κB inhibition469, 470. 
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miR-155 expression is also responsive to TNFα expression362 and therefore, altered by  
changes associated with NF-κB induction at 30 minute intervals following LPS 
stimulation346. Studies have shown that peak miR-155 expression in murine macrophages 
also occurs between 4 and 6 hours following LPS stimulation341. As we observed no 
significant increase in miR expression between 2 and 6 hours following TLR stimulation, 
we postulate that cord blood demonstrates delayed miR expression or alternative means of 
gene regulation.  
A limitation of the current study was our inability to characterise cord blood miR expression 
following TLR stimulation at 24 hours in vitro. Future characterisation of this time-point is 
critical as previous studies using term cord blood monocytes have shown miR-146a 
significantly increases after 24 hours LPS stimulation in vitro242. Others have used 
immortalised cell lines to investigate temporal feedback loops in the context of LPS-
stimulated miR expression323, which is also a plausible alternative for cord blood 
characterisation. Notably, however, both of these studies used isolated cell populations that 
were supplemented with cell culture media. In contrast to this, our model aimed to 
investigate cord blood as a more realistic analogue for the neonatal TLR response. Future 
studies could therefore characterise temporal miR responses using whole cord blood 
supplemented with appropriate cell culture media. This strategy would increase the 
likelihood of cell survival across the 6-36 hour period following TLR stimulation in vitro.  
Despite limitations in characterising gene expression, we observed a significant upregulation 
in IL6 protein expression over 24 hours following PGN and LPS stimulation in preterm but 
not term cord blood. Therefore, in addition to the lack of miR induction shown by preterm 
cord blood, our findings support a predisposition towards pro-inflammatory mediator 
expression over time. IL6 is associated with chronic and acute inflammatory diseases, as it 
has systemic roles in inflammation, including the secretion of acute phase proteins (e.g. C-
reactive protein)471. The regulation of IL6 is therefore key in influencing the magnitude, 
duration and outcome of inflammation472. While the robust IL6 response to TLR stimulation 
may be protective initially, its continued upregulation past 6 hours in preterm cord blood and 
a lack of regulatory gene expression appears pathological. The consistent upregulation of 
IL6 could lead to systemic inflammatory signalling that could underlie the increased burden 
of systemic inflammatory conditions in preterm neonates473, 474, though this requires more 
specific investigation.   
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Aberrant TLR signalling characterised by disrupted feedback loops has been associated with 
severe inflammatory conditions. As such, the pathogenesis of sepsis results from poorly 
timed and inappropriate anti-inflammatory mechanisms. Traditionally, sepsis is viewed as a 
biphasic response consisting of a systemic inflammatory response (SIRS) followed by a 
compensatory anti-inflammatory response (CARS) that ultimately prolong low-grade 
inflammatory signalling475. Preterm neonates with sepsis show increased numbers of Tregs 
in their peripheral blood, suggesting that they are downregulating inflammation that could 
lead to a chronic instead of acute inflammatory response (which would normally clear 
infection)476. More recent reviews, however, suggest no evidence for sequential SIRS and 
CARS, instead proposing a model for a ‘genomic storm’ where both pro- and anti-
inflammatory genes are upregulated475, 477. This occurs to the extent that elevated expression 
of anti-inflammatory IL10 is associated with higher rates of patient mortality478. The current 
study indicates an absence of temporal-gate switching to allow for changes from pro-
inflammatory to anti-inflammatory signalling in preterm cord blood. Further, data from 
Chapter 5 also support the model of a ‘genomic storm’, where we observed simultaneous 
increases in IL6 and IL10 mRNA in early preterm cord blood. Therefore, while further 
studies need to better characterise this feedback loop over longer periods of time, our data 
begins to suggest that preterm cord blood lacks effective regulatory relationships between 
inflammatory genes.  
In summary, while there was no change in miR or mRNA expression in term or preterm 
cord blood, preterm cord blood increased IL6 protein production over time following TLR 
stimulation. This may suggest temporal signalling switches are impaired, predisposing 
preterm neonates to harmful loops of inflammatory signalling. Future studies are required to 
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7.1. ABSTRACT 
Background 
Toll-like Receptor (TLR) signalling is regulated by complex networks of inflammatory 
genes, including microRNAs (miRs). The experiments described in previous chapters 
demonstrated increased TLR signalling in early preterm cord blood in the absence of 
regulatory gene expression following immune stimulation. Since miRs are ubiquitously 
expressed and affect different networks of genes, this chapter aimed to use bioinformatics 
approaches to identify alternative genes and network-level perturbations that may alter 
inflammatory signalling in preterm neonates.  
Methods and Results 
Publicly available microarray data published on the NCBI GEO database was used to assess 
the expression of genes in the TLR signalling pathway in peripheral blood from neonates 
with and without infection. Data on healthy adult blood cells from the ImmunoNavigator 
database was extracted and co-expression profiles of genes associated with TLR signalling 
were identified and assessed.  
Neonatal infection was associated with upregulated innate immune pathways and 
downregulated of adaptive immune pathways. Preterm neonates with infection upregulated 
STAT1 and CXCL8 compared to term neonates with infection. Co-expression profiles of 
adult cells found that neutrophils were associated with increased expression of MyD88 and 
NF-κB inhibitors compared to other leukocytes and lymphocytes. 
Conclusions 
Our bioinformatics analysis identified novel gene targets from innate immune signalling 
pathways. A unique pattern of gene expression was observed in preterm neonates, 
particularly those with infection, which supports they are biased towards increased 
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7.2. INTRODUCTION 
Preterm neonates are more susceptible to developing systemic inflammatory conditions 
compared to term neonates. These conditions are associated with high morbidity and 
mortality, which occur secondary to acute inflammation. Inflammatory regulation is 
complex and involves networks of genes that can be regulated by miRs, which exhibit time 
and tissue-specific patterns of expression. These pathways are sparsely characterised in 
neonatal immunity.  
Preceding chapters in this thesis have demonstrated that early preterm cord blood increases 
pro-inflammatory gene expression following TLR stimulation in vitro, which is comparable 
in magnitude to stimulated term cord blood. In association with this, TLR-stimulated term 
cord blood upregulates the expression of miRs known to regulate TLR signalling, whereas 
preterm cord blood does not. This apparent lack of miR expression may have wide-spread 
effects on neonatal physiology, given that a single miR can target over 200 mRNA 
transcripts479 and mRNA targets themselves can be regulated by multiple miRs480. To 
examine such patterns of regulation more broadly, bioinformatics pathway analyses have 
emerged as important tools for understanding large-scale cellular processes such as 
inflammation. Pathway analyses provide a wider perspective for the potential effects of gene 
changes and are useful for recognising the complexity of miR-based regulation and 
inflammation. Bioinformatics can be used to investigate patterns of gene expression in 
silico, where statistical analyses are driven by specific biological questions.  
Bioinformatics has previously been used to assess differential gene expression in neonates 
who develop infection390, 402. The results of genome-wide association studies (GWAS) have 
demonstrated that term and preterm neonates who develop sepsis less than 72 hours 
following birth (early-onset neonatal sepsis) show a unique profile of gene expression 
compared to neonates who develop sepsis at least 72 hours after birth (late-onset neonatal 
sepsis)402. Specifically, early-onset neonatal sepsis was associated with greater upregulation 
of pro-inflammatory interferons and IL1α, genes associated with neutrophil extracellular trap 
(NET) formation, and decreased expression of apoptotic genes, including sFAS (which 
contributes to inflammatory resolution). This genetic profile suggests early-onset neonatal 
sepsis is associated with a greater magnitude of inflammation compared to late-onset 
neonatal sepsis. This is an example of the same condition exhibiting unique transcriptomic 
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profiles that are dependent on timing (postnatal age) or mode of acquisition. Overall, these 
studies demonstrate the potential for GWAS in informing prognostic testing or novel 
methods of intervention.  
This chapter aimed to review publicly available microarray expression data examining gene 
expression in peripheral neonatal blood exposed to pathogens402, 403. Specifically, we aimed 
to assess TLR signalling pathways to identify any differentially expressed genes in neonates 
with and without infection. We used bioinformatics approaches to characterise pathways of 
genetic regulation in preterm cord blood to identify potential mechanisms that contribute to 
differences in inflammatory signalling between preterm and term neonates. Additionally, 
publicly-available array data generated from adult immunocytes was investigated to identify 
patterns of cell-specific gene expression in the context of TLR signalling. Overall, it was 
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7.3.  METHODS 
7.3.1. TLR SIGNALLING PATHWAY ANALYSIS 
In silico bioinformatics analyses were used to examine networks of gene expression in 
neonatal peripheral blood (see section 2.7.1). Publicly available custom Affymetrix gene 
array data profiling whole peripheral blood from neonates was analysed390, 402, 403. 
GEOquery and GEO2R packages were used to download the datasets (GSE69686 and 
GSE25504). The analysis involving GSE69686 selected individuals that were defined as 
preterm neonates with or without clinical sepsis. We selected individuals from the 
GSE25504 dataset that were defined as preterm or term neonates, with or without bacterial 
infection. Demographic and clinical data are presented as frequencies or mean ± SD for each 
of these study groups, unless otherwise indicated.  
Bioinformatics analyses were performed in collaboration with Dr Jimmy Breen 
(Bioinformatics core-facility manager, Robinson Research Institute, University of Adelaide) 
using the R software package, limma. Data were normalised using log transformation prior 
to analysis. Differentially expressed genes within the TLR signalling pathway (KEGG ID: 
hsa04620) were identified from each dataset and generated as heat-maps (counts per million, 
cpm). The top 20 KEGG pathways that were differentially expressed according to infection 
were presented for the data set GSE25504.  
7.3.2. CELL TYPE ENRICHMENT ANALYSIS 
The Immuno-Navigator database (http://sysimm.ifrec.osaka-u.ac.jp/immuno-navigator/) was 
used to query target genes in the TLR signalling pathway to identify correlation scores of 
gene co-expression in specific tissues (sorted by significance of expression enrichment; see 
section 2.7.2). The correlation network hub prediction tool was used to determine how many 
networks the listed genes were associated with in healthy, unstimulated adult immunocytes 
from peripheral blood.   
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7.4. RESULTS 
7.4.1. PATHWAY ANALYSIS OF DATA COLLECTED FROM NEONATES 
WITH BACTERIAL INFECTIONS 
Complete demographics for the dataset are reported in the original publication403, with 
samples extracted for our analysis summarised in Table 7.1. The data extracted for this 
analysis originated from peripheral blood collected from neonates admitted to the NICU, 
including preterm neonates with confirmed bacterial infection (n=22), preterm neonates 
without infection (n =8), term neonates with bacterial infection (n=3) and term neonates 
without infection (n=21). Infection was confirmed by positive blood culture results, with the 
most common culture-positive pathogen being Coagulase Negative Staphylococcus (CoNS). 
White blood cell (WBC) counts were decreased in term neonates with infection compared 
term neonates without infection, but increased in preterm neonates with infection compared 
to those without infection. Decreased platelet counts and increased numbers of neutrophils 
were associated with infection in both groups of neonates. 
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Table 7.1. Clinical characteristics of neonates extracted from the GSE25504 dataset and 
analysed in Chapter 7. Maternal demographics and neonatal characteristics of term and 
preterm deliveries with and without infection from the dataset GSE25504 (further 
summarised in the original publication403) used for the analysis of peripheral blood gene 
expression. Values are presented as mean± SD or n (%), unless otherwise indicated.  
 Term Preterm 
 
No infection Infection No infection Infection 
n=21 n=3 n=8 n=22 
Gestational age (completed 
weeks), median (min-max) 
40 (37-42) 37 (37-38) 34 (30-36) 29 (25-34) 
Neonatal demographics: 
Male sex 
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 Neonatal screen   
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KEGG pathways were compared in peripheral blood from term and preterm neonates with 
or without infection. Pathways were listed according to the number of differentially 
expressed (DE) genes between these groups, ranked in order of statistical significance. The 
top five KEGG pathways that were significantly upregulated according to the presence or 
absence of infection in this dataset involved the immune system (Table 7.2). Innate immune 
pathways, including NOD-like receptor (NLR) and TLR signalling pathways showed the 
greatest number of upregulated genes between infected and uninfected neonates (not 
differentiated by gestational age).  
The top five KEGG pathways that were significantly downregulated with infection in this 
dataset involved transcription (Table 7.3). These included Ribosomal pathways and RNA 
degradation pathways. T cell immunity pathways were also downregulated according to 
infection, including T cell receptor signalling pathways, and Th1, Th2 and Th17 cell 
differentiation pathways.   
Chapter 7: 
A Bioinformatics Analysis of TLR Signalling Pathways in Neonates Page 212 
Table 7.2. The top 20 KEGG pathways upregulated in peripheral blood from term and 
preterm neonates with or without bacterial infection. KEGG pathways upregulated in 
peripheral blood from term and preterm neonates with infection compared to uninfected 
neonates from the dataset GSE25504. Pathways are listed according to the number of DE 
genes ranked in order of statistical significance.  
KEGG 
Pathway ID 







hsa04621 NLR signalling pathway 168  54 1.01e-13 
hsa05164 Influenza A 173 45 2.43e-08 
hsa04380 Osteoclast differentiation 128 35 2.41e-07 
hsa04620 Toll-like Receptor Signalling 
Pathway 
104 30 5.01e-07 
hsa04137 Mitophagy-animal 65 22 8.63e-07 
hsa05162 Measles 134 34 2.35e-06 
hsa04216 Ferroptosis 40 15 1.17e-05 
hsa05134 Legionellosis 55 18 1.46e-05 
hsa04920 Adipocytokine signaling pathway   69 20 3.71e-05 
hsa05169 Epstein-Barr virus infection 203 42 4.10e-05 
hsa05168 Herpes simplex infection 185 39 4.98e-05 
hsa04066 HIF-1 signalling pathway   99 25 5.51e-05 
hsa05160 Hepatitis C 131 30 7.57e-05 
hsa04062 Chemokine signalling pathway 182 38 7.72e-05 
hsa045144 Malaria 49 15 1.76e-04 
hsa04920 NF-kappa B signaling pathway   95 23 2.14e-04 
hsa04920 Complement and coagulation 
cascades   
79 20 2.89e-04 
hsa04920 Leishmaniasis   74 19 3.36e-04 
hsa04920 Kaposi's sarcoma-associated 
herpesvirus infection 
173 34 5.93e-04 
hsa04920 TNF signalling pathway 108 24 6.17e-04 
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Table 7.3. The top 20 KEGG pathways downregulated in peripheral blood from term and 
preterm neonates with or without bacterial infection. KEGG pathways downregulated in 
peripheral blood from term and preterm neonates with infection compared to uninfected 
neonates from the dataset GSE25504. Pathways are listed according to the number of DE 
genes ranked in order of statistical significance.  
KEGG 
Pathway ID 






hsa03010 Ribosome 154   76 2.92e-28 
hsa03040 Spliceosome 134  50 6.81e-13 
hsa03018 RNA degradation 77  30 9.06e-09 
hsa03008 
Ribosome biogenesis in 
eukaryotes 106  
 
36 2.22e-08 
hsa03013 RNA transport 171  49 3.88e-08 
hsa04120 
Ubiquitin mediated proteolysis 137  
 
38 3.15e-06 
hsa00230 Purine metabolism 175  43 2.14e-05 
hsa04660 




Th1 and Th2 cell differentiation 92   
 
26 7.94e-05 
hsa00640 Propanoate metabolism 32   13 9.36e-05 
hsa04659 Th17 cell differentiation 107   28 1.85e-04 
hsa00280 
Valine, leucine and isoleucine 
degradation 48   
 
16 2.40e-04 
hsa01100 Metabolic pathways 1272  205 2.94e-04 
hsa03430 Mismatch repair 23   10 3.16e-04 
hsa05340 Primary immunodeficiency 37   13 5.12e-04 
hsa00062 Fatty acid elongation 25   10 7.05e-04 
hsa04110 Cell cycle 124   29 1.08e-03 
hsa03015 mRNA surveillance pathway 91   23 1.14e-03 
hsa00240 Pyrimidine metabolism 102   25 1.14e-03 
hsa03030 DNA replication 36   12 1.42e-03 
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Analysis using limma found CD14 and NF-κB1 showed the highest level of upregulation in 
term and preterm neonates with infection (≥ 11cpm; Fig.7.1). These genes were also 
upregulated in neonates without infection, but at a lower magnitude (9cpm). Other genes 
upregulated in most neonates with infection included TLR1, TLR5, TLR6, TLR8, CCL4, 
IL1B, MyD88 and LY96 (≥ 7cpm).  
Preterm neonates with infection upregulated STAT1 (12cpm), CXCL10 (in 6 samples, 
approximately 8cpm), CXCL8 (in 6 samples, 7cpm), PIK3R2 (≥ 9cpm), FOS (≥ 9cpm), IL1β 
(11cpm) and MAP2K3 (≥ 9cpm) compared to term neonates with infection. Other than these 
genes, term neonates with infection showed a similar phenotype to preterm neonates with 
infection. 
Neonates without infection upregulated the MAPK3, IKBKG and CCL5 gene clusters in both 
term and preterm samples (9cpm) more frequently than neonates with infection. TLR2 (≥ 
6cpm), TNF (≥ 6cpm), IRAK1 (≥ 6cpm) and IL6 (7cpm) were comparable, independently of 
gestational age or infection. TLR4 was increased in three preterm samples with infection, 
while TLR3 was not detected. Viral pathways or interferon gene clusters were not detected 
in any of the samples analysed. 
(Over page) Fig. 7.1. A heat-map of genes in the TLR signalling pathway differentially 
expressed in term and preterm neonates with and without bacterial infection. The gene 
expression profile of TLR signalling pathways in whole blood collected from term and 
preterm neonates with (“infected”) or without bacterial infection (“uninfected”). Individuals 
are represented along the x-axis: uninfected preterm (purple), uninfected term (green), 
infected preterm (blue) and infected term neonates (pink). Normalised expression levels are 
colour-graded for each gene, from red (high expression) to blue (low expression), 
represented as counts per million (cpm). Bars on the y-axis represent gene clustering 
according to similar profiles of expression.  
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Fig.7.1. A heat-map of genes in the TLR signalling pathway differentially expressed in 
term and preterm neonates with and without bacterial infection.  
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7.4.2. PATHWAY ANALYSIS OF GENES EXPRESSED IN PERIPHERAL 
BLOOD FROM PRETERM NEONATES WITH SEPSIS 
Complete demographics for the dataset (n=58) are reported by two previous publications390, 
402, with samples extracted for our analysis being summarised in Table 7.4 using all publicly 
available data. The subset of samples we analysed consisted of peripheral blood from 
preterm inpatients of the neonatal intensive care unit who suffered from sepsis (n=37; 
“infected”) and preterm neonates without sepsis (n=21; “uninfected”).  
Clinical characteristics are reported according to preterm neonates without infection, with 
clinical sepsis (n=22) or with culture-proven sepsis (n=15). Mean gestational age was 
comparable between the groups and a majority of patients were male. A majority of cases of  
culture-proven neonatal sepsis were associated with Staphylococci. Neutropenia was defined 
as having an absolute neutrophil count of <1500 cells/ mm3 and occurred most frequently in 
preterm neonates with culture-proven sepsis. White blood cell counts were decreased at 
magnitudes greater than 30% over 24 hours (indicating increasing leukopenia) in 40% of 
preterm neonates with culture-proven sepsis. C-Reactive Protein (CRP) was greater than 
45mg/L (indicating active inflammation) in all preterm neonates with clinical or culture-
proven sepsis.  
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Table 7.4. Clinical characteristics of neonates extracted from the GSE69686 dataset and 
analysed in Chapter 7. Clinical characteristics (as summarised from the original 
publication402) of preterm neonates that were diagnosed with clinical sepsis, culture-proven 
sepsis or that had no evidence infection (“uninfected”) from the dataset GSE69686 that was 
used for our analysis of neonatal peripheral blood gene expression. Values are presented as 
the mean or n (%), unless otherwise indicated. 
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Our analysis of the GSE69686 dataset focused on genes in the TLR signalling pathway, 
identifying differences between preterm neonates with or without sepsis (defined as CRP ≥ 
45mg/L, because culture-proven sepsis was not delineated by the NCBI GEO repository). A 
gene expression profile was generated as a heat-map of probe sets specific to genes in the 
TLR signalling pathway using normalised expression values (Fig. 7.2).  Genes were 
clustered hierarchically based on similar profiles of expression levels in grouped (infected or 
uninfected) samples.  
Gene clusters that were upregulated by neonates with sepsis compared to neonates without 
sepsis included MAPK14, TLR8, STAT1, RAC1 (approximately 8.5cpm); NF-κBIA, MyD88 
and FOS (7cpm); TLR2, IFNAR1, LY96, TLR5, IRAK4 (8cpm); and MAP2K6, PIK3CB, 
TLR1 (7cpm). TLR4 was also upregulated with sepsis compared to neonates with no sepsis 
(10cpm). Neonates with no infection showed upregulation of CCL5 (10cpm) and AKT2 
(8cpm) compared to neonates with sepsis. NF-κB, IRAK1 and TNF were comparable 
between the groups (6cpm), while IL6 and IL10 were not upregulated in either group 
(<4cpm).  
(Over page): Fig. 7.2. A heat-map of genes in the TLR signalling pathway differentially 
expressed in neonates with and without sepsis. Gene expression profile of TLR signalling 
pathway genes in whole blood collected from preterm neonates with (“infected”) and 
without sepsis (“uninfected”). The normalised expression of each gene (cpm) is colour 
graded from red (high expression) to blue (low expression). Bars on the left axis represent 
gene clustering according to similar profiles of gene expression. 
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Fig. 7.2. A heat-map of genes in the TLR signalling pathway differentially expressed in 
preterm neonates with and without sepsis.  
 
 
7.4.3. CELL TYPE ENRICHMENT ANALYSIS 
Select genes from the TLR signalling pathway were analysed using an immune 
transcriptome-wide repository of data on adult peripheral blood and analysed for differential 
expression in leukocyte subsets (Fig.7.3). This database collates evidence of the constitutive 
co-expression of genes from 4,639 healthy human samples and 19 cell types generated by 
191 studies to date408. We extracted data relating to a subset of leukocytes and assessed the 
co-expression of genes from the TLR signalling pathway, specifically including those that 
have been investigated previously in this thesis. We aimed to determine cell-specific 
expression of these genes, which could inform more targeted analyses of cell types in future 
studies.   
The results of this analysis are presented in Fig 7.3. Mean signals represent the average 
expression level of a gene per cell type. TLR2 and TLR4 were upregulated in neutrophils, 
monocytes and macrophages. MyD88 was upregulated in neutrophils. IRAK1 and NF-κB1 
were consistently upregulated in all immune cell types analysed. IL6 was expressed at low 
levels in all cell types, with the highest level of expression observed in conventional 
dendritic cells (cDCs). IL10 was most predominantly expressed in macrophages compared 
to the other cell types analysed. SOCS1 expression was upregulated in CD4+ T cells, Tregs, 
cDCs and granulocytes. Genes with mean signals ≤ 5 were not expressed by the represented 
cell types.  
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Fig. 7.3. A heat-map of genes in adult peripheral blood differentially expressed according 
to cell type. Gene expression profile of select genes from the TLR pathway genes (right 
axis) in healthy adult peripheral blood according to specified immune cell types (bottom 
axis). Genes are clustered according to their co-expression (left axis) and cell-specific gene 
expression is clustered on the top axis (mean signal of expression). Data were extracted from 
ImmunoNavigator website for analysis. 
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7.5. DISCUSSION 
This study used a bioinformatics approach to explore wider innate immune pathways that 
were differentially expressed with neonatal infection. We found that neonates with bacterial 
infection upregulated innate immune KEGG pathways and downregulated pathways 
associated with transcriptional regulation and T cell immunity, highlighting immature 
adaptive immunity. Within the TLR signalling pathway, both term and preterm neonates 
with infection increased CD14 and NF-κB expression. In the same gene cluster, however, 
preterm neonates with infection upregulated STAT1 compared to term neonates with 
infection. In our second analysis, preterm neonates with sepsis increased MAPK pathways 
and TLR signalling compared to preterm neonates without sepsis, however, other 
inflammatory pathways were similarly expressed between the groups. Cell-specific analyses 
using expression data on healthy adult blood showed neutrophils and monocytes were the 
main source of TLR-associated genes, including MyD88, NF-κB inhibitors and the IL6 
receptor. This could support a central role for neutrophils in contributing to TLR signalling 
in whole blood and argues for better characterisation of neonatal neutrophil function. 
Overall, our analysis supports an exaggerated pro-inflammatory phenotype and highlights 
specific pathways of activation in preterm neonates with infection.  
The current pathway analysis reinforces the significance of innate rather than adaptive 
immunity in neonates. As such, TLR and NLR pathways were among the top four 
upregulated pathways associated with neonatal infection, while pathways associated with T 
cell signalling and Th cell differentiation were downregulated. These findings agree with the 
original paper by Smith et al., who identified an ‘unbalanced homeostatic immune response’ 
characterised by increased myeloid regulatory signalling and inhibited lymphoid signalling 
in neonates with infections, independently of gestational age at delivery403. They found 
neonates with infection demonstrated an increased presence of monocyte- and neutrophil-
specific markers, alongside markers of suppressed T cell mediated immunity. This supports 
exaggerated innate immune responses and deficient adaptive immunity may both contribute 
to poor immune homeostasis by preterm neonates. The authors infer that dysregulation may 
result from an inability of the neonatal immune system to recognise a homeostatic 
inflammatory threshold has been reached and that regulatory mechanisms must be activated. 
This phenomenon could underlie the findings of this thesis from Chapter 6, where there was 
an absence of regulatory gene expression over at least the first 6 hours following TLR 
Chapter 7: 
A Bioinformatics Analysis of TLR Signalling Pathways in Neonates Page 223 
stimulation and inflammatory cytokines continued to be upregulated between 6 and 24 
hours. Altogether, this could highlight a more global deficit in immune regulation by 
preterm neonates, which extends past the targets we have investigated.  
Bioinformatics approaches are useful for identifying changes in entire pathways. Our 
analysis showed infection in preterm neonates was associated with an upregulation of the 
master regulators MAPK and STAT1 compared to term neonates. MAPKs phosphorylate p38 
and JNK, which are essential for pro-inflammatory cytokine transcription. Similarly, STAT1 
is a transcription factor that translocates into the nucleus on binding with IFNα, IFNγ or 
IL6481. Although the network analysis indicated IL6 expression was comparable according 
to gestational age and infection, results from Chapter 6 showed increased IL6 production by 
preterm cord blood following 24 hours of TLR stimulation in vitro. This would suggest 
differences in JAK-STAT signalling by preterm neonates. Evidence regarding this is 
currently limited, however a previous study has shown the phosphorylation of STAT1 and 
STAT3 by IL6 is comparable between term and preterm cord blood monocytes454. It would 
therefore be useful to characterise JAK-STAT signalling in whole blood to determine if it 
contributes to IL6 dysregulation in preterm neonates.  
Smith et al. established a 52-gene invariant signature of gene expression that predicted 
bacterial infection in neonates. Within this, they found a specific patient phenotype that was 
associated with increased TLR and IL6 signalling pathways. This specific phenotype could 
explain why certain preterm neonates are predisposed to developing inflammatory 
morbidities compared to others. While we could not confirm this in our analysis, the use of 
microarray analyses could be used by future studies to validate the dysregulation of these 
pathways. A novel study on preterm cord blood would be advantageous in comparison to the 
datasets currently available on the GEO repository, as it would avoid sampling unwell 
neonates as controls. As such, the individuals we analysed as ‘controls’ from the Smith et al. 
dataset were sampled due to maternal thyroid dysfunction which could affect gene networks 
associated with metabolism and adaptive immunity.  
Our bioinformatics analysis of peripheral blood from preterm neonates with sepsis 
reinforced a dysregulated innate immune phenotype. We observed that a majority of genes 
expressed in the TLR signalling pathway were comparable between preterm neonates with 
and without sepsis, including key regulators such as NF-κB, IRAK and TNF (that are not 
typically upregulated in the absence of infection). Although the obvious limitation of our 
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analysis was that the dataset grouped neonates with and without culture-proven sepsis, all 
neonates demonstrated CRP levels equal to or greater than 45mg/L. CRP is an acute phase 
protein expressed by the liver during severe inflammation, indicating that irrespective of 
pathogenic growth, these neonates reflected a pro-inflammatory state. This was confirmed 
by our analysis that showed septic preterm neonates increased TLR2, TLR4, FOS (a 
component of AP-1 that induces cytokine transcription) and MAPK pathways, with only 
slight increases in anti-inflammatory regulators such as NF-κBIA and IL10. Wynn, et al.’s 
paper on neonatal sepsis also analysed plasma cytokine production and found increased 
GCSF, IL8, TNFR1, sFAS and IL1β expression associated with both culture-positive and 
clinical sepsis. Further, they found that the timing of sepsis affected unique nodes of genes, 
specifically, leukocyte extravasation, despite activating similar immune pathways. In 
conjunction with our analysis, this may indicate early stages of TLR signalling are 
upregulated by preterm neonates with sepsis compared to those without sepsis. Specifically, 
we found increased expression of TLRs and other early signalling molecules, but 
comparable terminal molecule upregulation between infected and uninfected groups (i.e. 
NF-κB and cytokines TNFα, IL6 and IL10). The comparable expression of a majority of 
genes associated with pro-inflammatory TLR signalling between preterm neonates with and 
without sepsis reinforces the idea that their system may be naturally biased towards a pro-
inflammatory state.  
As our bioinformatics analyses examined whole blood samples, we also conducted a cell-
type enrichment analysis. Investigation of data from healthy adult haemocytes showed that 
genes associated with TLR signalling are upregulated in innate cell types compared to 
adaptive immune cells. We used adult cell gene expression as there were no data provided 
regarding neonatal cell-specific arrays that were publicly accessible, likely due to the 
constraints in neonatal blood volume available for analysis. Nonetheless, our analysis is 
applicable to neonates as they demonstrate some aspects of innate immune function that are 
comparable to adults202, 203, 258. Adult neutrophils appeared to be the primary source of TLR2, 
IL6ST, IL10RA, IL6R, MyD88 and NF-κBIA, which are central to activating TLR signalling 
and regulating NF-κB. The increased expression of NF-κB1 in early preterm cord blood 
following LPS stimulation in vitro (Chapter 5) may therefore be attributed to neutrophil 
activation or accumulation, but this requires further confirmation. Neutropenia is common in 
preterm neonates and is observed in our cohort of neonates with sepsis who showed less 
numbers of neutrophils and increased numbers of platelets (Table 7.1). Interestingly, 
Chapter 7: 
A Bioinformatics Analysis of TLR Signalling Pathways in Neonates Page 225 
preterm cord blood neutrophils demonstrate increased phagocytic function compared to 
term284. Our data also observed that preterm neonates with infection increased IL8 
expression, which could suggest increased neutrophil chemotaxis. Notably, aberrant IL8 
expression has been associated with chronic inflammation, including that observed with 
neonatal sepsis221 and inflammatory lung disease222. If the neutrophil response is not 
appropriately regulated by preterm neonates, as our results suggest, neutrophils may accrue 
at the sites of inflammation and their potent ROS and cytokine expression may become 
pathological482, 483. 
The two datasets we analysed showed notable discrepancies in neonatal blood cell counts. 
Term neonates with bacterial infection showed lower WBC counts compared to term 
neonates without infection, while preterm neonates showed higher white blood cell counts 
compared to uninfected preterm neonates, and all infected groups showed higher neutrophil 
counts compared to uninfected neonates. Conversely, in association with sepsis, white blood 
cell and neutrophil counts were lower. In context of the adult cell analysis, we observed that 
macrophages and monocytes were associated with increased TLR2, TLR4 and IL10 
expression. Further, studies on cord blood that have used flow cytometry show monocytes 
are primary producers of IL6 and IL10 in response to stimulation with whole bacteria204. 
This could mean the decreased number of WBCs associated with term infection underlies 
the observed absence of IL10 expression. Conversely, preterm WBCs increase with 
infection alongside IL10 and IL6 production that could lead to increased inflammatory 
activation. 
DCs are another important subset of antigen presenting cells that are critical to both innate 
and adaptive immunity. In the adult cell analysis, cDCs were associated with the highest IL6 
and SOCS1 expression. Interestingly, neonates have higher numbers of DCs compared to 
adults, however these cells show decreased function and TLR4 expression484. Further, while 
pDCs are known to upregulate IL6 in adults, they have a unique phenotype compared to 
neonate. Unfortunately, there are few studies that have investigated cell-specific cytokine 
production in neonates to support these findings48, 201, 485. Future studies would therefore 
need to validate the primary source of inflammatory gene expression in order to better 
characterise the direction of inflammation.  
A limitation of analysing large microarray datasets is the restricted ability to determine the 
contribution of different physiological exposures, particularly given the complexity of 
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preterm delivery. Notably, it would be difficult to obtain a ‘clean’ sample of preterm cord 
blood that has not been exposed to inflammatory perturbations in utero. The comparisons 
made using term peripheral blood in these datasets is therefore not ideal, even though they 
have been screened for the outcome of interest (in our case, infection). These ‘control’ 
samples were collected on the basis of other clinical indications, including jaundice or 
maternal thyroid disease. Despite not having obvious direct effects on inflammation, such 
factors may still perturb transcriptomic networks. Nonetheless, arrays are still useful 
exploratory exercises that can be used to direct future research by characterising larger 
patterns of gene co-expression and feedback loops. These analyses could identify sets of 
predictive genes for the development of diagnostic (using peripheral blood) or prognostic 
tools (using cord blood).  
Overall, our analysis presents several pathways for future elucidation in the context of 
preterm neonates. Future studies could characterise preterm neonatal neutrophil responses, 
perform microarrays on preterm blood and further investigate STAT and NLR pathways of 
signalling in order to fully characterise innate immunity. These studies would need to 
account for inflammatory activation and how different conditions affect gene and cell-
specific relationships in different preterm phenotypes. Ideally, cell-separation experiments 
and miR microarrays should be incorporated to fully analyse the process of innate immune 
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The innate immune response provides defence during neonates’ vulnerable period of 
transition to ex utero environment. Previous studies have demonstrated that preterm 
blood exhibits either decreased or comparable expression of pro-inflammatory 
cytokines compared to term following TLR stimulation (Table 1.2). Nonetheless, 
preterm neonates remain more susceptible to contracting infections and are unable to 
clear pathogens adequately, suggesting other mechanisms contribute to a defective 
innate immune response. As such, deficiencies in immune regulation could influence 
the increased prevalence of inflammatory conditions among preterm neonates34.  
The overarching aim of this thesis was to understand how preterm birth alters miRs that 
regulate TLR signalling in neonates. We characterised genes associated with TLR 
signalling in term and preterm placenta and cord blood, and reported how their 
expression changed in cord blood following TLR2, 3 and 4 stimulation. We found no 
difference in gene expression preterm placenta compared to term. Conversely, early 
preterm cord blood showed decreased constitutive expression of miR-155 and let-7e 
compared to late preterm and term cord blood, with no difference in other genes 
involved in TLR signalling. Following TLR2 and TLR4 stimulation, term cord blood 
increased expression of miRs (let-7e, miR-155 and miR-106a), inflammatory signalling 
genes (NF-κB1 and IL6) and cytokines (TNFα and IL6); while early preterm cord blood 
upregulated inflammatory pathways (IL6, IL10, NF-κB1) and cytokines (TNFα and IL6) 
without changing miR expression. Further, our time-course experiment showed preterm 
cord blood continued to increase IL6 production past 6 hours in vitro, while term cord 
blood IL6 plateaued at 6 hours. Together, our findings suggest the absence of regulatory 
miR expression by cord blood could be an underlying mechanism for uncontrolled 
inflammatory signalling in preterm neonates. 
8.1. THE SAMPLE POPULATION 
Preterm delivery is a complex condition with multiple phenotypes (see section 1.2). Our 
sample consisted of a single cohort of women that delivered at term and preterm 
gestation. A majority of samples were analysed in Chapter 4 (baseline cord blood gene 
expression). These consisted of a homogenous population of smokers, indigenous 
women and pre-eclamptic women, which are all characteristics associated with an 
increased risk of preterm delivery. Notably, the incidence of chorioamnionitis or 
maternal infection (e.g. GBS-positive women) was low in our cohort. While infection is 
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the most common risk factor for preterm delivery, it would have complicated the 
functional analysis of cord blood in our sample because antenatal infection such as the 
exposure to chorioamnionitis is known to affect the neonatal transcriptome390. A 
strength of the current cohort is its relative homogeneity and was random sampling that 
encompassed conditions such as pre-eclampsia and maternal smoking, with our analysis 
taking these factors into account as covariates.  
8.2. THE EXPERIMENTAL PARADIGM 
The TLR signalling cascade provides a useful experimental paradigm for investigating 
innate immune function. TLRs are evolutionarily-conserved PRRs and alterations in 
their function can reflect system-level perturbations in immunity. While TLRs 
demonstrate ubiquitous expression, they are involved in complex pathways of 
intracellular signalling that provide many checkpoints for regulation. miRs are post-
transcriptional regulators with temporal and tissue-specific sensitivity. The discovery of 
miRs has revolutionised thinking on post-transcriptional regulation of genes and in the 
context of large signalling networks such as inflammation. Notably, both miRs and 
TLRs are evolutionarily conserved, which highlights not only their important roles in 
immunity, but organism survival. 
Our experimental model investigated miRs known to regulate TLR signalling and the 
expression of their known targets, alongside other key genes in the TLR signalling 
cascade. We aimed to identify mechanisms by which preterm neonates are susceptible 
to uncontrolled inflammation, which is characteristic of common neonatal morbidities 
include NEC and neonatal sepsis. We hypothesised that preterm placenta and cord 
blood would show increased expression of pro-inflammatory genes compared to term 
placenta and cord blood at birth. It was further hypothesised that following TLR 
stimulation, preterm cord blood would exhibit increased expression of genes with pro-
inflammatory regulatory roles (miR-155, miR-106a and IL6) and decreased expression 
of miRs with anti-inflammatory roles (including let-7e, miR-146a and SOCS1). Overall, 
it was expected that preterm delivery would be associated with a pro-inflammatory 
phenotype driven by perturbed networks of innate immune gene regulation. 
The data presented in this thesis suggest the TLR signalling system is immature in early 
preterm neonates compared to late preterm and term neonates, where: 
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1. the association between regulatory miRs and their target mRNAs is not mature 
in the preterm placenta, which may create a predisposition towards uncontrolled 
inflammation in utero;  
2. early preterm cord blood shows decreased expression of regulatory miRs (let-7e 
and miR-155) compared to late preterm and term cord blood, which suggests a 
predisposition towards unregulated expression of their targets (TLR4 and 
SOCS1) during inflammation; 
3. TLR2 and 4 stimulation increases the expression of pro-inflammatory genes, 
including IL6 and NF-κB1 in early preterm cord blood without any change in 
regulatory miR expression, demonstrating a bias towards pro-inflammatory 
mediators during a response; 
4. following TLR4 stimulation, preterm cord blood increases IL6 production 
between 6 and 24 hours in vitro following TLR stimulation without any change 
in regulatory miR expression, while term cord blood IL6 expression peaks and 
plateaus at 6 hours; and 
5. preterm neonates with infection show an upregulation in inflammatory 
signalling pathways compared to term neonates with infection, providing in vivo 
evidence of a pro-inflammatory bias potentially associated with neutrophil 
dysfunction.  
8.2.1. Investigating the placenta as a window into the in utero environment 
Placental gene expression of TLR pathways was characterised to assess the phenotype 
of the intrauterine environment. Preterm delivery is most commonly associated with 
intrauterine inflammation10-13. Evidence of this is observed where chorioamnionitis is 
associated with increased TLR4428 and NF-κB1486 expression in the preterm placenta. 
The increased activation of inflammatory pathways in utero has been demonstrated to 
have profound effects on postnatal immune function in neonates. Animal models have 
shown that antenatal exposure to endotoxin attenuates the progeny’s subsequent 
responses to endotoxin ex utero101-104.  Our analysis was therefore aimed at determining 
whether the neonate was exposed to an active inflammatory milieu in utero.  
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8.2.2. Investigating cord blood as an analogue for neonatal immune 
function 
In addition to placenta, cord blood provides a snapshot of the in utero environment at 
delivery and neonatal immune status at birth. A majority of existing in vitro studies on 
cord blood have used isolated cells and have shown preterm CBMCs are less capable of 
mounting a cytokine response than term (Table 1.2). A strength of studying whole cord 
blood is that it accounts for interactions that more accurately reflect the in vivo immune 
response. Whole blood immune responses consist of a variety of cell-to-cell 
interactions, platelet activating factors and even unique cellular metabolism. 
Additionally, cells cultured in whole blood do not alter their phenotype as significantly 
as isolated cells over time in vitro62. Previous work within our laboratory has 
demonstrated an absence of time and dose-dependent changes in response to TLR4 
stimulation in CBMCs in vitro153. These findings contrast the time-dependent 
upregulation of IL6 and TNFα production by whole cord blood exposed to the same 
treatments in vitro (Chapter 6). The interaction between cells and/or plasma-based 
factors likely contributes to this robust response and is therefore a better reflection of 
the in vivo immune context. 
8.3. THE EFFECT OF GESTATIONAL AGE ON GENES 
ASSOCIATED WITH TLR SIGNALLING IN THE PLACENTA 
Chapter 3 profiled the expression of TLR associated genes in placental tissue from term 
and preterm deliveries. It was hypothesised the preterm placenta would demonstrate 
increased expression of pro-inflammatory genes due to sequelae commonly associated 
with preterm delivery10-13,14. Using murine models, others have demonstrated that 
preterm delivery is associated with increased TLR4 signalling in utero418. This suggests 
the placenta responds differently to inflammatory activation according to gestational 
age. Notably, our findings did not observe any differences in constitutive miR 
expression or inflammatory TLR expression between gestational age groups. We did, 
however, find the lack of a correlation between the miRs and their mRNA targets, 
which could suggest the way these genes interact with each other (i.e. their regulatory 
relationship) is immature in the preterm placenta, as these correlations were evident in 
term placenta. Ultimately, our assessment of total placental cell populations is better 
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reflective of the in utero environment and supports comparable expression of genes 
associated with TLR signalling according to gestational age at birth.  
While the current study focused on the status of the TLR signalling pathway at birth, 
responses to TLR stimulation may provide closer insight into immune regulation. 
Increased TLR signalling418 and IUI10, 11 are common sequelae to preterm parturition. 
Increased TLR expression by trophoblasts has also been observed in vitro following 
stimulation with TLR agonists427, 487, 488 and ex vivo, in association with 
chorioamnionitis428, 486. These studies demonstrate the role of the placenta as an 
immunomodulatory organ that can respond to different pathogens. The lack of 
differentially expressed miRs observed by our findings may therefore be due to the 
absence of inflammatory activation at birth in our sample. In vitro stimulation of 
placental explants is likely required to confirm any regulatory dysfunction in 
relationships between miRs and their targets as postulated by our correlational analyses. 
8.3. THE EFFECT OF GESTATIONAL AGE ON BASELINE 
EXPRESSION OF GENES ASSOCIATED WITH TLR SIGNALLING IN 
CORD BLOOD 
The aim of Chapter 4 was to compare the expression of inflammatory genes involved in 
TLR signalling in term, late preterm and early preterm unstimulated whole cord blood 
to understand the immune status of neonates at delivery. Previous studies have found 
comparable TLR mRNA and protein expression in cord blood according to gestational 
age82, 86. While our data confirmed that term and late preterm cord blood showed 
comparable expression of genes associated with TLR signalling, early preterm cord 
blood expressed decreased let-7e and miR-155. These miRs have opposing roles in 
regulating inflammation, so their simultaneous decrease may suggest more global 
immaturity of coordinated regulatory function. This could underlie the lack of any 
observed difference in the expression of their respective target genes, TLR4 and SOCS1. 
Further, the fact that miRs with opposing roles are both downregulated could suggest 
network level perturbations in inflammation, particularly because miR expression did 
not change with TLR stimulation in early preterm cord blood (Chapter 5). Previous 
studies have associated decreased miR expression with decreased expression of the 
processing molecule, Dicer in neonates who develop severe RSV455. Our data could 
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therefore reflect an absence of regulatory miR expression in preterm cord blood due to 
immature transcript processing. 
8.4. THE EFFECT OF GESTATIONAL AGE ON INNATE IMMUNE 
FUNCTION AND REGULATION 
In Chapter 5, we aimed to compare the expression of genes following TLR stimulation 
in term, late preterm and early preterm cord blood. We hypothesised that preterm cord 
blood would show increased pro-inflammatory and decreased anti-inflammatory gene 
expression compared to term cord blood stimulated with TLR agonists.  
We demonstrated that TLR2 and TLR4 stimulation increased regulatory miRs (let-7e, 
miR-155 and miR-106a) and pro-inflammatory IL6 expression in term cord blood. This 
supports miRs contribute to inflammatory regulation, which is critical for neonates in 
their adaptation to the ex utero environment. Term cord blood has previously been 
shown to increase miR-146a expression 24 hours following LPS stimulation, exceeding 
that of adult peripheral blood242. In a murine model of intestinal inflammation 
(exposure to E. coli), miR-146a upregulation was established as a critical factor for 
developing enteric tolerance in the neonatal intestine. The inhibition of miR-146a in this 
model was associated with increased intestinal epithelial cell apoptosis induced by E. 
coli, which is a characteristic feature of NEC in human infants. The lack of miR-146a or 
any change in expression of other miRs measured following TLR stimulation by early 
preterm cord blood may contribute to an inability to regulate inflammation and 
therefore, a decreased ability to develop immune tolerance to the ex utero environment.  
A majority of existing studies suggest preterm cord blood demonstrates attenuated 
responses to immune stimulation in vitro. These studies have observed decreased 
immune cell counts284 and impaired pathogen killing capacity in preterm blood283. In 
vitro studies have also shown decreased IL6 and TNFα expression without any change 
in IL10 in preterm compared to term cord blood in response to stimulation with TLR 
agonists35, 213, 288 and whole bacteria82, 252, 294. Recent data from our laboratory 
somewhat disagrees with these findings, demonstrating increased IL6 and no change in 
IL10 following TLR2 and 4 stimulation153. The disparity between these findings may be 
related to methodology, where previous authors compared gene expression between 
gestational age groups, but did not investigate the kinetics or change in the response 
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within gestational age groups. In further support of our postulated pro-inflammatory 
preterm phenotype, meta-analyses have shown that umbilical cord blood tissue from 
early preterm deliveries demonstrates a transcriptome reminiscent of FIRS286. This 
predisposition towards a pro-inflammatory bias may therefore explain increased 
expression of IL6 (that can be used to confirm FIRS489) and could also contribute to 
systemic inflammation by preterm neonates.  
Responses to TLR stimulation in late preterm cord blood showed a similar pattern of 
gene expression to that observed in term cord blood. TLR expression itself was also 
comparable between the gestational age groups, however, let-7e and SOCS1 were 
increased in late preterm following TLR stimulation, but not early preterm cord blood. 
This suggests a switch in maturation of these pathways could occur at around 32 weeks 
gestation.  
IL10 expression is thought to be inversely correlated with gestational age in cord blood 
responding to whole bacteria204, however we found IL10 expression was comparable 
between term and preterm placenta and cord blood, and did not change with cord blood 
TLR stimulation. Notably, however, we observed an increase in its regulator miR-106a 
following LPS stimulation of term cord blood. This suggests changes in IL10 
expression occur later during the neonatal response to TLR agonists. Further 
characterisation of IL10 is critical, as it has been shown to decrease up to 20% of genes 
associated with the body’s response to LPS490. This may be apparent in the case of other 
instances of in utero inflammation, as our analysis observed an interaction between 
increased IL10 expression and maternal smoking during pregnancy in cord blood and 
placenta. Notably, our bioinformatics has preliminarily suggested that IL10 is 
predominantly expressed by macrophages, at least in adults. This may again highlight 
the possibility of cell-specific functional deficits in cord blood. 
Despite a lack of change in miR expression following TLR2 and 4 stimulation, early 
preterm cord blood upregulated expression of the inflammatory genes NF-κB1 and IL6. 
Although NF-κB is a super-enhancer of pro-inflammatory gene expression, its p50 
subunit expression was only associated with miR-155 expression in term and not early 
preterm cord blood. The underlying mechanism for decreased miR expression in early 
preterm cord blood remains unclear and could be related to a dysfunction or absence of 
the miR-processing complex, Dicer. Overall, this thesis has demonstrated that early 
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preterm neonates are able to respond robustly to TLR stimulation through cytokine 
expression, but the absence of miR expression may mean that this is not regulated 
sufficiently, resulting in inadequate clearance of pathogens and/ or continuous 
inflammatory signalling.  
8.5. TEMPORAL RESPONSES TO IMMUNE REGULATION 
ACCORDING TO GESTATIONAL AGE 
In Chapter 5, we observed the lack of an association between regulatory miR expression 
and inflammatory genes in early preterm cord blood. Chapter 6 therefore aimed to 
identify whether these differences resulted in different temporal responses between 
gestational age groups. Specifically, we characterised gene expression following a 
resting period and at 2 and 6 hours after TLR stimulation in vitro. As no other studies 
have assessed this, we chose to examine a time point prior to the 6 hours (i.e. 2 hours), 
and one after the 6 hours (i.e. 24 hours). These time points correlate with NF-κB 
inhibition469 and a respective decrease in TNFα in vitro323. Again, we expected that 
preterm cord blood would increase pro-inflammatory and decrease anti-inflammatory 
gene expression over time following TLR stimulation.  
Our study found that gene expression did not appear to change over time, irrespectively 
of gestational age. However, term cord blood showed increased TNFα and IL6 protein 
production until 6 hours following TLR2 and 4 stimulation, when it plateaued. In 
contrast, preterm cord blood increased TNFα production until 6 hours following TLR 
stimulation and continued to increase IL6 production between 6 and 24 hours in vitro. 
The lack of time-sensitive mRNA or miR expression in response to TLR stimulation in 
preterm cord blood despite continued IL6 production, could indicate poor regulatory 
responsiveness by preterm neonates. 
These findings suggest IL6 may be uncontrollably upregulated, particularly because the 
miRs we assessed were not expressed in early preterm cord blood despite being 
upregulated in term cord blood following TLR stimulation by 6 hours. The regulation of 
IL6 is important because it is a systemic acting cytokine commonly associated with 
acute and chronic inflammatory disease. It also recruits mononuclear cells, stimulates 
endothelial cells and inhibits T cell apoptosis491. More notably, IL6 can breach the 
blood brain barrier during systemic inflammation to cause white matter injury during 
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NEC492, 493. The consequences of dysregulated IL6 signalling are therefore critical in the 
context of preterm neonatal immunology. 
TLR signalling is a time-dependent process that involves the gradual recruitment of 
adaptor molecules to result in the transcription of pro-inflammatory genes through NF-
κB or AP-1. Each stage of molecular recruitment provides a unique checkpoint for 
regulation. The progression of molecule recruitment, cytokine gene transcription and 
translation all occur at different times during an inflammatory response. The expression 
of miRs in the TLR signalling cascade therefore changes across time. For example, LPS 
increases miR-146a in cord blood between 12 and 24 hours following LPS exposure in 
vitro, but not before 12 hours242. Unfortunately, we were unable to validate miR 
expression following 6 hours TLR stimulation due to decreased RNA integrity after this 
time point. However, given that IL6 was significantly increased following stimulation 
in preterm cord blood compared to term between 6 and 24 hours, it may be possible that 
differences in miR expression become evident at later than 6 hours. Future studies 
should address optimal culture conditions that can enable this to be investigated further, 
potentially using isolated cell populations as we were unable to pursue this with our 
limited blood volumes.  
MiRs are ‘globally stable’, with a half-life ranging between 28-220 hours in vitro in 
immortalised murine embryonic fibroblasts or 8 hours in human Tcell lines, with 
corresponding mRNA transcripts showing a half-life of 20 hours in the same context494. 
Notably, the stability of miRs is context-specific where miR-21 and miR-223 are 
degraded after 3 hours in whole blood at room temperature, but remain stable for up to 
24 hours in serum at room temperature495. Additionally, LPS challenge decreases the 
stability of miR-21 in murine embryonic fibroblasts between 10 and 20 hours following 
challenge in vitro494. Unfortunately, there is a paucity of data available regarding the 
stability of transcripts of the miRs we measured in cord blood in vitro. The only study 
to date that has investigated miRs used CBMCs in vitro242, which likely enhanced cell 
and therefore, miR transcript survival. 
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8.6. NETWORKS OF GENES AFFECTED BY IMMUNE 
REGULATION ACCORDING TO GESTATIONAL AGE 
This thesis primarily investigated miR expression in whole blood following TLR 
stimulation. A limitation of Chapters 4-6 was the inability to assess the context of the 
select genes investigated or the contributions of individual cell types generating an 
immune response. The nature of assessing cord blood from very preterm neonates 
means that cell separation was not a viable option to generate sufficient RNA for 
analysis. Bioinformatics, however, can be informative in directing research and 
identifying likely pathways and cell types responsible for the effects we observed. This 
was the focus of Chapter 7, where we analysed the TLR signalling pathway in context 
of transcriptomic data generated by microarrays from peripheral neonatal blood during 
infection.  
Bioinformatics is utilised to identify critical pathways that are implicated in biological 
processes such as inflammation. This is critical to consider when examining miRs, as 
they can regulate entire networks of genes such that alterations in one miR can alter a 
whole system. Peripheral blood from preterm neonates with infection upregulated 
innate immune pathways including TLR, NLR and STAT-based signalling compared to 
term neonates with infection. Again, these findings highlight the potential bias towards 
pro-inflammatory signalling by preterm neonates, particularly because IL6 activates 
STAT1 and therefore, the increased expression of IL6 by preterm cord blood could 
perpetuate inflammation in more ways than originally thought.  
The model of innate immune activation that has been used in the preceding chapters of 
this thesis used whole cord blood, however identifying the source of cytokine 
expression may be critical to understanding the direction of inflammation. For example, 
if antigen-presenting cells show attenuated gene expression, it is likely to have flow-on 
effects with regards to attenuated adaptive immune development. Previous findings 
from our laboratory have shown CBMCs are unable to produce a dose or time-
dependent response to TLR stimulation in vitro, therefore we postulate that cell to cell 
interactions are critical in analysing the neonatal immune system. To understand the 
individual contribution of cells to gene expression and cytokine production in TLR 
signalling, we investigated cell-specific expression using publicly available data 
collected from healthy adults. We identified that neutrophils upregulated NF-κB-related 
Chapter 8: 
General Discussion  Page 238 
signalling genes more than mononuclear cell types (including adaptive immune cells, 
monocytes and macrophages). Further, preterm neonates with infection increased IL8 in 
comparison to term despite exhibiting neutropenia. IL8 is key for neutrophil chemotaxis 
and its aberrant expression can lead to immune cell accumulation. We therefore 
postulate that a reliance on neutrophil-driven inflammation may predispose neonates to 
inflammatory diseases such as CLD that are characterised by neutrophil 
accumulation222.  
Online databases of gene expression have demonstrated the promiscuous nature of 
miRs, where miR-155, for example, has 918 putative gene targets496. Others have 
reported 85 miRs and 41 genes associated with TLR signalling that are differentially 
expressed in cord blood leukocytes stimulated with LPS compared to and unstimulated 
leukocytes497, although this data was not publicly available for our consideration. The 
contribution of miRs to TLR signalling is therefore quite complex. As such, miR-155, is 
not only associated with increased NF-κB activation, but is also increased with STAT1 
activation, as the miR-155 promoter region shows putative STAT1 binding elements498. 
Further, SOCS1, which is also downregulated by miR-155, inhibits STAT activation. 
This supports the role of miR-155 as a master regulator of the innate immune response. 
Interestingly, miR-155 has been identified as a top upstream miR in peripheral blood 
from preterm neonates who are exposed to chorioamnionitis but did not develop 
postnatal infections, compared to those who did (where miR-155 was not identified)390. 
This could suggest the existence of a unique preterm phenotype that is unable to mount 
miR-based responses to inflammation and is therefore more susceptible to infection and 
increased pro-inflammatory gene expression. Future microarray analyses of neonatal 
blood with and without TLR stimulation will be important in separating the effects of 
decreased miR expression we observed in Chapters 4-6.  
8.7. HOW MATERNAL PHYSIOLOGY CONTRIBUTES TO 
NEONATAL INNATE IMMUNITY 
Maternal physiology impacts on the neonatal immune response as a product of immune 
priming in utero. Physiological insults that occur during pregnancy contribute 
differently to fetal physiology. Others have shown that pre-eclampsia is associated with 
increased Th1 cytokine expression in utero499 and increased cord blood IL8 and IL10 
expression500. Additionally, maternal smoking during pregnancy has been associated 
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with decreased TNFα and IL6 production following TLR2 stimulation of term cord 
blood in vitro162. The impact of pre-eclampsia or maternal smoking are not clearly 
characterised in preterm cord blood, though their effects could compound immature 
inflammatory regulation. Our analyses therefore incorporated the effects antenatal 
exposure to betamethasone, labour, pre-eclampsia, maternal smoking during pregnancy 
and chorioamnionitis into a statistical model. It was hypothesised that typically pro-
inflammatory perturbations such as pre-eclampsia, labour, chorioamnionitis and 
maternal smoking would contribute to a pro-inflammatory cord blood profile, while 
antenatal betamethasone would have anti-inflammatory effects due to its 
immunosuppressive properties452.   
Notably, the factors we investigated as covariates within our analysis may have unique 
‘magnitudes’ of inflammatory influence. For example, pre-eclampsia typically develops 
later in gestation, meaning the fetus is not exposed to its associated inflammatory 
signalling for the entire duration of pregnancy. Maternal infection or chorioamnionitis 
are likely to be acute and present towards the end of pregnancy, as they induce labour 
or are indications for premature delivery10-13. Alternately, maternal smoking during 
pregnancy is a chronic exposure as it occurs prior to and for the entire duration of 
gestation. Maternal cigarette smoking during pregnancy is also associated with poor 
perinatal outcomes including preterm delivery14, growth restriction155 and an increased 
risk of childhood atopy501 and asthma502. Smoking creates this pro-inflammatory in 
utero environment through ROS production and cellular apoptosis in the placenta163, 433. 
Therefore, it may shape neonatal immunity in a similar way to chronic infection. 
In the placenta, maternal smoking was associated with decreased regulatory let-7e 
expression alongside increased inflammatory TLR2, SOCS1, MyD88, IRAK1, NF-κB1, 
IL6 and IL10 (Chapter 3). This corroborates with a study that found a dose-dependent 
decrease in miR-146a expression in immortalised villous and extra-villous trophoblast 
cell lines cultured with nicotine and benzo(a)pyrene, which are the main constituents of 
cigarette smoke434. Similarly, our analysis of cord blood at birth showed decreased miR-
146b and increased all genes associated with TLR signalling (Chapter 4). Following 
TLR-stimulation, however, cord blood gene expression showed no interaction with 
maternal smoking in the context of our analysis. Notably, others have previously 
demonstrated decreased TNFα expression in response to TLR2, 3,4 stimulation in vitro 
and decreased IL6 in response to TLR2 stimulation in term cord blood from mothers 
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who smoked during pregnancy162. This suggests cord blood becomes hypo-responsive 
after being exposed to a pro-inflammatory in utero environment, however, postnatal 
immunity of these offspring is associated with a hypersensitive Th2 response503 and 
atopic or respiratory disease163, 504. Overall, while our analyses were independent of 
gestational age, all of these findings demonstrate some form of maladaptive immune 
regulation. Future studies should investigate maternal smoking as a sub-phenotype of 
preterm delivery in the context of neonatal TLR function in order to separate these 
effects.  
This thesis was unable to separate any effects of antenatal betamethasone in association 
with TLR signalling in preterm placenta or cord blood. Animal models have 
demonstrated that betamethasone exposure is associated with a state of 
immunosuppression by the neonate that is marked by decreased lymphocyte 
expression196 and decreased TNFα and IL1β expression following LPS challenge106. In 
vitro studies also show cord blood decreases pro-inflammatory cytokine expression in 
response to viral stimulation165 and inhibits neutrophil chemotaxis during LPS 
stimulation189. miR-155, which is normally decreased by glucocorticoid exposure in cell 
lines stimulated by LPS in vitro191, was therefore expected to decrease inflammatory 
pathways in cord blood consistent with immune suppression. Nonetheless, we were 
unable to discern such an effect. A follow-up study with larger numbers of preterm 
neonates without betamethasone exposure stratified according to gestational age at 
delivery may be ideal to separate this. Notably, such a cohort would be difficult to 
obtain given preterm deliveries without betamethasone exposure are more likely to 
occur spontaneously505. Overall, the impact of glucocorticoid exposure should be 
explored further as it could be an underlying contributor to our current findings. 
8.8. LIMITATIONS OF OUR FINDINGS 
As the field of neonatal miR regulation is in its infancy, the current findings are highly 
valuable, but represent only the early stages of such research. While other methods such 
as microarrays are able to characterise larger volumes of transcriptomic data, we 
specifically chose to investigate genes within the TLR signalling pathway as we could 
easily validate them using qPCR to determine how they change with TLR stimulation in 
vitro. Our findings could be expanded upon by focusing on more targets within the TLR 
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signalling pathway or using specific vectors or murine models to knockdown miR 
expression in vitro to confirm the expression of targets we investigated. 
Factors such as smoking, pre-eclampsia and antenatal betamethasone exposure can 
affect gene expression and although we adjusted for these in the analyses, we could not 
separate their effects within our sample. Future work is therefore required to stratify 
each of these factors and their influence on the preterm neonatal immune phenotype. 
Notably, a strength of the samples analysed by this thesis was that the recruited cohort 
was largely unexposed to maternal infection, which enabled us to identify TLR function 
more as a product of prematurity rather than exposure to inflammation in utero.  
The experimental chapters of this thesis have focused on whole cord blood as an 
analogue for neonatal immune function. While this strategy has many strengths, it 
provided limited insight into individual cell-types’ function or how their frequency may 
contribute to an inflammatory response. This may be particularly important, as our 
bioinformatics analysis suggested neutrophils may play a central role in dysregulated 
innate immunity. In this case it would have been useful to deem differential cell counts 
either from clinical testing or within the laboratory using flow cytometry analyses.  
8.9. THE ROLE OF INNATE IMMUNITY IN THE PRETERM 
NEONATE 
Preterm delivery occurs most commonly as a product of inflammation. Under these 
conditions, preterm birth may be an attempt by the fetus to escape adverse in utero 
conditions (such as intrauterine inflammation) to enhance chances of survival 
(Fig.8.1A, B). Preterm delivery exposes the neonate to an antigen-rich ex utero 
environment at a time when mechanisms of immune regulation may not be fully 
developed. A consequence of early parturition is therefore the increased risk of 
infection and inflammation. This thesis has highlighted early preterm neonates show a 
diminished capacity to regulate inflammation through the actions of miRs, which 
appears to be mature in term neonates. This included decreased let-7e and miR-155 
expression by early preterm neonates, which could indicate a primed state for 
inflammatory dysregulation (Fig.8.1C, D). As such, following TLR stimulation we 
postulate this culminates in increased expression of inflammatory genes (i.e. NF-κB1 
and IL6) without any change in regulatory miRs (Fig.8.1E). Conversely, late preterm 
Chapter 8: 
General Discussion  Page 242 
neonates increased regulatory genes such as let-7e and SOCS1 alongside pro-
inflammatory genes and showed a phenotype that was more similar to term neonates 
who increased let-7e, miR-155 and miR-106a on TLR stimulation. These experimental 
scenarios suggest that term neonates are able to return to immune homeostasis 
following inflammatory activation, while preterm neonates continue to upregulate 
inflammatory pathways, as reinforced by our time course analysis (Fig.8.1F).  
 
Fig 8.1. A theoretical representation of TLR signalling by the fetus/ neonate during 
gestation and following term, late preterm and early preterm delivery. Early preterm 
neonates are a most commonly a product of an inflammatory in utero environment from 
earlier during gestation (A) than late preterm neonates (B), which results in premature 
delivery. At birth, early preterm neonates show evidence of poor regulatory capacity 
(C) that becomes apparent during their adaptation to the ex utero environment (D). On 
immune challenge, early preterm neonates are unable to regulate inflammatory 
signalling, such that it becomes aberrant (E). Late preterm neonates show an ex utero 
response to immune challenge similar to term cord blood, suggesting a more mature 
system that shows some evidence of regulatory gene expression in vitro. Term fetuses 
typically encounter inflammation during labouring delivery and are born in an immune-
tolerant state, showing increased regulatory miR expression compared to early preterm 
neonates (C). Following immune challenge ex utero, they are able to downregulate 
inflammatory signalling appropriately, unlike early preterm neonates that perpetuate 
inflammatory signalling that may predispose them to inflammatory conditions (F).  
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Preterm neonates are born in a state where immune cell numbers, cell function and miR 
expression is mitigated, contributing to increased vulnerability to pathogen 
colonisation. Following immune challenge, they become hyper-responsive and 
inflammatory signalling exceeds that seen in late preterm and term neonates. Late 
preterm neonates are more likely a product of indicated delivery (such as pre-eclampsia 
or growth restriction) or intrauterine inflammation occurring later during gestation7. 
Late preterm neonates demonstrate a miR and mRNA profile of TLR-associated gene 
expression that was similar to term neonates. This indicates the timing of a maturational 
switch in TLR signalling pathways occurs later in gestation allowing for more effective 
inflammatory regulation. 
8.9.1. A PROPOSED MODEL FOR OUR FINDINGS 
The in utero environment preceding preterm delivery may include adverse exposures to 
inflammation, labour, maternal health (e.g. pre-eclampsia) or maternal health 
behaviours during pregnancy (e.g. maternal smoking) (Fig. 8.2.A). This thesis has 
demonstrated that at delivery, the early preterm neonate shows decreased expression of 
regulatory miRs, with no difference in cytokine expression compared to the term 
neonate (Fig. 8.2.B). Following exposure to an inflammatory stimulus, this appears to 
culminate in the dysregulation of inflammatory gene networks, such that inflammatory 
genes TLR4, IL6, IL10 and NF-κB1 are increased and IL6 production therefore exceeds 
that of the term neonate (Fig. 8.2.C). This is evidence of a hyper-responsive state 
following birth that predisposes preterm neonates to uncontrolled inflammation. An 
inability to regulate inflammation may predispose preterm neonates to acute and/ or 
systemic responses characteristic of morbidities such as NEC, PVL, neonatal sepsis, 
CLD and ROP (Fig. 8.2.D).  
Over page: Fig. 8.2. A proposed model for the development of inflammatory 
morbidities in preterm neonates. Early preterm neonates are exposed to a pro-
inflammatory in utero environment (A) and show decreased regulatory miR expression 
at birth (B). On exposure to inflammatory stimuli ex utero (when they are prone to 
contracting infections), their pre-existing dysregulated inflammatory gene networks 
upregulate pro-inflammatory genes without increasing regulatory genes (C). Preterm 
neonates that develop infections are prone to developing acute and/ or systemic 
inflammation that commonly results in the development of morbidities such as PVL, 
ROP, neonatal sepsis, CLD and NEC (D). Images presented in this figure are self-
illustrated or courtesy of open source designs (http://www.servier.com/Powerpoint-
image-bank).  
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Fig. 8.2. A proposed model for the development of inflammatory morbidities in 
preterm neonates. 
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8.10. FUTURE RESEARCH 
The current understanding of cord blood miR expression and its role in innate immunity 
in preterm and term infants remains in its infancy. This field of research still has great 
potential in informing the clinical management of preterm neonates. TLR signalling is 
critical to innate immune function and neonatal immunity overall. While miRs have 
considerable influence on the neonatal immune phenotype, there is still scope for 
investigation into other inflammatory pathways from signalling networks to cell-
specific signalling.  
Based on the limitations of this thesis, future studies could involve GWAS to identify 
perturbations involving other miRs or networks of expression associated with 
inflammation in preterm neonates. This could lead to the identification of phenotypes 
that are more susceptible to disease and therefore, direct prophylactic interventions or 
changes in clinical management. Further, microarrays could be conducted on samples 
of neonatal peripheral blood similar to our cohort (i.e. in isolation of infection) that are 
stimulated with LPS in vitro to determine the upregulation or perturbation of specific 
pathways or gene clusters that may contribute to uncontrolled inflammatory signalling 
in early preterm cord blood compared to late preterm and term. Although neonatal 
outcomes cannot necessarily be predicted using in vitro stimulation studies, larger scale 
investigations looking for key miRs that were characterised by this thesis (specifically, 
miR-155 and let-7e) could be used in conjunction with microarray data as proposed in 
Chapter 7, to assess their value (sensitivity and specificity) as diagnostic or prognostic 
tools. This research could lead to diagnostic advances such as establishing 
transcriptomic fingerprints and even sub-analyses for separating risk factors such as 
maternal smoking during pregnancy. Overall, such tools may be used clinically for 
prophylactic management (e.g. the use of probiotics) or to develop novel management 
strategies (e.g. to boost regulatory miR expression). 
On a more specific scale, identifying underlying factors that contribute to aberrant 
inflammatory signalling by immune cells is also necessary. This could include the use 
of murine or cell-line knockdown models that are valuable for isolating the function of 
specific molecules or pathways. Small interfering RNAs (siRNAs) can be used in vitro 
to silence mRNA translation. Therefore, introducing them to isolated cord blood cell 
populations during TLR stimulation would help isolate the precise mechanism for the 
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lack of miR expression in preterm cord blood observed by this thesis. For example, 
silencing TLR2 or TLR4 would support our investigation of the TLR signalling cascade 
as a primary contributor to uncontrolled IL6 production in preterm cord blood. Further, 
investigation into Dicer expression in cord blood and how it might affect early preterm 
miR expression could be the underlying mechanism that requires confirmation in this 
experimental model.  
We were also unable to confirm the contribution of different cell types to the preterm 
inflammatory response in vitro, which may reveal particular dysfunctional aspects of 
innate immunity. The use of flow cytometry to characterise cell-specific gene 
expression could therefore confirm our theory from Chapter 7, where we found that 
adult neutrophils were key producers of NF-κB-related genes. To date, the analysis of 
neonatal neutrophils is sparsely characterised, though they show comparable phagocytic 
function across gestational age454. Overall, neonatal neutrophil characterisation is 
therefore a key area for further research, particularly because neutropenia is associated 
with neonatal sepsis.  
Although we chose to focus on neonatal outcomes rather than the aetiology of preterm 
birth, maternal physiology is clearly an important influence on the neonatal immune 
system. Increased maternal CRP, IL6506 and IL1β507 have been proposed as predictors 
for preterm delivery in amniotic fluid and maternal blood. As a majority of deliveries in 
our cohort were not exposed to infection or PPROM, data on maternal CRP levels were 
not consistently available from clinical records. Future studies could incorporate these 
parameters and also, the expression of miRs in maternal serum to trace the effect of 
immune regulation and relate it to the neonatal system. In fact, others have associated 
specific patterns of miR expression in maternal serum with poor pregnancy outcomes, 
and recommended the use of these targets as diagnostic tools (for review see508).  
Clinical research is also important for investigating evidence of uncontrolled 
inflammation and managing it. Currently, the management of chronic or acute 
inflammation in preterm neonates (including sepsis), involves the use of antibiotics and 
immunomodulation therapy509. However, there remain complex obstacles between the 
translation of scientific findings and clinical outcomes. Altering cytokine 
concentrations, such as GMCSF supplementation to improve neutropenia in septic 
preterm neonates, has not been effective to date218. This may be because while early 
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preterm neonates can produce cytokines (as reinforced by this thesis), they show an 
inability to regulate their production temporally. Our data hereby highlights the need to 
manage preterm neonates’ immune dysregulation. Therefore, therapies that promote 
immune regulation and as such, the tolerance of commensal bacteria may be ideal. This 
could include breastmilk supplementation or the administration of antibodies that 
neutralise IL6 overexpression. 
The clinical management of preterm neonates is challenging. It is not feasible to 
completely inhibit pro-inflammatory cytokines or increase regulatory miRs, because 
they have ubiquitous roles in physiology and are simultaneously involved in unique 
networks of genes. Immunomodulating therapies such as Tocilizumab, which is a 
monoclonal antibody for IL6 receptor, have been trialled in the context of juvenile 
arthritis to reduce disease severity510. While it has been shown to decrease non-specific 
markers of inflammation such as CRP, Tocilizumab is associated with neutropenia and 
infection. Immune mediators such as Pentoxifylline are already used in the NICU to 
inhibit inflammatory signalling by TNFα and IL1 and decrease oxidative stress during 
neonatal sepsis and NEC509. Therapies involving miRs are yet to be trialled clinically, 
however, supplements such as curcumin are shown to decrease miR-155 in mice and 
protect against sepsis and tissue damage during acute LPS-driven inflammation in this 
model511. Overall, the systemic nature of miR signalling means they may be better used 
as a diagnostic tool rather than a therapeutic target, at least with our current level of 
understanding. 
8.11. SUMMARY 
Preterm neonates are susceptible to adverse health outcomes, a majority of which are 
associated with inflammatory conditions. Notably, preterm blood shows lower 
leukocyte counts, attenuated intracellular killing capacity and decreased pro-
inflammatory cytokine expression following immune stimulation in vitro compared to 
term blood. To date, studies have been unable to explain how such immune attenuation 
is associated with aberrant inflammation in preterm neonates. This thesis therefore 
aimed to characterise inflammatory gene expression and its regulation by miRs in the 
context of TLR stimulation. We demonstrated that inflammation in early preterm cord 
blood was not associated with any change in miR expression, but continued to increase 
pro-inflammatory gene expression. These findings reflect a poorly regulated, hyper-
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responsive immune phenotype that could underlie preterm neonates’ susceptibility 
towards developing inflammatory conditions. Further characterisation of miRs and 
other pathways associated with preterm innate immune regulation is therefore critical. 
This field of research could ultimately lead to the development of diagnostic tools and 
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REAGENTS AND CONSUMABLE MATERIALS 
 
Reagent Supplier Catalogue Number 
 






200 Proof Ethanol (C2H6O) 
(RNA grade) 
Sigma-Aldrich, St Louis, 
USA 
E7023 
2-Propanol (C3H8O) Sigma-Aldrich I9516-500ML 
Agilent RNA 6000 Nano Kit Agilent Technologies, 
Santa Clara, USA 
5067-1511 
 
Albumin from Bovine Serum 
(BSA)  
Sigma-Aldrich A7906-100G 
Cellstar® Flat Bottom 96 Well 




Chloroform (CHCl3) Ajax Finechem, Taren 
Point, AU 
1888 
di-Sodium Hydrogen Phosphate 
(Na2HPO4) 
Merck KGaA 7558-79-4 
Dulbecco’s Phosphate Buffered 
Solution, no calcium, no 
magnesium  
Gibco®, Thermofisher 
Scientific, Waltham, USA 
14190235 
Human ACTB Endogenous 




Human Cytokine/ Chemokine 








Human Duo Set ELISA 
Development Systems (TNFα, 
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Reagent Supplier Catalogue Number 
 
Hydrochloric Acid (HCl)  Merck, Kilsyth, AU 1789 







Escherichia coli (LPS) 
Sigma-Aldrich L4391 
 
miRNeasy Mini Kit Qiagen, Limberg, NL 217004 
 






Sigma-Aldrich  77140-10MG 
 
Polyinosinic:polycytidylic acid 
sodium salt (γ-irradiated) 
Sigma-Aldrich P0913-10MG 






RNA 6000 Nano Kit Agilent Technologies, 
Santa Clara, USA 
5067-1511 
RNase-Free DNase Set Qiagen, Limberg, NL 79254 
 
Reinforced 2mL tubes and screw 
caps 
Sapphire Bioscience 13119-500 
Sodium Chloride (NaCl) Merck KGaA, Darmstaat, 
DE 
S3014-5KG 
SuperScript III First-Strand 
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Reagent Supplier Catalogue Number 
 
Taqman ® MicroRNA Reverse 
Transcription Kit 
Applied Biosystems 4366596 
 
Taqman ® Universal PCR 
Master Mix II, No UNG 
Applied Biosystems 4440040 
Taqman ® MicroRNA Assays Applied Biosystems 4427975 
 
Taqman® Gene Expression 
Assays 
Applied Biosystems 4331182 
 





Tris-base Amresco, Solon, USA 0497-1KG 




TRIzol®  Reagent Ambion by Life 
Technologies 
15596018 
Tween®20 viscous liquid 
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2720 Thermal Cycler Applied Biosystems Life Technologies, 
Carlsbad, USA 
Agilent 2100 Bioanalyser Agilent Technologies, Santa Clara, USA 
HERAcell 150i CO2 Incubator Thermo Fisher Scientific, Waltham, USA 
Heraeus Fresco17 Microfuge Thermo Fisher Scientific, Waltham, USA 
Heraeus Multifuge X3R Centrifuge Thermo Fisher Scientific, Waltham, USA 
Implen Nanophotometer Thermo Fisher Scientific, Waltham, USA 
Luminex®  100/200 System Luminex Corporation, Austin, USA 
Multiskan EX Plate Reader Thermo Fisher Scientific, Waltham, USA 
pH510 pH/mV/°C meter Eutech Instruments, Thermo Fisher 
Scientific, Waltham, USA 
Precellys 24 Tissue Homogeniser Bertin Technologies, Montigny, FR 
QuantStudio 12K Flex Applied Biosystems by Life 
Technologies, Carlsbad, USA 
 
 
 
